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Micro-reactors are becoming increasingly popular as a high throughput tool 
for the optimization of chemical reactions. This is due to the fact that parallel 
screening of variables can be achieved with a minimal amount of reagents and 
precise control of the variables. In order to be useful as a tool for rapid 
screening of different variables, immobilization of catalysts is a prerequisite. 
In this study, immobilization of chemical or biological catalysts onto the inner 
wall of capillary micro-reactors to produce catalyst coated micro-reactors had 
been investigated. 
 Immobilization of palladium catalysts by the polymer encapsulation 
(incarceration) technique has been demonstrated with a glass capillary tube 
(inner diameter 2.0 mm; outer diameter 6.5 mm, length 115.0 mm). A 
polystyrene backbone polymer with crosslinkable functional groups was 
synthesized and characterized by GPC and NMR. The subsequent polymer-
encapsulated palladium which formed a coating on the inner wall of the micro-
reactor was characterized using TEM. This catalyst coated micro-reactor was 
used for the direct synthesis of hydrogen peroxide from the elements. It was 
found that optimization of the reaction conditions (solvent system, flow rates, 
ratios of substrates, etc.) can be done in a very short period of time. In addition, 
the reactor showed good stability over several days of continuous operation 
with minimal leaching of the catalyst.  
 The use of whole cells of recombinant E. coli over-expressing LbADH 
in the synthesis of chiral alcohols was examined. Various reaction conditions 
such as temperature, pH and substrate acceptance were tested. It was found 
that the recombinant E. coli was able to convert a number of pro-chiral keto-
 ix 
esters to the corresponding chiral alcohols with high conversion (94-100 %) 
and enantiomeric excess more than 99 %.   
 Further exploration of the immobilization of recombinant E. coli for 
large-scale production of chiral alcohols in a continuous flow reactor was 
carried out. The recombinant cells were successfully immobilized using 
alginate as immobilization matrix. Optimization of the immobilization 
conditions was carried out with respect to concentration of the matrix polymer, 
cell loading, pH, and the effect of divalent ions in the hardening bath. Cells 
immobilized by the optimized protocol show a better stability than the free 
cells operated in a membrane reactor, and the activity of the biocatalyst is 
maintained over more cycles. The calcium alginate immobilized cells were 
packed into a plug flow reactor (inner diameter 16 mm, length 480 mm) and 
the resulting packed-bed reactor was used for the continuous bio-reduction of 
ethyl acetoacetate (EAA) to (R)-ethyl hydroxybutyrate (EHB). In this set-up, a 
space time yield of 600 gEHB• L-1•day-1 and productivity of 1.4 gEHB•gwcw-1•h-1 
has been demonstrated.  
 Subsequently, the immobilization of recombinant E. coli cells onto the 
inner wall of a fused silica capillary column (inner diameter 530 μm) was done. 
A protein-based cationic polyelectrolyte, cationized bovine serum albumin 
(cBSA), was synthesized by modifying the acid groups of the protein with 
ethylene diamine and subsequently characterized using MALDI-TOF. The E. 
coli strains commonly used for laboratory studies are specifically selected to 
be planktonic, and non-biofilm forming. We have now demonstrated that 
cBSA serves as a biocompatible adhesion promoter for the biofilm formation 
of recombinant E. coli whole cells on glass surfaces. The cBSA coated surface 
 x 
has been characterized using contact angle measurement, AFM and QCM. All 
results confirmed the strong adhesion of the cBSA to the glass surface. The 
bio-reduction of EAA to EHB in a silica capillary enzymatic micro-reactor 
under continuous process proceeded with up to 40 % higher efficiency than 
observed when the cells are immobilized in calcium-alginate beads in a 
packed bed flow reactor. Besides that, the enzymatic micro-reactor is also 
suitable to be used to determine kinetic parameters such as the Michaelis-
Menten constant.  
 The potential of cBSA as adhesion promoter for mammalian cells has 
been further explored in this study. RGD is an adhesion peptide which is 
involved in the focal adhesion of mammalian cells on surfaces. Cyclic RGDfK 
(cRGDfK) was synthesized by a solid phase approach with subsequent 
cyclization, and was grafted on the cBSA surface via isothiocyanate 
functionalization. SDS-PAGE and MALDI-TOF were used to estimate the 
number of the peptide being grafted on cBSA. The cRGDfK grafted cBSA 
was coated on glass slides by simple incubation, and the prepared surfaces 
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Chapter 1  Introduction 
Chemical manufacturers have always strived to come out with the most 
efficient processes to deliver the highest quality products with the lowest 
production cost. This objective starts from the synthetic route design to the 
production of the chemicals. During synthetic route design, chemists generally 
perform synthetic work in round-bottomed flasks which are considered as 
batch reactors, and produce milligram to gram amounts of products. These 
batch reactions have to be halted at the end of the reactions in order to retrieve 
the products. Because of this, multiple individual batch reactions have to be 
performed for optimization of the various conditions for a particular reaction. 
This makes the optimizing process very time consuming and labor intensive. 
Scaling up the optimized reactions to production can give rise to process 
safety issues which relate to mass and heat transfer of the batch reactions. 
Therefore, an alternative to mitigate the problems is to use continuous 
processes. 
 Continuous processes using flow reactors refer to processes in which 
the products are being produced continuously. Since there is no need to halt 
the reactions in order to retrieve the products, using flow reactors serves as a 
high throughput approach for optimization of the various reaction conditions. 
In addition, miniaturized versions of flow reactors, namely micro-reactors, 
enable the least amount of reagents being used during the optimization 
process, while in the production stage of the chemicals; a continuous process 
offers an efficient route in producing products in higher yield and better 
quality. At the same time, the cost of production can be lowered because of the 
reduced energy consumption and better utilization of the equipment.  
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 Despite all the advantages of continuous processes, there are still 
chemical industries operating their production using batch reactors. This is due 
to the fact that batch processes are more mature within the industries. In 
October 2007, Novartis, a healthcare company from Switzerland, announced 
that it were to invest $65 million over the next ten years to fund the research 
activities at Massachusetts Institute of Technology (MIT) on integrating 
continuous processes for pharmaceuticals productions [1]. This collaboration 
between a chemical manufacturer and a research institute shows that much 
more research work and investments are needed to replace batch processes 
with continuous processes. 
 One of the important research areas in integrating continuous processes 
for chemical production is the immobilization of catalysts.  Most chemical 
reactions require catalysts in order to speed up the reaction. The catalysts 
involved in multiple step chemical production can be either chemical catalysts 
or biological catalysts or a combination of both. A suitable immobilization 
method of the catalysts is essential to enable recycle of the catalysts within the 
flow reactors. However, different criteria have to be taken into consideration 
when dealing with immobilization of chemical and biological catalysts. Before 
discussing more on the immobilization of catalysts, the following section will 
first discuss the mode of operations of three basic types of reactors.  
  
1.1  Type of reactors 
There are three different basic types of reactors which are commonly adapted 
in chemical synthesis. These reactors are the stirred-tank reactor (STR), 
continuously operated stirred-tank reactor (CSTR) and plug-flow reactor 
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(PFR). The STR is operated batch-wise while CSTR and PFR are operated 
continuously. Figure 1-1 describes the different type of reactors and their 
mode of operations [2].  
 
 
Figure 1-1. Different types of reactors and their mode of operations (redrawn 
from [2]).  
  
 In a STR, the substrate mixture is added to a tank and mixing is 
achieved by stirring. The reaction has to be halted to retrieve the products 
from the reaction mixture. The reaction is assumed to proceed under ideal 
mixing as a function of time, and the local concentration is the same 
everywhere in the reaction volume. Substrate concentration is depleting and 
product is building up with time. This type of batch reactor is the most 
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commonly adapted reactor on scale in the pharmaceutical and fine chemicals 
industry. 
 In a CSTR, substrate mixture is continuously fed into a tank and 
product is also continuously removed from the outlet of the reactor. Mixing of 
the reaction mixture is achieved by stirring. For this type of continuously 
operated reactor, the concentrations are independent of time and place.   
 In a PFR, usually catalysts are packed within a tubular reactor and the 
substrate mixture is fed to the reactor continuously. In this case, the substrate 
solution is forced to contact with the catalyst bed by flow, therefore, no 
stirring is required. The product concentration is increasing over the length of 
the reactor and the average reaction rate is usually faster than in a CSTR. Once 
steady state operation has been reached, the concentration remains constant at 
any given location along the reactor, independent of time.  
 By knowing the different characteristics of the reactors, it is possible to 
choose an appropriate reactor for a specific application [3]. This is essential 
when dealing with reactions which are limited kinetically or 
thermodynamically. For example, if a reaction suffers from undesired 
secondary reactions which lead to low selectivity towards the desired product, 
a PFR will be a good choice in which the substrate solution is in contact with 
the catalyst bed for only a short time to prevent undesired secondary reactions 
to take place.   
 As mentioned earlier, a continuous reactor offers the possibility to 
lower the manufacturing cost since the products are continuously being 
produced without the need of halting the reaction. Besides that, micro-reactors 
which operate continuously also provide a high throughput method for 
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optimization of the reaction conditions. The following section gives details on 
the characteristics of micro-reactor which make the process intensification 
possible. 
  
1.2  Micro-reactor 
A micro-reactor is defined as a device that contains micro structured features, 
with a submillimetre dimension, in which chemical reactions are performed in 
a continuous manner [4]. The application of micro-reactors is becoming 
popular due to their advantages in performing a variety of single and 
multiphase reactions. The small dimension of the reactor allows for the use of 
minimal amounts of reagents and allows the precise control of the reaction 
variables, making parallel rapid screening of the reactions possible [5]. This 
can improve the speed of the process design and enable a wide range of 
variables to be examined without increasing the workforce [6]. To obtain 
synthetically useful amounts of material; the reactors are simply allowed to 
run for a longer period of time, the so-called “scale out” principle [7]. This 
“scale out” approach is superior in scaling up a batch reaction because the 
mass and heat transfer within all the capillaries are essentially the same and 
this helps to eliminate the safety problems associated with the scale-up for 
production in a batch reactor.  
 The intrinsic advantages of micro-reactors lies in the narrow channels 
and the small volume hold up of the reaction. The extremely small diameter 
yields efficient mass and heat transfer due to the large surface-to-volume ratio. 
Specific surface areas of microstructures lies between 10 000 and 50 000 m2m-
3, while those of traditional reactors are generally about 100 m2m-3 and in rare 
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cases reach 1000 m2m-3 [8]. The small volume also becomes very useful for 
combinatorial synthesis which is always performed on a picomolar scale. In 
the field of catalysis, coating the channel walls with catalyst gives very 
efficient catalysis [9, 10]. Currently, micro-reactors have been extensively 
used for two major purposes: analysis and synthesis [11]. In analytical 
applications, micro total analysis (μTAS) makes it possible to conduct 
complete analyses encompassing derivatization, separation and quantification 
on one chip with different channels. For synthesis, micro-reactors can be 
utilized to conduct reactions within the explosive regime [12, 13] and for the 
safe handling of highly toxic compounds [14].  
 Research on the use of continuous flow micro-reactors in synthetic 
chemistry has been reviewed in [15]. Chemicals transformations [16-19], 
specifically also fluorination reactions [20, 21], polymerase chain reaction 
(PCR) [22, 23], and the synthesis of nano-particles [24-26] using micro-
reactors have been reported. Odedra et al. reported the first example of an 
asymmetric aldol reaction catalyzed by 5-(pyrrolidin-2-yl)tetrazole which 
conducted in a micro-reactor [18]. Typical transformation using amine 
catalysts suffers from long reaction time and high catalyst loading (20-30 
mol%). However, using a micro-reactor approach, complete conversion was 
observed in 20 min with 5 mol% catalyst loading. While the same reaction in a 
flask takes 2400 min to reach completion. This result suggests a strong proof 
of the excellent mass transfer within the small channel. Chambers et al. shows 
an example of the application of micro-reactor in the safe handling of highly 
toxic fluorine gas as reactant [20]. They found that the direct fluorination of a 
range of benzaldehyde derivatives by either conventional batch or continuous 
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micro-reactor processes give mixtures of fluoroarenes and benzoyl fluoride 
products in similar ratios. This piece of work has demonstrated that the 
application of micro-reactor has greatly improved the safe handling of the 
toxic reactant and enabled the reaction to proceed in a controllable fashion. 
Taking the full advantage of the enhanced heat transfer and strengthened 
mixing in a micro-channel, Yang et al. synthesized CdSe nanocrystals using a 
capillary micro-reactor [26]. They designed the substances to pass through 
two-temperature micro-reactor and found that the approach has led to better 
control of nucleation and growth kinetic of the nano-particles. Hence, 
improved uniformity of the nano-particles was achieved. The success of these 
research works serves as a proof-of-concept of the advantages offered by 
micro-reactor as compared to conventional batch reactor. In the same time, the 





Figure 1-2. Different types of two-phase flow in a channel: (a) dispersed 
bubble flow, (b) bubble flow, (c) Taylor flow, (d) churn flow, (e) annular flow 
(redrawn from [15]). 
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 Figure 1-2 shows the different two-phase flow patterns in a small 
channel. For multi-phase application, flow patterns within the channel greatly 
affect the mass/heat transfer characteristics. In general, bubbly patterns were 
observed within the liquid phase at low gas and liquid flow rate (Figure1-2a 
and 1-2b). Increase of gas flow rate leads to the formation of a Taylor flow 
pattern (Figure 1-2c), which consists of elongated bullet shaped bubbles with 
equivalent spherical diameter usually many times that of the channel diameter, 
separated by liquid slugs. Further increase of the gas and liquid flow rate leads 
to disruption of the Taylor flow and establishment of churn flow (Figure 1-2d) 
in which chaotic oscillations and churning can be observed. In annular flow 
(Figure 1-2e), which is observed at very high gas flow rates, a thin liquid film 
flows near the wall and gas flows through the middle of the channel with fine 
liquid droplets dispersed among the gas phase. Among all these flow patterns, 
Taylor flow has been identified to give the most efficient mass transfer due to 
the thin liquid film formed near the channel wall when the channel is 
intermittently filled with gas bubbles and liquid plugs. A circulating flow is 
induced in a moving liquid slug in the presence of the stationary wall. The 
gas-liquid interface of the gas bubble is continuously refreshed, which leads to 
a superior mass transfer rate between the phases. Independent of the mode of 
pumping, the flow inside the channel network of chip-based micro-reactors is 
generally laminar and the mixing of the reagents occurs by diffusion and 
convection [16]. Given the small dimensions of the devices, diffusion is very 
efficient, and mixing is effected within milliseconds [17]. 
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1.3 Immobilization of chemical catalysts 
Chemical catalyst is almost synonymous to catalyst involving metal. 
Transition metals and their compounds are always good candidates as catalysts. 
This is mainly due to the fact that in the ionic state, they have the ability to 
change their oxidation states or, in the metallic state, they are able to adsorb 
substrates on their surfaces and activate them during the catalytic process. A 
famous example for the application of a metal catalyst is the synthesis of 
ammonia using iron metal in the Haber process. Figure 1-3 shows the 
mechanism elucidated by G. Ertl at 1983. The ability of the iron in adsorbing 
the nitrogen helps to facilitate the cleavage of the triple bond. This leads to the 
formation of surface bound nitride, followed by imine and amide, and finally 
ammonia after hydrogenation.  
 However, if solid metal is used as the catalyst, the surface area is too 
low. This greatly reduces the efficiency of the catalysis. Therefore, often time, 
the use of nano-particles of metal catalyst which can provide a large surface 
area is of interest for catalysis. In order to produce nano-particles, the metal 
catalyst can be doped on a support with large surface area such as zeolites or 
other porous metal oxides to produce highly dispersed isolated metal nano-
particles. Another technique used to prevent agglomeration of the metal 
particles is through providing a “protecting shell” to encapsulate the metal 
particle. Some of the modes of stabilization are electrostatic, steric, 
electrosteric and solvent.  
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 Figure 1-3. Ertl mechanism of iron catalysis in the Haber process (redrawn 
from [30]). 
 
 In electrostatic stabilization [31], the electrostatic repulsion formed by 
the electrical double layer around the particles will prevent the agglomeration 
of the particles. However, the polarity of the solvent can dramatically affect 
the stabilization and dispersion of the metal particles. 
 Steric stabilization makes use of polymeric materials such as poly (N-
vinyl-2-pyrrolidone) (PVP) to adsorb on the surface of the metal particle and 
thus stabilize it [32, 33]. There is no actual covalent bond forming between the 
polymer and the particle but the stabilization is established by accumulative 
weak bonds. 
 Electrosteric is a combination of electrostatic and steric stabilization. 
Usually bulk molecules such as polymers or surfactants are used to adsorb on 
the surface of the particles.  The bulk molecules serve as a protecting shell to 
the metal particles and are prepared in medium which the bulk molecules is 
well solvated. An example is the use of tetra(octyl) ammonium chloride as 
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surfactant as shown in Figure 1-4 [34, 35]. The halide anions bind to the metal 
surface by ionic interaction while the alkyl chains are pointing out to the 




Figure 1-4. Electrosteric stabilization of palladium particles by using tetra 
(octyl) ammonium halides as surfactant (redrawn from [34, 35]). 
  
 Solvent effects can be used to stabilize the colloidal form of the metal 
particles. By dissolving the metal precursor in a medium with good solvation 
properties, and subsequently dispersing it in a poorly solvating medium, 
colloidal particles can be obtained. However, stabilizers such as polymers are 
required in order to produce colloidal nano-particles which are stable.  
 
1.4  Immobilization of biological catalysts 
Biological catalyst (biocatalyst) always refers to enzymes which are proteins 
that catalyze (i.e., increase the rates of) chemical reactions without itself 
undergoing permanent change [36, 37]. They are known for their specific 
selectivity towards the type of the reaction they promote and the substrate they 
accept. The specificity of the enzymes is governed by the complementary 
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shape, charge and hydrophilic/hydrophobic characteristics of enzymes and 
substrates. The famous “lock and key” model was introduced by Nobel 
laureate Emil Fischer in 1894. In this analogy, both the active site of the 
enzyme (lock) and substrate (key) has to fit exactly one to another by their 
complimentary geometric shape in order for the catalysis to occur. Figure 1-5 
illustrates the “lock and key” model. In 1958, D. E. Koshland suggested a 
modification to the “lock and key” model and introduced the Induced-Fit 
theory. In this theory, the substrate plays a role in determining the final shape 
of the enzyme. Since the enzyme is partially flexible, the active site is 
continually reshaped by interactions with the substrate as the substrate 
interacts with the enzyme [38].  
 
 
Figure 1-5. Perfectly match between the geometric shape of the substrate and 
the active site of the enzyme as described in the “lock and key” model.  
  
 Enzymes can be used either as isolated enzymes or in the naturally 
occurring form which is inside a cell (whole cell). The aspects that have to be 
considered when dealing with immobilization of biological catalysts are 
different from those with chemical catalysts. Since the specificity of the 
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reaction greatly depends on the active site of the biocatalyst, therefore, 
distortion of the active pocket of the enzymes or killing the whole cells during 
the immobilization process will cause the malfunction of the catalysts. 
Therefore, the immobilization method should be mild and the use of chemicals, 
solvents and high temperature has to be avoided.  
 Enzymes are considered as solutes in an aqueous phase, even though 
because of their size (10 kDa to 500 kDa), they form no true solution but 
rather a colloidal solution. Because of this, the separation of these 
homogeneous catalysts from the solution will be difficult [39-41]. More 
importantly, not all pure enzymes and whole cells are stable in solution, in 
particular in the presence of organic solvent [42]. Nevertheless, the stability of 
the biocatalysts can be improved via immobilization [43].  The choice of the 
support material for immobilization depends greatly on the prospective use of 
the biocatalyst and characteristics of the intended application [44]. Some 
support materials that have been successfully applied as carriers are listed in 
Table 1-1.  
 The properties of the support that need to be evaluated include physical 
properties (strength, porosity, permeability, shape and form of the support etc.), 
chemical features (hydrophilicity, functional group for modification etc.), 
stability (which may influence storage, maintenance of cell viability, 
resistance to pH/ organic solvent/ temperature etc.), operational safety 
(biocompatibility, toxicity etc.), and economic aspects such as availability and 
cost of the support material [45]. 




Table 1-1. Support materials for biocatalyst immobilization. 




































Cell (yeast, red 
blood) 
 
 Five principal methods used for immobilizing biocatalysts can be 
distinguished: adsorption, covalent binding, cross-linking, entrapment and 
encapsulation. These different methods are schematically shown in Figure 1-6.  
 
 
Figure 1-6. Principal methods of biocatalyst immobilization. (a) adsorption, (b) 
covalent binding, (c) cross-linking, (d) entrapment, (e) encapsulation. 
 
 Immobilization through adsorption (Figure 1-6a) is a simple and 
straightforward method without involving covalent binding. Adsorption of a 
biocatalyst on a support can be done via several approaches, mainly based on 
Van der Waals forces, ionic and hydrogen bonding. The interaction is weak 
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but sufficiently strong in the presences of a large number of accumulative 
forces. Existing surface chemistry on the biocatalyst and support is utilized in 
this method, therefore there is little damage inflicted on the biocatalyst [46]. 
Besides that, the forces are easily reversed to allow regeneration with fresh 
catalyst. However, the forces involved are non-specific binding and 
overloading of the support with biocatalyst might occur. Another significant 
shortcoming of the method is the probability of the leaching of the biocatalyst 
from the support under reaction condition. 
 Immobilization via covalent binding (Figure 1-6b) involves formation 
of covalent bonds between functional groups on the surface of the biocatalyst 
and the support. There are a large number of amino acid residues and sugar 
residues on the surface of the biocatalyst which could be targeted [47, 48]. 
There are usually amino groups (NH2) of lysine or arginine, carboxyl groups 
(CO2H) of aspartic acid or glutamic acid, hydroxyl groups (OH) of threonine 
or serine, and the thiol group (SH) of cysteine [49]. Covalent binding ensures 
a tight fixing of the biocatalyst to the support by multiple attachments; 
therefore deactivation due to leaching is minimal. However, selecting the 
functional group to be used is crucial to avoid participation of functional 
groups at the active sites in the immobilization which could lead to 
deactivation of the enzyme.  
 Chemical modification in most cases leads to inhomogeneous 
immobilization in one batch. A special case of covalent binding is cross-
linking (Figure 1-6c). Instead of covalently binding the biocatalyst to a support 
carrier, the cells are covalently linked together to form a large three-
dimensional complex structure. Bi- or multifunctional chemical reagents such 
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as glutaraldehyde and toluene diisothiocyanate are used [50]. However, the 
toxicity of these reagents to most living cells and enzymes is a major concern. 
In some cases, albumin and gelatin were used to provide additional protein 
molecules as spacer to minimize the close proximity problems [45]. An 
additional approach being explored is to first immobilize an enzyme on a 
carrier and perform cross-linking as a later step [51].  
 For immobilization via entrapment (Figure 1-6d), the biocatalysts are 
basically free in solution but with restricted movement by the lattice structure 
of the gel matrix. An optimum porosity has to be achieved within the 
entrapment matrix to ensure there is minimal cell leakage but at the same time, 
the substrate and products should not suffer from diffusion limitations.  The 
most commonly used mechanism of entrapment include ionotropic gelation 
with multivalent cations (as in the case of alginate), temperature-induced 
gelation (e.g. with agarose, gelatin) and organic polymerization by 
chemical/photochemical initiation (e.g. polyacrylamide) [45].  Ionotropic 
gelation occurs by mixing the biocatalyst with a polyionic polymer material, 
and then cross-linking the polymer with multivalent cations in an ion-
exchange reaction to form a lattice structure to trap the biocatalyst [52]. 
Temperature-induced gelation is simple in which the biocatalyst will entrap 
within the gel solution when the solution is cooled down. However, the 
resulting gels are usually soft and unstable. Alternatively, entrapment can be 
performed by mixing the biocatalyst with a monomer solution and which is 
then polymerized and cross-linked.  However, monomers such as acrylamide 
may be toxic to the cell and also special caution is needed during handling of 
the material.  
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 Encapsulation (Figure 1-6e) involves trapping the cells within a semi-
permeable membrane. The most widely used method in encapsulation is by 
using sol-gel technique. Sol-gels are highly porous silica materials that can be 
formed into any desired shape. They are generally thermally and mechanically 
stable [43].  A xerogel is a sol-gel derived gel which has been dried by solvent 
evaporation. Xerogels can be used for the purpose of encapsulation. In this 
process, a tetra-alkoxysilane is hydrolysed using acid catalyst. The hydrolysis 
(formally to Si(OH)4) is followed by  formation of a sol by condensation. A 
gel is formed when a three-dimensional network forms upon further 
condensation is carried out. Evaporation of the water and alcohol at this stage 
will lead to shrinkage of the gel size and some loss of the structure. The dry 
gel obtained is referred as a xerogel. The encapsulation is considered as a mild 
method to obtain an immobilized biocatalyst similar to entrapment and 
adsorption which do little damage to the biocatalyst. 
 
1.5  Aims of the study 
Different criteria can be considered when one aims to identify the best method 
for immobilizing a chemical or biological catalyst. Various methods and 
principles are available to achieve the purpose. However, not all the available 
immobilization principles are feasible to be applied to a continuous flow 
reactor especially for a micro-reactor since the diameter of the reactor is very 
small. The aims of the study can therefore be stated as: 
1. Investigation of immobilization of chemical catalyst (metal catalyst) 
suitable to be used in a micro-reactor which operates continuously. The micro-
reactor will be tested and used for optimization of reaction conditions in the 
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direct formation of hydrogen peroxide and sustainability of the micro-reactor 
will be studied. 
2. Investigation of immobilization of biological catalyst suitable to be 
used for continuous production of fine chemicals. Different immobilization 
methods developed for large and micro scale synthesis of fine chemicals in a 
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Chapter 2  Instruments and Techniques 
Various instruments and techniques have been used in the research work 
performed in this thesis. This chapter will discuss instruments and techniques 
such as nuclear magnetic resonance, mass spectrometry which have been used 
extensively for the purpose of characterization and analysis. Other methods 
such as gel electrophoresis to estimate the molecular weight of protein 
molecules will be discussed as well. Followed by that, instruments such as the 
atomic force microscope, contact angle measurement and quartz crystal 
microbalance for characterization of surface coating will also be discussed.  
 
2.1  Nuclear magnetic resonance 
In chemistry, NMR (Nuclear Magnetic Resonance) is used to analyze the 
chemical structure of a compound by studying the interaction of the nuclear 
spin magnetic moments. When nuclei of certain atoms are immersed in a static 
magnetic field, the energy levels of the two discrete levels – spin parallel and 
anti-parallel to the applied magnetic field become different, and transitions 
between the levels can be affected by exposure to a second oscillating 
magnetic field. Only nuclides with odd number of proton and/or neutron can 
be used in NMR study since they have non-zero magnetic spin. In contrast, the 
total spin magnetic moment for nuclides with even number of both cancels out 
and becomes equal to zero. In this thesis, one dimensional 1H and 13C NMR 
were used for characterization of the synthesized organic compounds. A 
Bruker AMX500 spectrometer was used in the experiments. Deuterated 
chloroform (CDCl3, δ(1H): 7.24 ppm, δ(13C): 77.23) or dimethylsulfoxide 
(DMSO-d6, δ(1H): 2.50 ppm, δ(13C): 39.51) was used as the solvent.  
 24 
 In 1H NMR, different protons in a molecule resonate at slightly 
different frequencies because of the different local chemical environment. The 
frequency shift of the different protons is measured relative to a standard 
reference resonance frequency (tetramethylsilane (TMS) is commonly used). 
The shift is expressed as a dimensionless value known as chemical shift. The 
chemical shift (δ) is expressed in parts per million (ppm) since it is calculated 
as δ = frequency difference between the two nuclei (hertz)/ operating 
frequency of the magnet (megahertz). By studying the chemical shifts of the 
different protons and the peak areas of the different type of the protons, it is 
possible to translate the information to confirm the molecular structure of that 
organic compound. Besides the chemical shifts, important information 
describing the structure of an organic compound is also derived from the spin-
spin coupling. Spin-spin coupling occurs due to the fact that the nuclei 
themselves are magnets which can influence each other when they are near to 
each other. Typically, the spin-spin coupling effect can be observed for 
protons which are separated three bonds away. Scalar splitting follows the 
(n+1) rule, in which n is the number of proton (in a different chemical 
environment) which are separated by three bonds. Figure 2-1 shows an 
example of scalar splitting. The frequency difference between the peaks is 
known as coupling constant (J). The coupling constant usually given in the 
unit of Hertz (Hz), and is independent of the applied magnetic field.  
 The size ratio of the peak of HA which is split by n number of HB can 
be calculated according to Pascal’s triangle which is shown in Figure 2-2. The 
splitting pattern can be complicated when the peak is split by protons with 
different chemical environment. If HA is split by two different protons (HB and 
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HC), this will give a doublet of doublets as the splitting pattern instead of a 
triplet. Figure 2-3 shows two examples of such splitting pattern in the presence 




Figure 2-1. (n+1) Splitting pattern for HA in the presence of different (n) 
number of HB. (a) doublet, (n=1), (b) triplet, (n=2), (c) quartet, (n=3). The 
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Figure 2-3. Splitting pattern of HA in the presence of more than one type of 
neighbouring protons (HB and HC), (a) doublet of doublets, (b) doublet of 
triplets.  
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 The splitting pattern of a proton peak provides useful information of 
the chemical structure of a compound and it helps in peak assignment for the 
proton. The intensities of the 1H NMR can also be used for a quantitative 
study. The peak area is directly proportional to the number of protons in the 
molecule. In this thesis, this was used to determine the ratio of different 
monomers within a copolymer by comparing the peak area of a protons 
characteristic for each of the different monomers. For bigger molecules, 
overlapping of the peaks in the 1H NMR is frequently encountered. In this case, 
13C NMR can be used to further confirm the chemical structure. 
 13C NMR is less sensitive compared to 1H NMR due to the fact that 
only the 13C isotope (1.1% abundance) can be detected in NMR and not the 
more abundant 12C isotope. Because of the low abundance of the isotope, a 
splitting pattern between 13C is generally not observed. In routine application, 
13C NMR spectra are always proton decoupled to remove the splitting between 
the proton and carbon which would further reduce the sensitivity of the 
technique. In this way, 13C gives only one signal for carbons which are 
chemically equivalent.   
 
2.2  Gel electrophoresis 
In this thesis, gel electrophoresis was used to resolve proteins with different 
molecular weight. A Hoefer Mighty small dual gel caster model SE 275 with a 
gel plate of 10 cm x 8 cm was used to cast the polyacrylamide gel. A Hoefer 
Mighthy Small II SE 250 was used as the electrophoresis unit. Typically, a 
constant current of 40 mA was applied to the unit during the electrophoresis.   
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 Before the electrophoresis, the protein sample is treated with an 
anionic detergent such as sodium dodecyl sulfate (SDS) to ensure that the 
separation is merely based on the size of the molecules. SDS dissociates the 
individual chains of protein complexes and unfolds the individual 
macromolecules. By doing so, the protein molecules only retain their primary 
structure. It then coats the outside and provides a net negative charge, so that 
each protein molecule has approximately the same charge to mass ratio. This 
is shown in Figure 2-4. 
 
Figure 2-4. Protein sample treatment with SDS to remove the secondary, 
tertiary and quaternary structures of the protein.  
 
 Electrophoresis of proteins is normally carried out by applying the 
samples to a gel like porous matrix. An electric field is applied to the gel and 
the negatively charged proteins are driven towards the anode. The distance 
traveled by the proteins in the gel depends on the mass, the charge of the 
macromolecules and the pore size of the gel. Since after the SDS treatment, all 
protein molecules have almost the same mass/charge ratio, therefore, the 
separation of the sample is governed by the motion of the protein molecules 
through the channels of the gel. The larger molecules can only travel through 
large channels, whereas smaller ones have more options. Because of this, the 
smaller protein molecules travel further than the larger ones. 
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 After the electrophoresis process, the protein bands can be stained with 
different dyes (coomassie stain, silver stain, etc.) to make the bands visible. 
Generally, a protein marker will be loaded together with the protein sample 
during the electrophoresis. This marker is usually permanently stained so that 
it serves as a tracking dye which is visible in the gel. The electrophoresis can 
be halted when the marker has traveled from one edge to another edge of the 
gel. The protein marker also contains several proteins with different molecular 
weight which separate during the electrophoresis, so that the molecular weight 
of the different bands in the protein samples can be estimated by comparing 
their travel distance with the protein marker.  
 However, this method only provides a rough estimation of the 
molecular weight of the macromolecules. For a more accurate determination 
of the mass of the sample, MALDI-TOF (Matrix-Assisted Laser 
Desorption/Ionization, Time-Of-Flight) mass spectrometry can be used and 
this technique will be introduced in the following section. 
 
2.3  Matrix-assisted laser desorption/ionization, time-of-flight  
MALDI-TOF is a mass spectrometry method which adapts a soft ionization 
technique to determine the mass of large biomolecules and polymers. The soft 
ionization techniques enable the detection of the mass of the molecule without 
fragmentation; however, multiply charged ions of the same molecule will 
possibly appear in the spectrum. In MALDI, the macromolecules have to be 
‘evaporated’ into the vacuum of the instrument and to be ionized for detection. 
Normally, a pulsed nitrogen laser beam at 337 nm is used for this purpose. A 
sample matrix usually is required to facilitate the vaporization and ionization 
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of the samples, in the same time protecting the sample from the destructive 
energy of the laser [1]. Common matrix used in preparing MALDI-TOF 
samples are sinapinic acid, ferulic acid, dihydroxybenzoic acid and others. The 
choice of the matrix is sample depended and a suitable matrix for a particular 
sample has normally to be identified by trial and error.  
 Time-of-flight (TOF) is a mass spectrometry technique in which the 
mass to charge ratio of ions (m/z) is determined from the time that it takes an 
ion to reach the detector. After the sample is desorbed and ionized using 
MALDI, the ions are accelerated by an electric field of known strength [2] and 
then move along the field-free drift zone where they get separated 
Theoretically, all ions are given the same kinetic energy from the extraction 
pulse and thus heavier ions will travel with slower speed and spend more time 
to reach the detector. From the required time of the ions to reach the detector, 
one can deduce the m/z of the ion. However, in practice, there is a kinetic 
energy distribution for ions with the same m/z because not all the ions receive 
the same energy intensity from the extraction pulse. This results in a lower 
resolution since there is a time of flight distribution for each m/z [3]. The 
resolution can be improved by adding a reflector at the end of the drift zone 
which is opposite to the direction of the accelerating field before the ions 
reach the detector [4]. Figure 2-5 shows the two different modes of operation 
for the TOF analyzer, i.e, the linear mode and the reflectron mode. In the 
reflectron mode, ions which move faster will penetrate deeper into the 
opposing field and hence take longer time to be reflected and reach the 
detector. By doing so, ions with the same m/z can reach the detector in the 
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same time; this procedure which was suggested by Mamyrin and Shmikk in 




Figure 2-5. TOF analyzer (a) linear mode, (b) reflectron mode (redrawn from 
[5]). 
 
 Figure 2-6 shows the MALDI-TOF spectra of polystyrene with 
average molecular weight of 11 kDa using the different TOF modes. The 
spectrum produced using the reflectron mode has better signal to noise ratio 
and the isotopic pattern is nicely resolved as compared to linear mode. 
However, the maximum distribution of the molecular weight is at 10,700 Da, 
whereas the value obtained from size exclusion chromatography is 11,600 Da. 
The spectrum measured in the linear mode yields a maximum in the 
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distribution at 11,200 Da which is much closer to the expected value, although 
the isotopic pattern cannot be resolved anymore. The effect of the observed 
lower molecular weight in the reflectron mode is due to the channel depletion 
on the dual microchannel plate detector. In order to produce a spectrum with a 
good signal to noise ratio at higher masses, more ions need to be collected, but 
at the same time the signal output for the later arriving ions is lower than it 
should be, leading to the inaccuracy in the average molecular weight 
determination. Therefore, it is always recommended to use the linear mode to 
analyze sample with masses above 10,000 g/mol [7]. 
  
 
Figure 2-6. MALDI-TOF spectra of polystyrene, Mp = 11,600 Da in: (a) the 
reflectron mode, (b) the linear mode. [8] 
  
 For the reported work, mass spectra of proteins were recorded on a 
Bruker Autoflex II MALDI-TOF instrument with a pulsed nitrogen laser 
operated at 337 nm; the pulse and ion extraction was set to be 70 ns. Sinapinic 
acid (saturated sinapinic acid in 0.1 % TFA(aq.): acetonitrile  2:1) was applied 
as sample matrix. The laser power was 37 % at 25 Hz with 30 shots each time, 





2.4  Electrospray ionization mass spectrometry 
Similar to MALDI-TOF, ESI-MS (ElectroSpray Ionization Mass Spectrometry) 
is also a mass spectrometry technique using soft ionization. The major 
difference between the two techniques is the method of ionization. In ESI-MS, 
a sample solution is sprayed from a capillary tube into a strong electric field to 
create a fine aerosol. Normally, nitrogen gas is used to assist the nebulization 
process. The solvent of the sample will get evaporated when it passes through 
the vacuum chamber causing the charge on the droplets to increase. These 
multiply charged ions will then enter the mass analyser. A typical solution 
present in the capillary consists of a polar solvent in which the analyte is 
soluble. Methanol or acetonitrile (acetonitrile-water) are often used as solvents. 
Since ESI-MS is a sensitive method, an analyte concentration of 10-7 to 10-3 
mole/L is sufficient for the analysis [9]. Normally, the ions observed using 
ESI-MS may be due to the addition of a hydrogen ion (M+H) + or the addition 
of cations such a sodium ion (M+Na)+ or potassium ion (M+K)+.  Figure 2-7 
shows an ESI mass spectrum of such cation addition in positive mode. In a 
negative mode of the detector, the ionization could be due to the removal of a 
proton (M-H)-. Multiply charged ions such as (M + nH)n+ are often observed. 
Figure 2-8 shows an example of the ESI mass spectrum of a penta-peptide 
compound in which multiply charged ion was detected.  
 In this study, peptide analysis using ESI was performed with Finnigan 
LCQ quadrupole ion trap mass spectrometer. The sample was dissolved in a 
mixture of acetonitrile and water in the ratio of 9:1 and filtered through a 0.45 
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Figure 2-7. ESI mass spectrum of a linear penta-peptide RGDfK, showing the 
molecular peak with addition of hydrogen ion at 1064.51 and sodium ion at 
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Figure 2-8. ESI mass spectrum of a cyclic penta-peptide, showing the addition 




2.5  Atomic force microscopy  
AFM (Atomic Force Microscopy) is a high resolution microscopy technique 
which can provide the three dimensional profile of a surface at a nanometer 
scale. In contrast to SEM and TEM, which require a high vacuum [10], 
samples for AFM can be analyzed under ambient conditions. The microscope 
uses a probe (sharp tip) which is supported by a flexible cantilever. The sharp 
probe touches the surface of a sample and scans the surface; the small forces 
between the probe and the surface are measured. A photodiode detector was 
used to measure the bending of the cantilever during the motion of the probe 
across the surface. The measured cantilever deflections are used to plot out a 
map of the surface topology.  
 There are several operation modes that can be used in AFM: contact 
mode, tapping mode and non-contact mode. In this thesis, only tapping mode 
is considered. In tapping mode, the cantilever is oscillated at its resonant 
frequency; the probe only lightly “taps” on the sample surface during the 
scanning. By maintaining a constant oscillation amplitude, constant tip-sample 
interaction is established and thus an image of the surface of the sample is 
obtained. The vertical and lateral resolution is very good using this method, 
since there is less interaction with the sample as compared to contact mode 
(especially lateral forces are greatly reduced) [11]. This imaging mode is 
particularly suitable to prevent damage of a soft sample and is good for 
biological samples.  
 In this thesis, AFM measurements were performed on a VEECO 
dimension 3100 nanoscope IV using the tapping mode. A tip with a force 
constant of 40 N/m operated at a resonant frequency of 300 kHz was used. 
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2.6  Contact angle measurement 
The contact angle describes the wettability of a surface. The sessile drop 
method is the most commonly used method to evaluate wettability [12]. In a 
contact angle goniometer, the image of a liquid drop on a surface was captured 
and the contact angle between the liquid/solid is analyzed by software. Figure 
2-9 depicts the process. The contact angle is defined as the angle formed 
between the three phase boundary of gas/liquid/solid.  
 
 
Figure 2-9. A small liquid drop spreads over a horizontal solid surface. (a) 
side view of the small spherical liquid drop of volume (V) prior deposition, (b) 
side view of the drop spreading on the surface, (c) side view of the drop after 
spreading has ceased with contact angle (θ) indicated (redrawn from [12]). 
 
 
 Surfaces with contact angle greater than 90o are considered non-
wetting (hydrophobic) and surfaces with low contact angles are considered 
well wetted (hydrophilic) (Figure 2-10).  A zero contact angle represents 
complete wetting of the solid surface. In this thesis, contact angles of the 
coated surface were determined by the static sessile drop method on a DFTA 
1000 (First Ten Angstroms Inc.). The images were analyzed using the 




Figure 2-10. Different liquid wetting ability of surfaces results in a different 
contact angle between the liquid droplet and the surface.   
  
 
2.7  Quartz crystal microbalance  
The QCM (Quartz Crystal Microbalance) is a sensitive mass sensor which is 
able to measure changes of mass in the nanogram range in real time. In 
biotechnology, this technique is often used to study the hybridization of 
DNA/RNA with complimentary strands, specific interactions between protein 
ligands by immobilized receptors, adhesion of cells or proteins, and the 
formation of biofilms (or their prevention).  
 As shown in Figure 2-11, a QCM device consists of a thin single 
crystal of quartz with metal electrodes deposited on the top and bottom 
surfaces. Quartz crystals are able to oscillate with a very sharp resonance 
frequency (typically 5 MHz to 10 MHz), driven by a voltage applied to the 
electrodes. Due to the very sharp resonance, the very small shift to lower 
frequency which occurs when small amounts of mass adsorb on the electrode 
surface, can still be readily detected. In this thesis, a Q-Sense E1 model (Q-
Sense, Gothenburg, Sweden) with AT-cut quartz crystals (QSX 303) with a 
fundamental resonant frequency of 5 MHz was used to characterize the 




Figure 2-11. (Bottom) QCM device, (Top) An enlarged cross-sectional view 
of the centre of the QCM showing the motion of the resonance oscillation of 
the quartz crystal as well as a submonolayer of adsorbed noble gas atoms on 
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Chapter 3  Polymer Encapsulated Palladium for the Direct Formation 
of Hydrogen Peroxide in a Micro-reactor 
 
3.1  Introduction  
From the view of green chemistry and atom economy, hydrogen peroxide is 
perhaps the best single-oxygen donor, second only to molecular oxygen. The 
oxygen is cleanly transferred, and the only byproduct is water. Applications of 
hydrogen peroxide in organic synthesis are reviewed in [1]. On a commercial 
scale, hydrogen peroxide is used as a bleach in the pulp and paper industry, as 
a disinfectant in the cosmetic and pharmaceutical industry and as an oxidant in 
water treatment. In highly purified form, it is used for etching and cleaning in 
the electronics industry. Recently, several propylene oxide plants have come 
on stream that utilize hydrogen peroxide for the catalytic oxidation of 
propylene [2]. However, the hydrogen peroxide used by these units is still 
manufactured by the Riedl-Pfleiderer process via anthraquinone autooxidation 
[3, 4]. This now over 70 year old process remains the only process used 
commercially to produce hydrogen peroxide. Because of the complexity of the 
process, economics of scale dictate the use of big production units. However, 
this makes it necessary to transport hydrogen peroxide in concentrated form 
over large distances to the consumers. The cost of transportation adds 
substantially to the price of the hydrogen peroxide for the end user. Therefore, 
despite its advantage as a clean oxidant, hydrogen peroxide is still not 
economically competitive for the production of bulk chemicals or for more 
widespread use in wastewater treatment [5]. For most applications, relatively 
dilute solutions of hydrogen peroxide are adequate and an on-site production 
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in smaller-scale facility would be highly desirable as it would minimize 
handling and eliminate the need for transportation of concentrated hydrogen 
peroxide over long distances.  This can be achieved by an alternative route to 
produce hydrogen peroxide via direct catalytic formation from hydrogen and 
oxygen.  
 
3.1.1  Direct formation of hydrogen peroxide 
Extensive studies have therefore been carried out on the direct catalytic 
formation of hydrogen peroxide (Figure 3-1). The reaction is triphasic, 
involving a gas (H2 and O2), liquid, and solid phase (catalyst). Control of the 
selectivity of hydrogen peroxide formation and its subsequent decomposition 
and hydrogenation to water remains a major challenge. In order to achieve a 
more favorable equilibrium and higher conversion, most reported processes 
involve high pressures of 50 - 96 bar [6-9].   
 
 
Figure 3-1.  Formation of H2O2 from H2 and O2 and competing reactions. 
 
Palladium has been identified as the best catalyst. It has been used in a 
variety of forms, e.g., as colloids [10-12] or supported on preferably acidic 
supports such as silica, titania, or zirconia, or as alloys [13-23] in acidified 
ΔH = -105.8 kJ mol-1





H2O + ½ O2  
H2O 
ΔH = -241.6 kJ mol-1
+ O + H2 2
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aqueous or methanolic solutions. Using palladium supported on alumina, 
Choudhary et al. [16] studied the effect of various halide ions and established 
that bromide ions is a very efficient promoter for hydrogen peroxide formation. 
Furthermore, leaching of palladium from the support was reduced in the 
presence of phosphoric acid. The nature of the support has a major influence 
on the selectivity of the catalyst. Edwards et al. [20] observed that 
pretreatment of activated carbon with acetic acid prior to the deposition of 
Au/Pd nano-particles to form the catalyst completely suppressed the reduction 
of hydrogen peroxide by hydrogen. Using a non-explosive mixture of 3.6 % 
(v/v) of H2 and 7 % O2 in CO2 at a total pressure of 40 bar and a temperature 
of 2 oC, these authors obtained a productivity of 0.175 molH2O2/h·gcat at a 
remarkable selectivity of > 98 %.  
An obvious drawback in the formation of hydrogen peroxide from H2 
and O2 is the very wide explosive regime, 5 – 96 vol % in the H2/O2 system. 
To avoid the potential hazards from direct contact between H2 and O2, 
catalytic membranes [24-28] and a fuel cell design [29, 30] have been 
proposed. Melada et al. [23] studied the continuous formation of hydrogen 
peroxide over Pd/Pt on carbon coated membranes. A relatively low hydrogen 
peroxide concentration of 400 ppm was obtained using O2-saturated acidic 
solutions in the presence of bromide ions and hydrogen, fed in at 3 bar. 
Another safer approach in carrying out direct formation of hydrogen peroxide 





3.1.2  Application of micro-reactors for the direct formation of hydrogen 
peroxide 
Micro-reactors mitigate the inherent hazards of a thermal runaway because 
their large surface to volume ratio allows for highly efficient heat transfer. 
Furthermore, the free radicals that are needed to sustain the chain reaction 
during an explosion are efficiently quenched through wall collisions. Besides 
that, the volume hold-up in micro-reactors is very small. Micro-reactors are 
therefore inherently safe. In many cases, higher product yield and purity have 
been achieved in micro-reactors than in conventional equipment due to a much 
higher gas-liquid mass transfer coefficient [31]. Another advantage of these 
small-scale systems is that they can be built at the point of use, and a simple 
numbering-out allows for rapid capacity increases. Despite these advantages, 
there are only a few reports on the use of micro-reactors for the direct 
synthesis of hydrogen peroxide. Using a single channel packed-bed micro-
reactor at 20 bar and 50 °C, Voloshin et al. [32-34] obtained hydrogen 
peroxide as a 1.3 wt% solution. Maehara et al. [35] reduced the total system 
size by using water electrolysis to generate H2 and O2 instead of feeding these 
gases from gas cylinders. The gases were subsequently passed through a Pd/C 
coated stacked micro-reactor. A relatively modest hydrogen peroxide 
concentration of 8.3×10−3 mol/L (0.028 wt. %) was obtained at 10 °C in a 0.1 
mol/L solution of HCl with a residence time of 93 s.    
Our group reported previously on the synthesis of hydrogen peroxide 
over silica-supported Pd/Pt using two different packed bed micro-reactor 
designs [36]. Experiments with a multi-channel design with multiple parallel 
channels revealed difficulties in maintaining a constant and uniform two-phase 
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flow through all channels. Because of the high surface tension of the liquid, 
liquid plugs can form, leading to a much increased pressure drop over the 
affected channel. In turn, the gas will flow through the other channels and no 
catalytic reaction can take place in the plugged channel.  
 Micro-reactors can be made from a wide range of materials, and a 
variety of fabrication techniques have been proposed such as LIGA (German: 
Lithographie-Galvanoplastik-Abformung, translating to lithography, 
electroforming and moulding), DRIE (Deep Reactive Ion Etching), laser 
ablation, photolithography, hot embossing, injection moulding, powder 
blasting and microlamination [37]. However, all these techniques require 
special fabrication equipment and skills. This study proposed a simpler, easier 
and cheaper design, namely a single-capillary micro-reactor for the direct 
formation of hydrogen peroxide.   
 
3.1.3  Immobilization of palladium nano-particles by polymer 
encapsulation 
In order to overcome the pressure drop problem which occurs in a packed bed 
micro-reactor, an open channel wall-coated system was chosen instead, where 
the palladium catalyst nano-particles are encapsulated within a thin film of 
polymer. The polymer-micelle incarceration (PMI) technique developed by 
Kobayashi and collaborators is used for the immobilization of palladium [38, 
39]. In this method, an amphiphilic polystyrene-based copolymer was used. 
The catalyst is microencapsulated and followed by cross-linking. The structure 
of the amphiphilic polystyrene-based copolymer and the immobilization 
process are shown in Figure 3-2.  
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 Figure 3-2. (a) Amphiphilic copolymer with polystyrene backbone, (b) polar 
teraethylene glycol arms and oxirane as active sites for thermally induced 
cross-linking. Redrawn and edited from [39].  
 
 According to their method, the copolymer is first dissolved in THF and 
Pd(PPh3)4 is added as a core. Hexane is then added and micelles are formed, at 
this point, the copolymers will envelope the metal cores. The Pd (0) is 
assumed to be immobilized based on the interaction between π-electrons of the 
benzene rings of the polystyrene-based copolymers and the vacant orbitals of 
the palladium atoms [39, 40]. Here, ligand exchange from phosphine to 
copolymers is taken place. This solution is then introduced to the glass surface 
of the micro-reactor to allow the precipitation of the micelles onto the surface 
by solvent evaporation. After that, the surface is washed, dried and heated at 
150 oC. It is assumed that the micelles are immobilized onto the surface by the 
binding of the epoxides to silanols on the glass surface, in the same time, 
cross-linking of the polymer side chains is occurred [39] to produce a thin film 
of polymer micelle incarcerated palladium onto the surface of the micro-
reactor.  
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 Previous applications of these polymers for microencapsulated 
scandium, ruthenium, and palladium catalysts have demonstrated their 
resistance to leaching [41-45]. This is attributed to the strong interaction 
between the π-electrons of the benzene rings in the polystyrene backbone and 
the vacant orbitals on the metal. Because the liquid phase used for the 
formation of hydrogen peroxide is normally acidic, leaching of the metal 
catalyst is a severe problem. Hence, the PMI technique for immobilizing 
palladium is evaluated as a potential approach to overcome or at least mitigate 
the leaching problem. 
 
3.2  Materials and methods 
2-phenylpropene and sodium hydride (60 % in mineral oil) were purchased 
from Aldrich. N-Bromosuccinimide (NBS) was purchased from Sigma 
Aldrich. Tetraethyleneglycol was purchased from Sigma. Glycidol was 
purchased from Fluka. Styrene, silica gel 60, titanium dioxide (TiO2), 
dimethylformamide (DMF), chloroform and ammonium chloride were 
purchased from Merck. Sodium sulfate was purchased from GCE. Diethyl 
ether, tetrahydrofuran (THF), ethyl acetate (EtOAc) and hexane were 
purchased from TEDIA. Azobisisobutyronitrile (AIBN) was purchased from 
TCI. 
 
3.2.1  Synthesis of 3-bromo-2-phenylpropene  
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The synthesis of 3-bromo-2-phenylpropene was carried out following 
references [45] and [46]. A mixture of 2-phenylpropene (22.4 g, 190 mmol), 
NBS (23.7 g, 133 mmol) and bromobenzene (76 mL) was heated in an oil bath 
at 160 oC until NBS was totally dissolved. Upon cooling to room temperature, 
the yellow precipitate formed was removed by gravity filtration and washed 
with chloroform. The filtrate was purified by distillation (bp 80–85 oC/ 10 
mbar) to yield 3-bromo-2-phenylpropene together with some 1-bromo-2-
phenylpropene (10 g). 1H NMR (500 MHz, CDCl3) δ = 4.38 (s, 2H), 5.49 (s, 
1H), 5.55 (s, 1H), 7.33–7.51 (m, 5H).  
 
Figure 3-3. 1H NMR spectrum of the monomers mixture. Chemical shifts for 
(□) 3-bromo-2-phenylpropene, (○) 1-bromo-2-phenylpropene.  
 
 From the 1H NMR shown in Figure 3-3, by comparing the peak area of 
1-bromo-2-phenylpropene at 6.48 ppm and 3-bromo-2-phenylpropene at 5.55 
ppm which both represent a peak area corresponding to one proton, the 
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purified mixture contained about 77 % of the desired 3-bromo-2-
phenylpropene. 13C NMR (500 MHz, CDCl3) δ = 34.8, 117.8, 126.7, 128.4, 
128.9, 138.2, 144.8. The compound was also subjected to gas chromatography 
analysis: HP-5 capillary column in constant pressure mode at 10 psi; 
temperature program: 60 oC, 2 min, 20 oC/ min to 300 oC and hold 5 min. The 
retention times for 1-bromo-2-phenylpropene and 3-bromo-2-phenylpropene 
were 8.692 min and 8.806 min, respectively. 
 
3.2.2  Synthesis of 2-[(2-phenylallyloxy)methyl]oxirane.  
 
                 
The synthesis was carried out according to reference [45]. Glycidol (7.4 g, 100 
mmol) in DMF (5 mL) was added to sodium hydride (60 % in mineral oil, 1.6 
g, 40 mmol) suspended in dry DMF (75 mL) at 0 oC. A solution of 3-bromo-2-
phenylpropene (77 %, 5.12 g, 20 mmol) in DMF (10 mL) was added and the 
mixture was stirred under nitrogen for 24 h at room temperature. A clear 
orange-yellowish solution was obtained.  After cooling to 0 oC, the solution 
was diluted with diethyl ether, and saturated aqueous ammonium chloride was 
added to quench the reaction. The aqueous layer was extracted with diethyl 
ether and the organic layers were combined and dried over anhydrous sodium 
sulfate. The solvent was removed under vacuum and the residue was purified 
by flash chromatography (silica, 80 % hexane, 20 % EtOAc, Rf = 0.56) to 
afford 2-[(2-phenylallyloxy)methyl]oxirane (1.15g). 1H NMR (500 MHz, 
CDCl3) δ = 2.60 (dd, 1H, J= 2.70, 5.05 Hz ), 2.78 (dd, 1H, J= 4.25, 5.05 Hz), 
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3.14-3.17 (m, 1H), 3.47 (dd, 1H, J= 5.70, 11.45 Hz), 3.79 (dd, 1H, J= 3.05, 
11.6 Hz), 4.42 (d, 1H, J= 12.65 Hz), 4.48 (d, 1H, J= 13.25 Hz), 5.35 (s, 1H), 
5.54 (s, 1H), 7.33-7.48 (m, 5H). The NMR spectrum of the compound is 
shown in Figure 3-4. For gas chromatography analysis, a HP-5 column was 
used. The operating conditions were: constant pressure mode at 10 psi, 60 oC, 
2 min, 20 oC/min to 300 oC and hold 5 min. The retention time for the 
compound was 10.772 min. 
 
 
Figure 3-4. 1H NMR of 2-[(2-phenylallyloxy)methyl] oxirane. 
 
3.2.3  Synthesis of tetraethyleneglycol mono-2-phenyl-2-propenyl ether  




The synthesis procedure is based on reference [45]. Oxygen- and moisture-
free THF was prepared using a standard protocol with sodium as drying agent 
and benzophenone as indicator. Tetraethyleneglycol (8.81 mL, 45.4 mmol) 
was added to sodium hydride (60% in mineral oil, 1.82 g, 45.4 mmol) 
suspended in dry THF (70 mL) at 0 oC. All additions of chemicals and 
solvents were done under nitrogen atmosphere. After stirring the reaction 
mixture for 1 h at room temperature, the 3-bromo-2-phenylpropene (77 %; 
5.81 g, 22.7 mmol) was added and the mixture was stirred for another 15 h. 
The mixture was cooled to 0 oC and diluted with diethyl ether. Saturated 
aqueous ammonium chloride was added to quench the reaction and the 
aqueous layer was extracted with diethyl ether. The combined organic layers 
were dried over sodium sulfate anhydrous and the solvent was removed using 
a rotary evaporator. The residue was purified by flash chromatography (silica, 
80 % hexane, 20 % acetone, Rf = 0.08) to yield tetraethyleneglycol mono-2-
phenyl-2-propenyl ether (1.68 g).  
 
 
Figure 3-5. 1H NMR of tetraethyleneglycol mono-2-phenyl-2-propenyl ether. 
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 The corresponding NMR spectrum is shown in Figure 3-5. 1H NMR 
(500 MHz, CDCl3) δ = 2.79 (s, 1H), 3.58-3.72 (m, 16H), 4.42 (s, 2H), 5.34 (d, 
1H, J= 1.1 Hz), 5.52 (s, 1H), 7.26-7.36 (m, 3H), 7.45-7.49 (m, 2H). Gas 
chromatographic analysis was carried out using a capillary HP-5 column 
operating in constant pressure mode at 10 psi, 60 oC, 2 min, 20 oC/min to 300 
oC and hold 5 min. The retention time for the compound was 15.464 min. 
 




The copolymerization procedure followed the procedure given by Miyamura 
et al. [45]. Styrene (4.38 g, 42.05 mmol), 2-[(2-phenylallyloxy)methyl]-
oxirane (1.00 g, 5.26 mmol), tetraethyleneglycol mono-2-phenyl-2-propenyl 
ether (1.63g, 5.24 mmol) and AIBN (62 mg) were combined in chloroform 
(6.7 mL). After stirring for 24 h at reflux temperature under nitrogen, the 
mixture was cooled to room temperature. The resulting polymer solution was 
slowly poured into cold methanol. The precipitated polymer was centrifuged, 
washed several times with methanol and dried for 24 h under vacuum to afford 
2.09 g of the desired copolymer (30 % yield) as a transparent to white powder.  
The molar ratio of the components was determined by 1H NMR (500 MHz, 
CDCl3); (x:y:z = 57:26:17) as shown in Figure 3-6. Mw = 27860, Mn = 12050, 












Figure 3-6. 1H NMR of copolymer with polystyrene backbone. Chemical 
shifts for (○) polystyrene, (●) 2-[(2-phenylallyloxy)methyl]oxirane, (□) 
tetraethyleneglycol mono-2-phenyl-2-propenyl ether. 
 
3.2.5  Preparation of polymer micelle incarcerated palladium (PMI-Pd) 
The synthesized copolymer (54 mg) and Pd(PPh3)4  (12 mg) were dissolved in 
THF (1 mL). Cyclohexane (3 mL) was slowly added to this mixture to form 
polymer micelles. Glass capillary tubes (inner diameter 2.0 mm; outer 
diameter 6.5 mm, length 115.0 mm), were washed successively with 1 N 
NaOH, water and ethanol, dried and filled with the PMI-Pd solution. When we 
attempted to use longer segments of the glass tubes, we observed that it was 
difficult to evaporate the solvent from the polymer solution to form a uniform 
coating. Therefore, several shorter pieces were coated on the inside and later 
combined to provide the necessary length of the reactor. The tubes were 
mounted horizontally in a fixture in which they could be slowly rotated, and 
left overnight to precipitate the polymer micelles onto the glass and to allow 
the solvent to evaporate. After drying, a yellow precipitate covered the inner 
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surface of the tube as a uniform film. The coated glass tubes were washed with 
hexane, dried and subjected to heat treatment for 5 h at 150 °C. During this 
heat treatment, the film changed to a black colour. The high temperature leads 
to cross-linking of the copolymer by reaction between the oxirane rings and 
the free alcohol groups on the tetraethyleneglycol side chains. In the same 
time, the oxirane groups will react with the silanol groups on the glass surface, 
thus forming a thin film of encapsulated palladium nano-particles on the inner 
wall of the glass channel. The glass tubes were then washed with acetonitrile 
to remove the liberated triphenylphosphine and any excess (unbound) 
palladium. Washing was continued until all triphenylphosphine had been 
washed out as confirmed by the absence of the UV absorption at 266 nm. To 
analyze for washed-out palladium, all washings were combined and 
evaporated to dryness. Concentrated nitric acid (0.1 mL) was added to 
dissolve the palladium and the solution was made up to 10 mL using deionized 
water. The washed-out palladium was quantitatively determined by 
inductively coupled plasma-atomic emission spectroscopy (ICP-AES). The 
amount of palladium catalyst retained in the coating was then calculated as 
amount of palladium from the gained weight of the reactor before washing 
minus the amount washed out. Typically, more than 90 % of the palladium 
was bound in the polymer matrix. Transmission electron microscopy (TEM) 
measurements on the fresh and used PMI-Pd catalysts were performed with a 
JEOL JEM 3010 HRTEM at operated at 300 kV. The samples were prepared 
by depositing a droplet of a suspension containing scraped out and ground 
pieces of the film in ethanol onto a formvar coated copper grid. 
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In another series of experiments, functionalization of the glass surface 
was done before coating the PMI-Pd. 2-aminopropyl derivatized glass surfaces 
were prepared as described in the literature [38]. The cleaned and washed 
capillary tubing was filled with a solution of 2-aminopropyl trimethoxysilane 
in methanol and left at room temperature for 15 h. It was then dried before 
coating with the polymer micelle solution as described above.  
 
3.2.6  Direct formation of hydrogen peroxide 
Three of the catalyst-coated glass capillary tubes were joined end-to-end with 
Teflon tubing to form a reactor of 34.5 cm length. All other connections were 
made with standard HPLC fittings. Gas flows were separately controlled via 
mass flow controllers (MKS). Typical hydrogen and oxygen flow rates were 2 
and 4 mL/min, respectively. The two gases were mixed using a T-coupling. 
The liquid phase, a solution of 0.1 N HCl and 0.281 mM KBr (aq) in methanol 
was added to the gas stream through the side port of another T-coupling at a 
rate of 0.5 mL/h via a syringe pump (Harvard Apparatus). The reactor effluent 
was passed through a gas/liquid separator kept in an ice bath. To avoid the 
accumulation of dangerous concentrations of hydrogen gas, the outlet of the 
reactor was diluted with nitrogen to below the explosive limit and removed 
through a vent line. The reaction setup is shown in Figure 3-7.  
 The system was allowed to stabilize for 2 h at ambient temperature and 
pressure before the liquid effluent was collected. The hydrogen peroxide 
formed was quantitatively determined by colorimetry using the 
TiOSO4/H2SO4 reagent [47]. The reagent was prepared by dissolving 0.25 g 
TiO2 in about 10 mL concentrated H2SO4 by heating, the solution was then 
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cooled to room temperature and topped up to 50 mL as final volume. To 
measure the concentration of the produced H2O2, an appropriate amount of 
sample solution is added to 1.5 mL of TiOSO4/H2SO4 reagent and topped up 
to 10 mL using 0.1 M H2SO4 in methanol. The UV-absorption of the complex 
was measured at 425 nm. The absorbance was always kept below 1.0 
absorbance units to utilize the full sensitivity of the technique. The 
concentration of the produced H2O2 (mM) was calculated as 
(absorbance425nm/1.3306) x dilution factor, where 1.3306 is the slope 
determined from the calibration curve of absorbance425nm against concentration 
of H2O2 (mM). The productivity of the H2O2 (mmol/min) can be calculated as 
concentration of H2O2 (mM) x flow rate of liquid system (L/min).  
 
 
Figure 3-7. (a) Reaction setup of the micro-reactor with a coating of polymer 
encapsulated palladium catalyst for the direct formation of hydrogen peroxide, 
(b) schematic diagram. 
 
 In order to determine the conversion and selectivity of the reaction, the 
total gas flow at the inlet and after the reactor was determined with a bubble 
flow meter. Samples of the gas before and after reaction were also collected 
with a gas tight syringe and analyzed for H2 and O2 with a gas chromatograph 
(Hewlett-Packard 5890 Plus with chopped thermal conductivity detector; 
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column: molecular sieve 5A, 9’ x 1/8”; carrier gas N2). An example of the 
calculation for quantification of the inlet gas composition is shown below: 
 
 (1) Flow rate in the inlet (H2+O2) = 5.45 mL/min = 0.2235 mmol/min  
The number of moles of gas can be obtained from flow rate (mL/min) / 24.4 
(L/mole). 
The actual ratio of the gas composition of the inlet was determined from a 
calibration curve done by GC. For example, with the composition given by the 
integrator of the gas chromatograph in % of signal: 
 Inlet H2 (GC) =  45.52 %                
 Inlet O2 (GC) = 54.48 %   
 (2) Inlet H2/O2 = (45.52/ 54.48)/ 1.9572 = 0.4269 
Here, 1.9572 is the relative detector response obtained from a calibration 
curve of H2/O2 (GC) against H2/O2 (actual).   
 From (2), inlet O2 = inlet H2/0.4269 
Substitute (2) to (1), H2 + (H2/0.4269) = 0.2235 (mmol/min) 
Therefore, (inlet) H2 = 14269.0
4269.02235.0
+








OHinletinletflowrate   
Quantification of outlet gas for H2 and O2 is the same as above. The formula 















mmolOH   
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 The mobile phase in the reactor is composed of a gaseous and a liquid 
phase. Under the prevailing conditions, the reactor was in the plug flow 
regime (see 1.2 from chapter 1). Due to the slow pumping speed used in the 
experiment, only one liquid plug was observed within the length of the micro-
reactor at any one time. Subsequent liquid plugs appeared only after the first 
liquid plug had passed through the micro-reactor. Therefore, the velocity of 
the liquid plug can be determined from the time required for a liquid plug to 
pass through the micro-reactor. The time required for subsequent liquid plugs 
to appear was also measured. As the length of the micro-reactor is known, the 
distance between two liquid plugs can be estimated.  The length of one unit 
cell refers to the length of one liquid plug plus one gas plug. 
 To determine the leaching of the palladium during the reaction, all the 
effluent was collected and the solvent was evaporated off under reduced 
pressure, the sample was then prepared as described in procedure 3.2.5 and 
sent for ICP-AES. 
 
3.3  Results and discussion 
3.3.1  Surface pretreatment  
Surface pre-treatment with an amine functionalizing group had been reported 
to covalently link the PMI-Pd to the glass [38]. The free amino group reacts 
with the oxirane function of the polymer to form a secondary amine which 
links the polymer covalently to the capillary wall. However, we found that the 
presence of the amine linker was incompatible with the reaction conditions to 
produce hydrogen peroxide. The acidic liquid medium used in the tri-phasic 
reaction rapidly hydrolysed the bond and weakened the attachment between 
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the polymer and the glass surface. As a consequence, the palladium-containing 
film was washed out from the reactor, and the production of hydrogen 
peroxide at a concentration of 200 mM could only be sustained for two days. 
For subsequent experiments, the PMI catalyst was therefore deposited directly 
on the surface of the glass capillaries without prior chemical surface 
functionalization. 
 
3.3.2  Composition of the solvent system  
The composition of the solvent system was varied in order to assess the effect 
of different modifiers on the direct formation of hydrogen peroxide (Table 3-
1).  
 











MeOH 28 0.05 47 0.65 
MeOH/KBr 47 0.08 36 1.4 
MeOH/HCl 107 0.18 nd nd 
MeOH/H2SO4 156 0.26 21 7.7 
MeOH/ H2SO4/KBr 278 0.46 3.9 77 
MeOH/HCl/KBr 326 0.54 nd nd 
Reaction conditions: Pd: 0.30 mg; O2: 4 mL/min, H2: 2 mL/min; liquid rate: 
0.5 mL/h, 0.1 N H+ and 0.281 mM KBr (aq); Conversion of H2; Selectivity to 
H2O2; nd = not determined. 
 
 Initial trials with pure water gave low H2O2 yields. Methanol was 
therefore chosen as the solvent because the solubility of H2 is three times and 
that of O2 eight times higher in methanol than in water [19]. Methanol is 
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highly flammable; nevertheless, the efficient heat transfer within the micro-
reactor should greatly reduce the potential safety hazards associated in the 
reaction. Furthermore, alcoholic hydrogen peroxide would be compatible with 
subsequent processes, e.g., in the production of propylene oxide [12-14, 31]. 
Using pure methanol as the solvent, the hydrogen conversion was as high as 
47 %, but hydrogen peroxide was obtained only with a concentration of 28 
mM. After addition of potassium bromide to the methanol, the concentration 
increased to 47 mM. Even better results were obtained when the methanol was 
acidified. Sulfuric acid was tested as it does not cause the specific corrosive 
effects of halide ions such as pitting and stress corrosion. The achievable 
hydrogen peroxide concentration increased significantly, from 28 mM to 156 
mM. When the methanol was acidified with hydrochloric acid, the final 
concentration was slightly lower at 107 mM. A further increase in the 
hydrogen peroxide concentration was obtained when potassium bromide was 
added to the acidified methanol. Using MeOH/H2SO4/KBr as the solvent 
doubled the hydrogen peroxide concentration to 278 mM, while in the 
MeOH/HCl/KBr system, the hydrogen peroxide obtained had a concentration 
of 326 mM. With the latter liquid phase composition, the productivity of the 
hydrogen peroxide at 0.54 mol/h·gPd is about ten times that observed in pure 
methanol. Both the proton and halide ions (Cl-, Br-) are known to promote the 
hydrogen peroxide yield by inhibiting the hydrogen combustion and 
decomposition of the formed hydrogen peroxide. The formation of H2O and 
H2O2 is suggested to occur at different Pd active sites (consisting of ensembles 
of metal atoms) [11, 15, 48]. Formation of H2O2 involves a diatomic type of 
adsorbed oxygen on the Pd active sites.  On the other hand, dissociation of O-
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O bond is required for the formation of H2O. The halide ions presumably 
selectively block the active sites for dissociation of the O-O bond which leads 
to the formation of water. However, the presence of proton is essential in the 
solvent system. It acts as a stabilizer for the hydrogen peroxide and inhibits the 
decomposition of hydrogen peroxide [49]. This is reflected in the dramatic 
increase in the hydrogen peroxide selectivity from 0.65 % without additives to 
77 % in the system with H2SO4 and Br-, which is the result of a largely 
decreased H2 conversion (from 47 % to only 3.9 %).  
 
3.3.3  Influence of catalyst loading 
Different palladium loading into the polymer was achieved by varying the 
amount of Pd(PPh3)4 in the micelle precursor. Representative TEM 
micrographs of the resulting PMI-Pd catalysts are shown in Figure 3-8.  
 The palladium clusters, represented by the black dots, are well 
distributed throughout the polymer support. The clusters had a relatively 
uniform particle size around 2.5, 2.7 and 3.6 nm for 1, 2 and 4 wt% Pd loading, 
respectively (Table 3-2). Comparing their activity, the productivity of 
hydrogen peroxide normalized to the amount of palladium increased from 0.25 
to 0.34 mol/h·gPd as the loading increased from 1 to 2 wt%. However, the 
productivity became lower when the palladium loading was further increased 
to 4 wt%. While the decrease in activity may be related to the bigger particle 
size and consequently lower metal dispersion at the higher metal loading, the 
initial increase appears to indicate a size effect similar to that observed by 
Edwards et al [21]: the activity of the nano-particles for H2O2 formation is 
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optimum at a certain size, but decreases for even smaller particles, over which 




Figure 3-8. TEM images for fresh PMI catalyst for (a) 1 wt%, (b) 2 wt%, (c) 4 
wt% Pd and (d) 2 wt% PMI-Pd after reaction. 
   
 






 particle size (nm)





1 0.14 2.5 71.2 0.25 
2 0.37 2.7 254 0.34 
4 0.59 3.6 293 0.25 




Several micro-reactors were prepared with polymer films containing 
palladium at a concentration of 2 wt% with respect to the polymer. The 
amount of catalyst in the reactor was increased by increasing the film 
thickness through applying multiple coats of the polymer. The concentration 
of the hydrogen peroxide generated in the micro-reactor increased linearly 
from 123 to 254 mM as the catalyst amount increased from 0.19 to 0.35 mg Pd 
(Table 3-3).  
However, the productivity normalized to the amount of catalyst 
remained essentially constant, varying only slightly from 0.32 to 0.36 
mol/h·gPd. This shows that the polymer film was well penetrated by the 
reactants so that all the encapsulated metal particles were readily accessible 
for the reaction. Furthermore, the decomposition of hydrogen peroxide was 
not significant even at the highest loading of catalyst. 
 
Table 3-3. Influence of palladium loading varied by repeated coating with 
PMI-2 wt% Pd. 







0.19 123 0.32 
0.28 207 0.36 
0.35 254 0.34 
Reaction conditions: O2: 4 mL/min; H2: 2 mL/min, liquid (MeOH/HCl/KBr): 
0.5 mL/h 
 
3.3.4  Flow rate of the liquid phase 
The flow rate of the liquid plays an important role in the mass transfer within 
the micro-reactor. In a 2 mm inner diameter capillary, increasing the liquid 
feed rate from 0.2 to 1.0 mL/h resulted in an increase in the productivity of 
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hydrogen peroxide from 0.24 to 0.46 mol/h·gPd (Table 3-4).  However, the 
hydrogen peroxide concentration decreased from 409 mM to 160 mM due to 
dilution by a larger volume of liquid. Bercic and Pintar [50] found that the 
gas-liquid mass transfer in a methane/water system under Taylor flow 
condition is well described by the relation: 







⋅=               Eq. (1) 
 
 
Table 3-4.  Effect of liquid pumping speed in a 2 mm inner diameter capillary 
reactor. 
Pumping  Speed 
(mL/h) 
Conc. of H2O2 
(mM) 
Productivity of H2O2 
(mol/h·gPd) 
 0.2 409 0.24 
0.5 254 0.34 
1.0 160 0.46 
Reaction conditions: Pd: 0.35 mg; O2: 4 mL/min; H2: 2 mL/min, liquid: 
(MeOH/HCl/KBr). 
 
In this equation α, β, γ are constants, and LUC is the length of one “unit 
cell”, i.e., of one gas bubble and the liquid plug separating it from the next gas 
bubble, εg is the volume fraction of the gas bubbles and u is the flow velocity 
of the unit cell. Inspection of this equation shows that an increase of the flow 
velocity u or a decrease of the unit cell length LUC will have the strongest 
impact on the mass transfer coefficient KLa. The numerical value for exponent 
γ in our experiments was calculated to be 0.56. The flow velocity u remains 
essentially the same if the liquid feed rate is varied at constant gas flow rate 
because under our experimental conditions, the volume flow rate of the gas is 
very much bigger than that of the liquid. Therefore, the main parameter 
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affected by a change in liquid feed rate is the length of the unit cell. At a 
higher liquid feed rate, the length of the unit cell becomes shorter as more 
liquid plugs are introduced into the channel per unit time. The shorter unit cell 
length increases the gas-liquid mass transfer and therefore leads to higher 
hydrogen peroxide productivity. 
In Figure 3-9, the estimated unit cell length and productivity of 
hydrogen peroxide are plotted against different liquid feed rates. The results 






































Figure 3-9. Dependence of the unit cell length and productivity of H2O2 on 
pumping speed. () unit cell length, (○) productivity. Reaction conditions: Pd: 
0.35 mg; O2: 4 mL/min; H2: 2 mL/min, liquid: (MeOH/HCl/KBr).  
 
 
3.3.5  Influence of diameter of the micro-reactor  
According to equation 1, the mass transfer can also be improved by increasing 
the flow velocity u of the unit cell. Higher velocity of the unit cell is achieved 
by maintaining a constant gas and liquid flow rate and decreasing the inner 
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diameter of the reactor at the same time. The results in Table 3-5 show that the 
productivity of hydrogen peroxide increased from 0.34 to 2.28 mol/h·gPd when 
the reaction was ran in narrower capillaries.  
 The productivity per unit palladium obtained with a micro-reactor of 
0.53 mm diameter was about six times higher than in one with 2 mm inner 
diameter. These results clearly confirm that a smaller diameter resulted in a 
higher velocity of the unit cell and therefore a better liquid-gas mass transfer. 
However, the concentration of the hydrogen peroxide was lower for the 
smaller diameter reactor. This is due to the significantly smaller amounts of 
catalyst coated on the wall of the narrower capillary. The amount of catalyst 
deposited onto the walls of the capillary depends on the volume of the solution 
from which the catalyst was deposited. It will therefore scale with r2 (r is the 
radius of the capillary) if a constant number of impregnation steps is used.  
 










2.00 0.37 254 0.34 
1.00 0.12 144 0.61 
0.53 0.02   81.7 2.28 
Reaction conditions: O2: 4 mL/min; H2: 2 mL/min, liquid (MeOH/HCl/KBr): 
0.5 mL/h 
 
3.3.6 Varying gas ratios and secondary reactions 
Figure 3-1 shows that except for the decomposition of hydrogen, all other side 
reactions involve hydrogen. Therefore, it is crucial to optimize the ratio of the 
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H2 : O2 for maximum formation of hydrogen peroxide. When the amount of 
hydrogen is stoichiometric (1:1) or higher than that of oxygen (2:1), the 
formation of hydrogen peroxide is four to seventeen times lower as compared 
to that for a H2:O2 ratio of 1:2 (Table 3-6). An excess of hydrogen favours the 
subsequent hydrogenation of hydrogen peroxide to water. Therefore, a 
moderate oxygen excess is essential to suppress the reduction reactions. The 
H2:O2 ratio of 1:2 was established as close to the economic optimum. 
 
Table 3-6. Variation of H2:O2 gas ratio on hydrogen peroxide formation. 
Gas ratio 
(H2:O2) 
Conc. of H2O2  
(mM) 
Productivity of H2O2 
 (mol/h·gPd) 
1:2 254 0.34 
1:1 58.8 0.08 
2:1 17.1 0.02 
Reaction conditions: Pd: 0.35 mg; gas flow: 6 mL/min, liquid 
(MeOH/HCl/KBr): 0.5 mL/h. 
 
To investigate the secondary reactions that hydrogen peroxide 
undergoes in the micro-reactor, hydrogen peroxide at a concentration of 200 
mM was added to the liquid feed. The hydrogen peroxide concentration in the 
product stream was measured as a function of the gas phase composition 
(Table 3-7). 
 In the absence of hydrogen, the final concentration of hydrogen 
peroxide remained unchanged. Hence, the catalytic decomposition of 
hydrogen peroxide was negligible within the short retention time of about 7 – 
8 s in the micro-reactor. A very significant decrease in hydrogen peroxide 
concentration was observed in the presence of hydrogen gas. In a He and H2 
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(2:1) gas mixture, almost half of the initial hydrogen peroxide was reduced to 
water, and the hydrogen peroxide concentration decreased from 200 mM to 
121 mM. Using our standard synthesis gas mixture of H2 and O2 in the ratio of 
1:2, the decrease in hydrogen peroxide concentration was smaller, from 200 
mM to 165 mM. This was the same concentration that could be obtained with 
this reactor in the synthesis mode. Obviously, under these conditions, 
formation of hydrogen peroxide occurs, but at a lower rate than the reduction 
of hydrogen peroxide. The final value, 165 mM, is the steady state between 
formation and decomposition reaction. We conclude that the main secondary 
reaction within our micro-reactor system is the reduction of hydrogen peroxide 
by hydrogen rather than its decomposition. Our results confirm earlier 
observations by Han and Lunsford [11] who had shown that under batch 
conditions, hydrogen peroxide was stable in the presence of O2 but was readily 
reduced to water by H2.  
 
Table 3-7. Effect of gas composition on the reduction/decomposition of 
hydrogen peroxide in feed. 
Gas composition 
 
Conc. of H2O2 (outlet)  
(mM) 
He  201 
He : H2 (4 : 2) 121 
H2 : O2 (2 : 4) 165 
He : O2 (2 : 4) 198 
Reaction conditions: Pd: 0.58 mg; liquid (MeOH/HCl/KBr): 0.5 mL/h; gas 




3.3.7 Lifetime of the catalyst in the micro-reactor 
The long-term behavior of the micro-reactor for the continuous production of 
hydrogen peroxide was investigated (Figure 3-10). A hydrogen peroxide 
productivity rate of 0.34-0.35 mol/h·gPd was sustained over the first three days 
at a daily operation time of ten hours (for safety reasons, the reactor was only 
operated in the presence of an operator). The productivity decreased over the 
next three days to stabilize at a constant value of 0.27 mol/h·gPd, which is 77 
% of the initial activity. The productivity was maintained at this level until the 
experiment was terminated after another five days. The concentration of 






















Figure 3-10. Productivity of hydrogen peroxide as a function of time. 
Reaction condition: Pd: 0.283 mg; O2: 4 mL/min; H2: 2 mL/min, liquid 
(MeOH/HCl/KBr): 0.5 mL/h. 
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 The observed decrease in activity between day 4 and day 6 can be 
attributed to a loss of palladium from the micro-reactor. This may be 
palladium particles which are not tightly incarcerated in the polymer and can 
be easily removed by the acidic liquid phase. Indeed, no further decrease in 
hydrogen peroxide productivity was observed with continued operation of the 
micro-reactor after this time. A control experiment, using an acid- and 
halogen-free solution of methanol in water as the liquid phase, showed that the 
amount of palladium in the reactor effluent was below detection limit. The 
palladium content in the film was analyzed by ICP-AES after the run and 
found to be 10 % lower than in the fresh film. This loss in palladium can 
account for half of the observed decline in productivity. Another contributing 
factor is the formation of bigger palladium particles and agglomeration of 
palladium clusters. Transmission electron micrographs of the polymer film 
after the reaction (Figure 3-8d) showed the presence of palladium crystallites 
with a diameter of  up to 4.8 nm, in addition to many small particles that were 
similar in size or even smaller than the 2.7 nm particles in the as-synthesized 
film (Figure 3-8b). The growth of bigger palladium particles at the expense of 
smaller ones (Ostwald ripening) will result in lower catalyst dispersion which 
adequately explains the observed reduction in activity up to day 6. The stable 
hydrogen peroxide productivity obtained thereafter suggests that the tightly 
bound PMI-Pd crystallites were stable towards leaching and particle growth. 
 
3.4  Conclusions 
The catalytic capillary micro-reactor was shown to be a suitable approach for 
the intrinsically safe in-situ generation of hydrogen peroxide from the 
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elements. Over a wall-coated Pd nano-particle catalyst, this reaction takes 
place under mild conditions, i.e., room temperature and atmospheric pressure, 
without dilution by an inert gas. A moderate excess of oxygen in the feed 
stream over the stoichiometric 1:1 ratio for O2 : H2 is necessary to suppress the 
catalytic reduction of the formed hydrogen peroxide to water.  A two-fold 
oxygen excess was identified as close to the economic optimum. 
The immobilization of palladium from a soluble precursor using the 
PMI method resulted in uniform palladium nano-particles of 2.5 to 3.6 nm 
diameter for palladium loadings of 1 to 4 wt. %. The presence of bromine and 
hydrogen ions in the solvent system is essential for achieving high 
productivity of hydrogen peroxide. Despite the corrosive conditions, the PMI 
catalyst showed little leaching. The long time stability of the catalyst could be 
demonstrated during the continuous production of hydrogen peroxide for 
eleven days. Using a 2 mm inner diameter micro-reactor coated with PMI-Pd, 
a maximum concentration of 1.4 wt% of H2O2 corresponding to a turnover 
frequency of 0.54 molH2O2/h·gPd was obtained in continuous operation.  
Our obtained result is comparable to the reported literature which 
described the application of micro-reactor in the direct formation of hydrogen 
peroxide. However, our design is more convenient, cheaper and more 
importantly the reaction is conducted in milder condition. Thus, this has 
greatly mitigated the safety issue related to the reaction. Furthermore, the open 
channel catalyst coated micro-reactor has eliminated the difficulties arise due 
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Chapter 4  Recombinant Escherichia coli for the Synthesis of Chiral 
Alcohols 
 
4.1  Introduction 
Most biologically active compounds including many pharmaceuticals have 
chiral molecular structures with one or more stereogenic centres. Because of 
safety, therapeutic and regulatory concerns, it is necessary to evaluate and test 
all drugs in their enantiomerically pure form [1]. The ready access to chiral 
synthons is therefore very important. Routes to single enantiomers of small 
molecules can be classified into four groups: chiral pool synthesis, resolution, 
biological, and chemical asymmetric techniques [3].  
 For pharmaceuticals synthesis, it is always desirable to have the 
desired chirality built into the intermediates so that the yield of the final 
product with the desired chirality can be maximized. Optically active 
secondary alcohols are widely used by the pharmaceutical industry as 
intermediates for the introduction of chirality [2]. The asymmetric reduction of 
the corresponding pro-chiral ketones has been established as one of the most 
effective and promising routes to chiral alcohols [4]. This reduction reaction 
can be carried out either by using chemical catalyst of biocatalyst. A chemical 
catalyst always requires a chiral ligand in order to introduce chirality to the 
reaction. 2,2'-bis(diphenylphosphino)-1,1'-binaphthyl (BINAP) reported by 
Nayori [5] represents one of the most famous and efficient chiral ligands 
introduced into the catalyst for the asymmetric reduction of ketone. This chiral 
ligand is then further adapted widely in a lot research dealing with reduction 
of ketones. Wang et al. investigated the reduction of methyl acetoactetate 
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using a chirally functionalized periodic mesoporous organosilica with built-in 
BINAP ligand [6]. 99 % conversion with 99.9 % ee of the product was 
obtained after 24 h when the reaction was carried out in methanol using 4 MPa 
of H2 at 50 oC. Similarly, Yuan et al. used a 7,7-disubstituted BINAPs on 
ruthenium to carry out the reduction of the same substrate in ethanol at 50 oC 
and 30 atm of H2 pressure, complete conversion and 99 % ee of the product 
was obtained in 12 h [7]. However, the synthesis of the necessary chiral 
organometallic catalyst is always complicated and expensive. Harsh condition 
such as high pressure is also necessary to run the reaction with good product 
yield. 
  On the other hand, biocatalytic approaches using oxidoreductases are 
attractive as compared to chemical methods involving transition metal 
catalysts and organic solvents. Biocatalysts are able to reduce pro-chiral 
ketones with remarkable chemo-, regio- and stereoselectivity [8]. It is a major 
advantage of enzymes as catalysts that functional group 
protection/deprotection strategies are usually not necessary. Moreover, 
biocatalytic reductions can be carried out at ambient temperature and 
atmospheric pressure [9]. Thus, biocatalytic reactions can simplify 
manufacturing processes, making them economically more attractive and at 
the same time more environmentally acceptable [10]. As an example, Inoue et 
al. investigated the reduction of pro-chiral ketones to chiral alcohol using 
alcohol dehydrogenase isolated from Leifsonia sp. and NaDH as cofactor [11]. 
Complete conversion of ethyl acetoacetate to 99 % ee of (R)-ethyl 
hydroxybutyrate in aqueous buffer pH 7 was obtained at 25 oC after 24 h. 
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 However, other important parameters such as productivities (g⋅L-1h-1), 
final product concentration, and/or complex downstream processing of 
biocatalytic process are factors that still argue against the use of enzymes for 
industrial applications [12]. A minimum of 0.1 g⋅L-1h-1 of space-time-yield 
and minimum final product concentration of 1 g⋅L-1 is required for fine 
chemical industrial production [13, 14]. For pharmaceuticals, the focus is on 
an efficient time-to-market strategy rather than on production costs [15,16], 
with estimated minimum process requirements of 0.001 g⋅L-1h-1 volumetric 
productivity and 0.1 g⋅L-1 for product concentration [14]. Nevertheless, recent 
technology advancements such as the development of recombinant DNA 
technology have lowered some of the mentioned hurdles and increased the 
likeliness that biocatalysts will be applied in industrial processes. In the 
following sections, the importance of chirality will be discussed first, followed 
by the introduction of recombinant DNA technology in overcoming obstacles 
towards high productivity using biocatalysts. 
 
4.1.1  Chirality in chemistry and pharmaceuticals 
Chirality, exists when two objects are mirror images of each other but these 
objects are non-superimposable [17]. In chemistry, chirality is often caused by 
the presence of an asymmetric carbon atom (carbon atom to which four 
different groups of atoms is attached) [18]. A chiral molecule always exists as 
a pair of enantiomers or optical isomers, which refer to the two mirror images 
of the chiral molecule. These enantiomers are often designated as “left 
handed” or “right handed”.  
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  In chemistry, the geometry at a chiral centre of a molecule is defined 
as R (for Rectus) or S (for Sinister). The substituents on the chiral centre are 
assigned a priority according to the atomic number based on the IUPAC rules, 
substituent with higher atomic number receive the higher priority. The 
molecule is then oriented in space so that the substituent with lowest priority is 
pointed away from the observer. According to the Cahn-Ingold-Prelog (CIP) 
rule, R is designated to the chiral centre if the priority of the substituents is 
decreasing in clockwise direction, whereas S is designated if it decreases in 
counter clockwise direction. Figure 4-1 shows an example for a pair of 




(S)-ethyl hydroxybutyrate                     (R)-ethyl hydroxybutyrate 
Figure 4-1. The two enantiomers of ethyl hydroxybutyrate; the chiral centre is 
indicated by the *. Atoms in light grey: carbon; white: hydrogen; dark grey: 
oxygen. 
  
 Chiral molecules will have exactly the same chemical and physical 
properties, but can be differentiated by their interaction with optically active 
(chiral) entities.  The term optical activity refers to the ability of the chiral 
molecule to rotate the plane of linearly polarized light. The isomer in the (+) 
form will rotate the polarized light clockwise, vice-versa for the isomer in (-) 
form. If both the (+) and (-) form of the isomers are present in a solution with 
equal concentration, then the optical activities of the components in this 
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racemic mixture will cancel out each other. The direction of the rotation of the 
plane of the polarized light (+, -) can only be determined experimentally by 
using a polarimeter and has no fixed relation with the (R, S) nomenclature. 
 Although the chemical property of the enantiomers of a chiral 
molecule generally is the same, but it behaves very differently in the presence 
of another chiral molecule. This can be seen from the biological activity of the 
enantiomers. For example, the S enantiomer of Ethambutol is used to treat 
tuberculosis; however, the R enantiomer causes blindness to the patient. The 
safety issues related to the use of chiral drugs has motivated the Food and 
Drug Administration (FDA) of the United States to formulate a guideline on 
chiral drugs in 1992 [19]. This guideline enforces that the purity of chiral 
drugs has to be determined before the drugs are sent for pharmacokinetic 
evaluation to avoid the misleading assay due to the different disposition of the 
enantiomers. In addition, it is important to evaluate both enantiomers clinically 
and consider developing only one when both enantiomers are 
pharmacologically active but differ significantly in potency, specificity, or 
maximum effect. Enantio-purity of a chiral compound is usually described 
using the term enantiomeric excess (ee). The following formula explains how 














ee(R) is the ee of the (R)-form compound in the mixture, and [C](R) and [C](S) are 
the concentration of (R)- and (S)-compound respectively. 
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4.1.2 Application of alcohol dehydrogenase in the synthesis of chiral 
alcohols 
Alcohol dehydrogenase (ADH) (EC 1.1.1.1) is an enzyme which can catalyze 
the reversible reduction of functional groups such as ketones and keto-esters to 
chiral alcohols in the presence of a cofactor. Generally, ADHs can be divided 
into short chain ADH, medium chain ADH and long-chain ADH [20]. Table 
4-1 shows the biochemical and microbiological information of ADHs.  
 
Table 4-1. Biochemical and microbiological information of ADHs [21]. 
Parameters Short-chain 
ADH 






























































1These short-chain dehydrogenase contain Zn2+ and require Mg2+ for their 
activity. 
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 Cofactors involved in the reduction of the ketones are nicotinamide 
adenine dinucleotide (NADH) and/or nicotinamide adenine dinucleotide 
phosphate (NADPH). The structures of the reduced and oxidized form of the 
cofactors are shown in Figure 4-2. The chiral alcohols are produced either in 
the (R) or (S) form, depending on the type of the enzyme used. As shown in 
Figure 4-3, if the hydrogen is transferred to the re-face of the substrate, then 
the S enantiomer will be formed. However, if the hydrogen is being transferred 




Figure 4-2. (a) Reduced form of nicotinamide adenine dinucleotide 






Figure 4-3. Hydrogen transfer to re-face or si-face of a pro-chiral ketone 
(ethyl acetoacetate) resulted in chiral alcohol with different chiral selectivity. 
 
 The most commonly used ADHs are those available from yeast, horse 
liver and Thermoanaerobium brockii. Most of these enzymes reduce the 
ketones by transferring the hydrogen from the cofactor to the re-face of 
substrate forming (S)-alcohols in a process characterized by Prelog’s rule [22]. 
However, enzymes isolated from the Lactobacillus strains L. kefir and L. 
brevis catalyze the formation of (R)-alcohols from a wide range of substrates 
in good yields and high enantiomeric excess (94-99 %) [20, 23].  
Free enzymes have several disadvantages for technical applications, 
notably insufficient long-term stability and limited substrate acceptance [24]. 
The need for cofactors is a particularly serious problem in cases where isolated 
enzymes are used for oxidation or reduction reactions. The cost for the 
required stoichiometric amounts of NADH and/or NADPH is prohibitive, and 
even if the cofactor can be regenerated, such cofactor regeneration schemes 
are complex and add to the processing costs. All this provides a significant 
economic obstacle against using alcohol dehydrogenases for commercial 
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processes [25]. The regeneration of cofactors can be achieved in different 
ways, such as coupled enzyme [26, 27], coupled substrate [28], as well as by 
electro-enzymatic, photochemical, and chemical approaches [12].  
Whole cell fermentation offers an alternative to the use of isolated 
enzymes. The whole cell biocatalyst acts as a mini-reactor with all the 
necessary cofactors and sequences of enzymes available within one cell. By 
using a coupled substrate approach to regenerate the cofactors, the same 
enzyme, ADH, catalyzes the reduction of the substrate and the oxidation of the 
cosubstrate isopropanol (IPA) to regenerate the NAD(P)H as shown in Figure 
4-4 [29].  In addition, IPA acts as cosolvent and increases the solubility of the 
organic substrate in the aqueous phase in which the biocatalytic reaction is 
carried out. Furthermore, the enzymes are more stable within the cell where 
they are in their natural environment [30].  
The wild forms of microorganisms frequently contain several enzymes 
that can act on the same substrate, usually with different stereoselectivity. This 
compromises the enantiomeric excess. In a study by Ribeiro et al. on the 
reduction of ethyl acetoacetate by different wild type microorganisms, the 
highest ee was 81% with a Hansenula sp [31]. This situation improved 
dramatically with the development of “designer bugs”. Using recombinant 
technology, only those enzymes specific for the desired biotransformation can 




Figure 4-4. Whole-cell reduction: substrate and cosubstrate enter the cell 
where the enzymatic reduction takes place under regeneration of the cofactor 
NAD(P)H. 
 
4.1.3 Recombinant DNA technology 
Recombinant DNA (rDNA) is a form of artificial DNA that is created by 
combining two or more genes that would not normally occur together [33]. 
This technology enables the insertion of foreign DNA into the existing 
organismal DNA without disrupting the original genome of the organism. This 
artificial DNA can be introduced into the host organism in the form of 
plasmids. A plasmid is a self-replicating extrachromosomal DNA molecule 
separate from the chromosomal DNA. In many cases, it is circular and double-
stranded. Plasmids used in genetic engineering are called vectors.  
 The discovery of restriction endonucleases by W. Arber, D. Nathans 
and H. Smith in the early 1970’s was a key development which made the 
recombinant DNA technology possible. Restrictions endonucleases are special 
enzymes which recognize specific loci in double stranded DNA and cleave the 
DNA in both strands [34]. Nucleases that cut nucleic acid molecules internally 
are endonucleases, and those that degrade from the ends of nucleic acids are 
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exonucleases. The discovery of the restriction endonucleases made the 
effective analysis of DNA possible and also provided the capability to cut out 
different DNA fragments. These DNA fragments can be joined together later 
to create new recombinant DNA, a process termed as gene cloning.  
 In order to optimize a biocatalyst for a specific industrial application, 
genetically modified microorganisms such as bacteria and yeast can be 
produced to meet the requirements. This involves the precise control on the 
changes in the metabolism of the microorganism. The recombinant process is 
shown in Figure 4-5. The process begins with the identification and isolation 
of the desired gene. Some microorganisms produce special substances. After 
identifying the gene responsible for this behaviour, the particular DNA 
fragment will be cut out using restriction endonucleases. After that, the coding 
fragment is inserted into a plasmid together with the antibiotic resistance gene. 
The recombinant plasmid is then inserted into the bacteria cell (host cell) and 
this process is called transformation. Bacteria are then exposed to ampicillin to 
drive the uptake of plasmids. Cells that are not transformed die on the 
ampicillin-containing medium. However, transformation occurs with a quite 
low frequency, and only a few cells are transformed by incorporation of a 
single plasmid molecule. Once incorporated into a host cell, a plasmid can 
replicate independently of the host-cell chromosome. In particular, the 
protecting genes are expressed (activated for transcription and subsequent 
translation into proteins) and the expressed proteins breaks down the 
antibiotics. As a transformed cell multiplies into a colony, at least one plasmid 
segregates to each daughter cell. These resulting recombinant cells can then be 
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cultured to produce a large amount of biocatalyst to be used for the desired 
catalyzed reaction. 
 By combining the application of whole cell and recombinant DNA 
technology, it is possible to prepare a biocatalyst which shows high 
enantiomeric selectivity for a particular reaction. In the following, the 
application of a recombinant Escherichia coli (E. coli) over-expressing 





Figure 4-5. Process of recombinant DNA technology [35]. 
 
4.2  Materials and methods 
Plasmid pBtac-Lbadh (X-zyme - a Subsidiary of Johnson Matthey Catalysts; 
Düsseldorf, Germany) was a gift from Prof. Christian Wandrey and his 
research group of the Institute for Biotechnology, Research Center Jülich, 
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Germany. E. coli BL21 Star (DE3) and Super Optimal broth with Catabolite 
repression (SOC medium) was purchased from Invitrogen (Singapore). Other 
chemicals were obtained from the following sources: BactoTM peptone, 
BactoTM yeast extract and BactoTM Agar from BD (Becton, Dickinson and 
Company); Ampicillin, antifoam 204, potassium phosphate monobasic 
(KH2PO4) and potassium phosphate dibasic trihydrate (K2HPO4•3H2O) from 
Sigma; Ethyl acetoacetate (EAA), methyl acetoacetate (MAA), acetophenone 
and methyl propionyl acetate from Aldrich; Isopropylthiogalactoside (IPTG), 
methyl isobutyl acetate, ethyl 4-chloroacetoacetate and glucose from Fluka.  
 
4.2.1  Transformation of E. coli with plasmids bearing the gene encoding 
for LbADH   
The plasmid pBtac-Lbadh bearing the adh gene from Lactobacillus brevis as 
well as an ampicillin resistance gene was employed as expression vector for 
the E. coli BL21 Star (DE3) host cells. Competent E. coli cells were 
transformed by adding 5 μL of the plasmid solution into an Eppendorf tube 
containing 100 μL of E. coli in a buffer. The cells were incubated for 20 min 
at 4 oC to induce the uptake of plasmids. The cells were then heated in a 42 oC 
water bath for 90 s to inactivate the nucleases, and then cooled to 4 oC again 
for 5 min before 400 μL of Hanahan’s SOC medium was added [36]. The cells 
were then incubated at 37 oC for one hour with light shaking to allow the cells 
to repair the cell membranes. 25 μL of cell suspension was streaked on a LB-
agar plate containing 100 mg/L of ampicillin and the plates were incubated 
overnight at 37 oC. The ampicillin present in the LB agar selects for cells that 
were successfully transformed. A colony of transformed E. coli was selected 
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randomly from a LB agar plate and used to inoculate 100 mL LB medium 
containing 100 mg/L ampicillin in a 250 mL Erlenmeyer flask. This preculture 
was incubated overnight at 30 oC with stirring at 150 rpm. Aliquots of this 
preculture were used for subsequent cell cultivation.  
 Table 4-2 shows the medium composition required for both the Luria 
Bertani (LB) and Terrific Broth (TB) medium. To prepare 100 mL of the LB-
agar plate, all the ingredients except glucose and ampicillin were mixed in 80 
mL of milli-Q water and autoclaved for 30 min. Glucose must be sterilized 
separately from other medium composition to avoid browning through a 
Maillard-reaction with the proteins. Therefore, glucose and ampicillin were 
mixed in 20 mL milli-Q water and stirred until fully dissolved. Gentle heat (< 
40 oC) can be applied since ampicillin has limited solubility in water. The 
solution was filtered through 0.2 μm syringe filter with polyethersulfone 
membrane and combined with the previously autoclaved medium. The 
medium was swirled and quickly poured over to Petri dishes in a cell culture 
hood. Each Petri dish requires about 10-12 mL of medium for fully coverage. 
For the preparation of LB medium in solution, the procedure is the same but 
excluding the agar in the medium composition.   
 For the preparation of 1 L TB medium, peptone and yeast extract were 
mixed in 600 mL of milli-Q water and autoclaved for 30 min. The phosphate 
salts were separately dissolved in 350 mL of milli-Q water. The phosphate 
salts have to be autoclaved separately because other minerals such as 
magnesium, potassium, ammonium, and sodium can become unavailable 
when heating together with phosphate anions owing to the formation of 
various insoluble salts. Therefore, the two solutions should be cooled to at 
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least about 50 oC in a laminar flow fumehood before being mixed together. 
Meanwhile, glucose and ampicillin were stirred to dissolve in 50 mL of milli-
Q water and filtered into the final mixture through a 0.2 μm syringe filter.  For 
storage, the culture medium was kept at 4 oC.  
 




Peptone 10.0 12.0 
Yeast extract 5.0 24.0 
Agar 15.0 - 
NaCl 10.0 - 
KH2PO4 - 2.3 
K2HPO4•3H2O - 16.4 
Glucose 4.0 - 
Glycerol - 5.0 
Ampicillin 0.1 0.2 
 
4.2.2  Cultivation and storage of recombinant E. coli biocatalyst  
0.5 mL of the preculture as described in section 4.2.1 (OD660~0.6) was further 
cultured in a 1 L Nalgene bioreactor containing 500 mL of TB medium and 
ampicillin at a concentration of  0.2 g/L. The temperature was kept at 37 oC 
and the stirring rate was 300 rpm. The fermentation was aerated through a 
sparger using a small aquarium pump. Antifoam in ppm level was added to 
reduce foaming. Culturing was continued until the OD660 reached about 0.6-
0.8 which took approximately 5-6 hours. At this point, IPTG was added to a 
final concentration of 0.2 mM to induce gene expression. Culturing was 
continued for a total of 24 hours. The cells were harvested by centrifugation 
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(4000 rpm, 20 min) and were stored at 4 oC as a 50 gwcw/ L cell suspension in 
50 mM potassium phosphate buffer pH 6.0. The recombinant E. coli cell line 
can be maintained by plating the cells monthly on new LB-agar plates 
containing 0.1 g/ L of ampicillin. The cells were incubated at 37 oC overnight 
and subsequently stored at 4 oC. The amount of harvested cells was calculated 
based on the calibration curve shown in Figure 4-6. The graph shows the 
actual optical density (OD); for measurements, the samples were diluted to 
keep the OD always below 1.0. The actual OD was calculated as: actual OD = 
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Figure 4-6. Calibration curve of cell density (wet cell weight) against the 
optical density measured at 660 nm. 
 
4.2.3  Batch bio-reduction of pro-chiral ketones 
0.1 gwcw of biocatalyst was weighed in a 100 mL conical flask and suspended 
in 25 mL of 50 mM potassium phosphate buffer pH 6. Substrate and 
isopropanol were added to the buffer to a final concentration of 100 mM and 
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200 mM, respectively. The flask was shaken with a shaker (Gallenkamp) at 
120 rev/min and 37 oC for 3 h. The cells were spun down by centrifugation 
(4000 rpm, 10 min), and the supernatant was extracted thrice with an equal 
volume of diethyl ether. The solvent was evaporated off and the sample was 
analyzed using GC (see section 4.2.5).  For the recycle study, the E. coli cell 
pellet was resuspended in 25 mL of 50 mM potassium phosphate buffer pH 6, 
the cells were spun down again and the washing buffer was discarded. The 
resulting cell pellet was again suspended with 25 mL of the same buffer and 
the reaction was carried out again.  
 
4.2.4  Effect of different pH  
The bio-reduction was carried out using different buffers in the pH range from 
4 to 9. All the buffers were prepared with 50 mM buffer strength. Sodium 
acetate-acetic acid was used to prepare acetate buffers pH 4 and pH 6. Tris-
HCl was used to prepare pH 7 and pH 9 buffers.  
 
4.2.5  Analysis of samples 
The conversion of the substrate was determined by using an Agilent 6890 GC 
with a capillary column HP-5, and the enantiomeric excess of the sample was 
determined with a chiral capillary column Supelco BetaDex 325.  Figure 4-7 
shows an example of the GC chromatogram of a mixture of ethyl acetoacetate 
(EAA) and ethyl hydroxybutyrate (EHB) analyzed with the HP-5 column. The 
peak appearing at 3.935 minutes is attributed to EHB. EAA is known to exist 
as an equilibrium mixture of the keto and enol forms [37-39]. The peak at 
3.417 minutes is the enol form of EAA and at 4.157 minutes is the keto form 
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of EAA. The surprising observation that the keto- and enol forms interconvert 
so slowly that they can be separately detected by gas chromatography had 
been first reported by Jackson et al. [40] using a Gas Chromatography-Mass 
Spectrometry-Matrix-Isolation Fourier Transform InfraRed spectrometry (GC-




Figure 4-7. GC chromatogram of a mixture of EAA and EHB, program: 80 oC 
(5 min), 25 oC/ min to 250 oC (5 min).  
 
 
 For the analysis of the enantiomeric excess, it was necessary to have a 
racemic mixture as reference standard. This was prepared by reducing the 
prochiral ketone substrate overnight with 1.2 equivalents of NaBH4 in alcohol 
(depending on the side chain of the ester group, eg. MeOH for methyl 
acetoacetate and EtOH for ethyl acetoacetate) to prevent possible 
transesterification. The reaction mixture was quenched with excess water and 
neutralized with HCl. The solution was then extracted thrice with diethyl ether 
and the organic phase was washed with saturated aqueous sodium bicarbonate. 
The resulting organic phase was dried over anhydrous sodium sulfate and the 
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solvent was evaporated under reduced pressure. The sample to be analyzed 
with a chiral column has to be diluted in order to get a good separation of the 
enantiomers. Figure 4-8 shows an example of the separation of the racemic 
mixture of EHB (Figure 4-8a) and the chiral EHB produced from the 
enzymatic reduction (Figure 4-8b). The optical activity (+, -) of the product 
was further confirmed using a polarimeter (Perkin Elmer Model 341). 
 





Figure 4-8. GC chromatogram for (a) racemic mixture of EHB, (b) EHB 
product from enzymatic reaction, program: 80 oC (20 min), 20 oC/min to 180 
oC (5 min). 
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4.3  Results and discussion 
4.3.1  Genetically modified biocatalyst E. coli BL21 star (DE3) 
E. coli cells were successfully transformed on an ampicillin containing LB 
plate. In the presence of ampicillin, only those E. coli which have the plasmid 
copies can survive. For a selection of colonies which produce a high level of 
LbADH, the concentration of the ampicillin was increased from 50 mg/L in 
the original protocol to 100 mg/L to ensure that only bacterial cells with a 
higher number of plasmid copies were selected. By doing so, a strain of 
recombinant E. coli which had a very high activity for the production of chiral 
alcohol was obtained. 
 
4.3.2  Cultivation of recombinant E. coli 
The cultivation conditions are very important in order to obtain a large amount 
of active biocatalyst. For typical 500 mL batch fermentation, antifoam in ppm 
level has to be added in order to reduce the foaming caused by the air pump 
but at the same time, excess antifoam is unfavorable because this will reduce 
the amount of dissolved oxygen which is available to the bacterial cells, 
causing a reduced amount of the harvested bacterial cells.  
 Besides that, it was also found that a higher concentration of ampicillin 
(200 mg/L) is needed in order to retain the high activity of the biocatalyst 
when conducting the fermentation at a large scale. Figure 4-9 shows the 
growth curve of the recombinant E. coli. The graph was plotted as mean ± 
standard deviation based on three individual experiments. The graph shows 
that there was a 3 h induction period (lag phase) before the bacteria started to 
grow. After that, the cell growth followed an exponential growth and 
 95 
eventually leveled off. The bacterial cells were induced with IPTG when the 
OD660 of the culture reached between 0.6-0.8; this took usually about 5-6 h 
fermentation time. IPTG is used as a molecular mimic of allolactose, a lactose 
metabolite that triggers transcription of the lac operon. However, the thioether 
bond within the molecular structure cannot be hydrolyzed so that the cells 
cannot consume or degrade the inductant. Therefore, the inductant level will 
















Figure 4-9. Growth curve of the recombinant E. coli. Cell culture condition: 
500 mL TB medium,  0.2 g/L ampicillin, 37 oC, 0.5 mL preculture with 
OD660=0.6. The arrow shows the time point where IPTG induction was carried 
out. 
 
4.3.3  Kinetic study of the bio-reduction of EAA to (R)-EHB  
The bio-reduction of the pro-chiral ketone EAA using recombinant E. coli was 
studied. It is known that native E. coli also carries an ADH [41], therefore a 
control test has to be done. It was found that native E. coli did not show any 
activity towards the reaction even after 24 h reaction time. Therefore, the 
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contribution of the native E. coli ADH towards the reaction is considered 
negligible. Figure 4-10 shows the kinetics of the reaction catalyzed by the 
recombinant E. coli. From the result, the recombinant E. coli gives an initial 
production rate of 0.6 mmolEHB•min-1•gwcw-1. The reaction yielded about 98 % 
conversion to produce >99 % of (R)-EHB in 3 h reaction time.  
 IPA was added to the reaction as a co-substrate for the regeneration of 
the cofactors. The oxidation product of IPA is acetone, which is much more 
volatile and should easy to be removed from the equilibrium. Besides that, 
IPA also served as a co-solvent to increase the solubility of the organic 
substrate in aqueous buffer solution. The solubility of EAA is 2.86 g/ 100 mL 
in water which corresponds to 0.2 M. However, with IPA as a co-solvent in 
the ratio of 2 IPA: 1 EAA, the maximum solubility of the organics in the 


















Figure 4-10. Kinetic study of the bio-reduction of EAA to (R)-EHB. Reaction 
conditions: 100 mM EAA, 200 mM IPA in 50 mM phosphate buffer pH 6, 0.1 
gwcw at 37 oC. 
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 Michaelis-Menten kinetics in a batch reaction were determined by 
varying the concentration of EAA in the study. The reaction time was varied 
from 1.5 to 11 min in order to obtain the initial rate of the reaction in which 
the conversion of EAA is always below 10 %. The result is shown in Figure 4-
11. No product inhibition was observed from the plot. Non-linear fits of the 
data (Origin software) were used to calculate the Michaelis-Menten constant 
(KM) which was 2.38 mM. The relatively small KM value shows that the 
recombinant ADH has high affinity towards the EAA substrate because it only 
requires 2.38 mM of the substrate to reach half saturation of the biocatalyst. In 
our reaction condition, the initial substrate concentration was always much 
larger than the KM value, so that the reaction rate only depends on how fast the 
biocatalyst-substrate complex turns to product and not how fast the biocatalyst 
meets the substrate.  






























Figure 4-11. Michaelis Menten plot for bio-reduction of EAA to EHB. 
Reaction conditions: EAA: IPA = 1:2, 25 mL, 0.015 gwcw, 37 oC, 110 rev/min. 
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 A Lineweaver-Burk plot is useful to present the measurement 
graphically as shown in Figure 4-12. The maximum reaction rate (Vmax) and 









M +=  
in which v is the reaction rate, KM is the Michaelis-Menten constant, Vmax is 
the maximum reaction rate and [S] is the substrate concentration.  






















Figure 4-12. Lineweaver-Burk plot for bio-reduction of EAA to (R)-EHB. 
Reaction conditions: EAA: IPA = 1:2, 25 mL, 0.015 gwcw, 37 oC, 110 rev/min. 
 
 
 From the plot, the maximum reaction rate for this reaction is 7.17 
μmolEHB/min and the KM value was determined to be 2.13 mM. However, the 
KM determined from the non-linear fits is more accurate than the value 
obtained using the Lineweaver-Burk plot; this is due to the fact that more 
errors will be imposed during the linearization process by taking the reciprocal 
of the reaction rate as the y-axis and a large extrapolation has to be made. 
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Nevertheless, the KM of 2.13 mM obtained from the Lineweaver-Burk plot is 
very similar to the value of 2.38 mM determined from the non-linear fits.  
 
4.3.4  Effect of pH and temperature of reaction 
Optimization of the reaction conditions was carried out by varying the 
temperature and the pH. The reaction temperature was varied from 25 oC to 55 
oC and the results are shown in Table 4-3. At 25 oC, the conversion during the 
first hour of reaction was reduced. On the other hand, a very fast reaction rate 
is observed at the higher temperature of 55 oC. However, upon recycle, the 
activity of the bacterial cells was drastically reduced; this confirms the 
instability of the cells at higher temperature. To gain a balance between 
reaction rate and reusability of the biocatalyst, 37 oC was chosen for further 
experiments. 
 
Table 4-3. Effect of temperature on bioreduction of EAA to (R)-EHB.  
Reaction condition: 0.1 gwcw, 100 mM EAA, 200 mM IPA, 1 h. 
Conversion (%) 
Cycle 
25 oC 37 oC 55 oC 
1 32 70 90 
2 32 70 59 
 
 The effect of the pH was also investigated and the result is shown in 
Figure 4-13. It is unsurprising to observe that recombinant E. coli cells work 
best at reaction condition close to neutral pH. The bacterial cells showed a 
significant loss of activity when they were recycled after the reaction had been 
carried out at extreme pH such as pH 4 and 9. However, pH 6 was chosen over 
pH 7 as the optimal reaction condition due to the observation that the reaction 


















Figure 4-13. Effect of pH on bio-reduction of EAA to (R)-EHB. (□) fresh 
biocatalyst, (■) recycle biocatalyst. Reaction condition: 0.1 gwcw, 100 mM 
EAA, 200 mM IPA, 37 oC, 3 h.  
 
4.3.5  Bio-reduction of other keto- esters and acetophenone 
Recombinant E. coli over-expressing LbADH is able to convert a number of 
keto esters to the corresponding chiral alcohols with excellent enantiomeric 
excess (Table 4-4). This include chlorine atom containing compound such as 
ethyl 4-chloro-3-oxobutanoate (entry 4). However, the branched molecule, 
methyl 4-methyl-3-oxopentanoate, was not accepted as substrate (entry 5). 
This is probably caused by the more bulky residue attached to the carbonyl 
group of this keto ester which can not fit into the active site of the enzyme. 
The activity of the cells for the reduction of simple ketones was also 
investigated. Acetophenone is reduced at a much lower rate compared to the 
other keto esters. This confirms the observation by Weckbecker et al. who 
reported that the activity of LbADH towards EAA was 4.36 relative to that of 
acetophenone which was taken as 1 [24].  
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Table 4-4. Different substrates for bio-reduction using recombinant E. coli. 
 
Entry Substrate Conv.% Product ee % 
 
 
 In all cases, the recombinant cells produce alcohols with the same 
absolute configuration at the optically active center. This is generally the (R)-
form, except for the case of methyl 4-chloro-3-oxobutanoate where the 

















































> 99 (R) 
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4.4  Conclusions 
The biotransformation of E. coli into a recombinant whole cell “cell factory” 
over-expressing an alcohol dehydrogenase of L. brevis (Lb) and the 
subsequent cultivation of the cells was successful. The resulting recombinant 
cells were used for the reduction of several pro-chiral ketons to chiral alcohols 
using a substrate coupled approach for co-factor regeneration. This whole cell 
biocatalyst approach is highly promising in this reaction which involves 
cofactor. The regeneration of the cofactor using the substrate coupled 
approach is highly economic. The recombinant E. coli over-expressing 
LbADH shows excellent conversion and enantiomeric excess to yield 
generally the (R)-form of the chiral alcohols and the reaction conditions are 
mild (aqueous buffer pH 6, 37 oC, atmospheric pressure). This is in contrast to 
reductions using expensive chiral versions of complex hydrides such as 
NaBH4 or LiAlH4 or hydrogen gas at elevated pressure in combination with a 
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Chapter 5  Immobilized Recombinant Escherichia coli for Continuous 
Production of Chiral Alcohols  
 
5.1  Introduction 
 As shown in Chapter 4, recombinant DNA technology has enabled the 
creation of “designer bugs”. The resulting recombinant Escherichia coli (E. 
coli) cells are capable to reduce pro-chiral ketones with high conversion and 
excellent enantiomeric excess. However, in order to be applied to continuous 
reaction, immobilization of the biocatalyst within the reactor is a prerequisite. 
Therefore, this chapter will discuss the immobilization of E. coli whole cells 
for continuous production of chiral alcohols. 
 Immobilization of the cells on a support is promising for cell reuse, 
because it eliminates the costly processes of cell recovery by centrifugation or 
cross-flow filtration, and moreover, offers stability advantages over free cells 
[1, 2]. The principal methods for whole cell immobilization are adsorption, 
covalent binding, encapsulation, entrapment, crosslinking, or combinations 
thereof [3-5]. The successful immobilization of a variety of cells in different 
matrices has been reported such as calcium alginate [6-10], carrageenan [11, 
12], porous glass beads [13], porous material with cationic polymers [14], 
polyurethane foam particles [15-17], and others [18-22]. Schroer et al. showed 
the first example of a continuously operated biotransformation process 
catalyzed by recombinant E. coli using a membrane reactor [23]. Using a 0.05 
L membrane reactor equipped with an ultra-filtration membrane (10 kDa 
MWCO), they successfully produced (R)-methyl-3-hydroxybutyrate with a 
maximal space time yield 700 g• L-1•day-1 by the substrate coupled approach 
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for cofactor regeneration. The biomass concentration within the reactor ranged 
from 50 to 200 gwcw/L. However, problems such as membrane failure are 
common for membrane reactors and the higher cost of the ultra-filtration 
membrane adds to the cost of production. In this chapter, we describe an 
alternative for easier and cheaper immobilization matrices of the biocatalyst 
for effective continuous production of chiral alcohols. Since whole cells are 
generally more sensitive towards immobilization than isolated enzymes, only 
immobilization of whole cells by the entrapment approach has been 
investigated in this study. Two matrices for entrapment were chosen namely 
alginate and polyacrylamide. 
 Alginate is one of the biopolymers that have been studied extensively 
as immobilization matrices. Alginates are linear heteropolysaccharides 
consisting of residues of 4-linked β-D-mannuronic acid and its C-5 epimer, α-
L- guluronic acid, which occurs in blocks. Alginate is normally obtained in the 
sodium salt from the cell wall of brown algae. Alginate has to contain a certain 
proportion of guluronic acid monomers in series in order to react with divalent 
ions to form a gel as can be seen in Figure 5-1a. The divalent ions such as 
calcium ions fit into the guluronic acid structure like an egg in the eggbox as 
shown in Figure 5-1b [24]. Immobilization of cells occurs on the entrapment 
during the gelation process in the presence of divalent ions such as calcium 
and barium ions by ion exchange with the sodium ions. Each calcium ion 
(shown as black dot in Figure 5-1b) coordinates to two alginates chains, in this 
way linking them together.  
 Fatima et al. investigated the use of calcium alginate immobilized 
Candida viswanathii for the reduction of various aryl and heteroaryl pro-chiral 
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ketones [25]. They found that the calcium alginate immobilized cells can be 
used in an aqueous system and also in the presence of organic solvents and 
ionic liquids. This is desirable because organic substrates normally will have 
limited solubility in aqueous systems, and the addition of suitable organic 
solvents will help to increase the concentration of the substrate in the aqueous 
system. Quintana immobilized a recombinant strain of E. coli pKST11 over-
expressing toluene dioxygenase from Pseudomonas putida UV4 with barium 
alginate [26, 27]. The production of toluene cis-diol in a fluidized-bed reactor 
packed with the barium alginate immobilized cells in the presence of flowing 
oxygen was more than 24 times higher than the values reported in the 


















     (a)       (b) 
Figure 5-1. (a) Calcium ion positioning between the guluronic acid dimmers, 
(b) alginate gelation. 
 
 Polyacrylamide gels are formed by copolymerization of acrylamide in 
the presence of a bifunctional crossliker such as methylbisacrylamide (bis) in 
aqueous solution. This free-radical initiated reaction produces a polymer with 
a three dimensional mesh-like network, with acrylamide chains interconnected 
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by the crosslinker as shown in Figure 5-2. The cells will be trapped and 
immobilized within the polymer network during the polymerization process.  
 Lin et al. immobilized Lactobacillus delbrueckii ssp. bulgaricus in 
polyacrylamide and the immobilized cells were tested for the production of a 
conjugated linoleic acid (CLA) [28]. Entrapment of the cells in 
polyacrylamide gave a significant improvement in total CLA level. The 
polyacrylamide immobilized cells showed four times higher production of 
CLA as compared to free cells and two times higher than chitosan 





Figure 5-2. Copolymerization of acrylamide and bis. 
 
 
 Based on the above reviews, significant improvement of the chemical 
productivity and increased stability are observed via immobilization. In 
addition, immobilization also provides a convenient and effective way to 
recycle the biocatalyst for subsequent chemical synthesis. Our work in 






5.2  Materials and methods 
Alginic acid sodium salt from brown algae, acrylamide and methyl 
bisacrylamide (bis), were purchased from Fluka. Tetramethylethylenediamine 
(TEMED) and ammonium persulfate were purchased from Pharmacia Biotech.  
 
5.2.1  Immobilization of recombinant E. coli in calcium alginate 
The procedure for transformation of E. coli with plasmids bearing the gene 
encoding for LbADH and subsequent cultivation of the cells has been 
described in 4.2.1 and 4.2.2 respectively. To prepare calcium alginate 
immobilized cells, 2.0 g alginic acid sodium salt was heated in 80 mL of 50 
mM acetate buffer pH 6 to give a clear solution. The alginate solution was 
then cooled to room temperature with stirring. 2.0 g of wet cells were washed 
once with 50 mM acetate buffer pH 6 and suspended in 20 mL of the same 
buffer and added to the alginate solution to give a final concentration 2 % (w/v) 
sodium alginate solution containing 20 mgwcw/mL of cells. The homogeneous 
mixture was extruded drop-wise into 200 mL of 0.1 M calcium chloride 
solution via a syringe needle (20 G x 3.5” BD™ Quincke spinal needle). The 
calcium chloride hardening bath was stirred at 100 rpm during the addition. 
The experimental setup is shown in Figure 5-3.  
 After finishing the addition, the formed beads with the immobilized 
cells were kept stirring for another one hour to ensure complete hardening. 
After that, the beads were filtered off and washed with 100 mL of 0.1 M 
calcium chloride solution. They were then suspended in 100 mL of the same 
solution and kept at 4 oC overnight for complete curing. Figure 5-4 shows the 
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calcium alginate immobilized E. coli cells. The immobilized biocatalyst was in 





Figure 5-3. Experimental setup for preparation of calcium alginate 










5.2.2  Effect of pH on the preparation of calcium alginate immobilized E. 
coli cells 
Two different buffers were used in dissolving the sodium alginate and 
suspending the cells, namely a 50 mM acetate buffer for pH 6 and a 50mM 
Tris buffer for pH 7. The procedure was otherwise the same as for the 
preparation of calcium alginate immobilized cells described in 5.2.1. 
 
5.2.3  Immobilization of recombinant E. coli in polyacrylamide polymer 
A stock solution of 16 % (w/v) acrylamide and 0.4 % (w/v) bis was prepared 
using 50 mM phosphate buffer pH 6. 5 mL of this monomer and crosslinker 
solution was deaerated under vacuum to remove the dissolved oxygen. After 
that, a cell suspension in 50 mM phosphate buffer pH 6  (1 gwcw in 5 mL) was 
quickly mixed with the deaerated solution and this yielded a monomer 
solution with final concentration of 8 % (w/v) acrylamide and 0.2 % bis 
solution containing 0.1 gwcw/mL of cells. To this solution, 50 μL of 18 % (w/v) 
ammonium persulfate (initiator) and 14 μL of TEMED (catalyst) were added. 
The solution was swirled to mix and quickly cast into a dual gel caster (Hoefer 
Mighty Small, 10 cm x 8 cm x 0.075 cm). 100 μL of milli-Q water was 
layered at the top of the solution to prevent the contact of the mixture with air 
which could result to inefficient polymerization of the polyacrylamide. Each 
gel caster could hold up 5 mL of solution and this will give a resulting 
polyacrylamide sheet with dimension (8.3 cm x 8 cm x 0.075 cm).  After 
polymerization for 2 h, the polyacrylamide gel was washed with 50 mM 
phosphate buffer pH 6 and cut into small sheets of dimension of 1 cm x 1 cm x 
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0.075 cm.  The gel was washed thrice with 50 mM phosphate buffer pH 6 and 
can be stored in the same buffer at 4 oC. 
 
5.2.4  Determination of cell loading  
For calcium alginate immobilized cells, the calcium alginate beads were 
dissolved as described by Xue et al. [29]. A known amount of immobilized E. 
coli (10 beads) was weighed and added to a 0.06 M trisodium citrate solution 
pH 7.8- 8.2 in a 5 mL volumetric flask. The beads were stirred at 200 rpm 
until they were totally dissolved and yielded a cloudy cell suspension. The 
optical density (OD) of the suspension was measured at 660 nm. The cell 
density corresponding to the OD was determined from a calibration curve. For 
polyacrylamide immobilized cells, all the cells were assumed to be 
successfully trapped within the gel. Therefore, the cell loading for the gel was 
taken as 0.1 gwcw/ cm3.  
 
5.2.5  Batch bio-reduction of keto-esters and acetophenone 
For bio-reduction using free cells and immobilized cells, the same amount of 
0.1 gwcw of biocatalyst was used. The batch reaction using free cell has been 
described in section 4.2.3. For reaction with immobilized cells, beads 
containing 0.1 gwcw of cells (based on cell loading) were weighed and 
suspended in 25 mL of 50 mM phosphate buffer pH 6 in a 100 mL conical 
flask. Substrate and isopropanol were added to the buffer to a final 
concentration of 100 mM and 200 mM, respectively. The reaction flask was 
shaken with a shaker (Gallenkamp) at 120 rev/min and 37 oC for 3 hours. 
After the removal of the immobilized biocatalyst by gravity filtration, the 
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reaction mixture was extracted thrice with an equal volume of diethyl ether. 
The solvent was evaporated off and the sample was analyzed using GC. The 
details of the GC analysis have been given in section 4.2.5. For recycle, the 
beads were separated from the reaction mixture by filtration and washed with 
100 mL of acetate buffer pH 6, and then used for the subsequent recycle test.  
 
5.2.6  Continuous bio-reduction of EAA 
Continuous bio-reduction of EAA was studied using a plug flow reactor as 
shown in Figure 5-5.  
 
 
Figure 5-5. (a) Experimental setup for continuous bio-reduction of EAA using 
calcium alginate immobilized E. coli cells, (b) schematic diagram. 
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 The calcium alginate beads with the immobilized cells were packed in 
a water jacketed tubular reactor (inner diameter 16 mm, length 480 mm), and 
the temperature was maintained at 37 oC. The amount of wet cells in the 
reactor was about 1.7 to 2.0 gwcw (based on three individual experiments). The 
retention time was controlled at 3 h. Substrate solution containing EAA and 
IPA in the ratio of 1:2 in 50 mM of acetate buffer and 2 mM of MgSO4 was 
continuously fed into the reactor. The eluent was continuously monitored 
using a polarimeter (Perkin Elmer Model 341) by recording the optical 
rotation. Table 5-1 summarized the parameters used in the reaction.   
 
Table 5-1. Parameters setup of continuous bio-reduciton of EAA.  
 
Tubular reactor Inner diameter:16 mm, Length: 480 mm  
Reactor volume 96 mL 
Flow rate  32 mL/h 
Retention time (τ) 3 h 
EAA: IPA 1: 2 
Temperature 37 oC 
Product monitoring Optical rotation (Perkin-Elmer 341) and 
GC (Agilent with capillary column HP-5) 
5.3  Results and discussion 
5.3.1  Choice of entrapment matrix 
In this study, polyacrylamide and calcium alginate were used as the 
entrapment matrix for the whole cell biocatalyst. Kinetic studies with cells 
immobilized in different matrices were carried out and compared with results 
obtained with the free cells. The result is shown in Figure 5-6. Both the 
polyacrylamide and calcium alginate immobilized cells gave the same reaction 
rate as the free cells, and all of them performed equally well in term of 
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reaction rate and could achieve 98 % conversion in 3 h reaction time. This 
result indicates that no substrate and product diffusion limitation occurs for 
polyacrylamide or calcium alginate immobilized cells. However, further 
investigation of the reusability of the biocatalyst reveals that calcium alginate 
immobilization gave a better entrapment of the cells, and a high activity could 



















Figure 5-6. Conversion against time for the bio-reduction of EAA. (○) free 
cells, (□) polyacrylamide immobilized cells, (▲) calcium alginate 
immobilized cells. Reaction condition: 100 mM EAA, 200 mM IPA in 50 mM 
acetate buffer pH 6, 0.1 gwcw, 37 oC. 
 
 
Table 5-2. Recycle test of immobilized cells in different entrapment matrices. 
Conversion (%) 
Cycle 
Calcium alginate Polyacrylamide 
1 97.7 97.6 
2 97.1 97.1 
3 97.5 92.9 
4 97.4 89.6 
Reaction condition: 100 mM EAA, 200 mM IPA, 0.1 gwcw, 37 oC, 3 h.  
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 Therefore, alginate was chosen as the immobilization matrix for 
subsequent optimization. In addition, because alginate is cheap, easily 
available, and nontoxic, it is preferred over polyacrylamide. Calcium alginate 
immobilized cells are also easily prepared in a spherical geometry which 
facilitates the packing of the biocatalyst into a plug flow reactor. On the other 
hand, polyacrylamide was prepared in a thin sheet geometry which stacked 
over each other during packing and probably gave rise to diffusion limitations 
accompanied by a more complex flow pattern within the reactor.   
 
5.3.2  Concentration of alginate 
Different concentrations (1 % to 4 %) (w/v) of sodium alginate were used to 
prepare the immobilized biocatalyst. It was found that the conversion of EAA 
to EHB was independent of the concentration of sodium alginate. With all of 
the immobilized biocatalysts, about 98 % conversion of 100 mM EAA could 
be achieved within 3 h reaction time. This is probably due to the fact that EAA 
is a rather small molecule; diffusion through the alginate network does not 
noticeably affect the reaction rate. Table 5-3 shows the cell loading on the 
calcium alginate beads which were prepared from different alginate 
concentrations. With higher alginate concentration, the cell loading in wet cell 
weight (wcw) per wet bead weight (wbw) is lower. From an economical point 
of view, it would be more favourable to choose a higher cell loading per 
weight of entrapment matrix. Therefore, it is more reasonable to choose 1-2 % 
(w/v) concentration of alginate. In addition, during the preparation of the bead, 
3 % and 4 % sodium alginate solutions are much more viscous, making the 
extrusion of the solution into the hardening bath more difficult. 2 % sodium 
 119 
alginate solution was preferred over 1 % for further studies because it only 
gives a slightly lower cell loading per wet bead weight but the higher 
mechanical strength of the bead significantly increases the potential for 
reusability.  
 
Table 5-3. Cell loading on calcium alginate bead prepared by using different 
alginate concentration. 
 






5.3.3  Effect of cell loading  
The bio-reduction of EAA was investigated as a function of the cell loading 
within 2 % sodium alginate beads. Figure 5-7 shows that the exact cell loading 
per bead was linearly proportional to the initial cell concentration used during 
the immobilized cell preparation. The result suggests that 2 % alginate is 
sufficient to entrap all the cells at least up to 120 mg/mL without any 
observable cell leaching. However, further studies of the bio-reduction of 
EAA in batch mode revealed that higher cell loading per bead resulted in a 
lower conversion of EAA as shown in Figure 5-8. Under these conditions, the 
cells agglomerate, and this reduces the surface area available for the bio-
reduction. Only cells near the surface take part in the reaction, whereas cells 
deeper inside the beads cannot be reached by the substrate. Besides that, 
smaller pores might also lead to additional diffusion limitation problems. All 
of these causes lead to a slower reaction rate for the immobilized cells at a 
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higher cell loading. Therefore, for subsequent optimization, a cell 
concentration of 20 mg/mL was used as the initial cell concentration in 
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Figure 5-7. Exact cell loading of the 2 % calcium alginate immobilized E. coli 



















Figure 5-8. Effect of cell loading on the bio-reduction of EAA to (R)-EHB. (●) 
20 mg/mL, (○) 40 mg/mL, (x) 60 mg/mL, ( _ ) 80 mg/mL, (▲) 100 mg/mL. 
Reaction condition: 100 mM EAA, 200 mM IPA in 50 mM acetate buffer pH 
6, 0.1 gwcw, 37 oC, 3 h. 
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5.3.4  Influence of the ions for the hardening bath 
It is known that the affinity of alginates for alkali metals increases in the order 
Mg2+<< Ca2+ < Sr2+ < Ba2+ [30]. Calcium and barium ions were chosen as the 
divalent ions in the hardening bath to study the effect on the mechanical 
strength of the beads. The results of the repetitive batch reaction during an 



















Figure 5-9. Effect of divalent ions used in the hardening bath. (▲) barium 
alginate, (○) calcium alginate. Reaction condition: 100 mM EAA, 200 mM 
IPA in 50 mM acetate buffer pH 6, 0.1 gwcw, 37 oC, 3 h. 
 
 Both the calcium alginate and the barium alginate immobilized 
biocatalyst gave similar results when tested over 15 cycles at 37 oC. Calcium 
alginate dissolves in sodium citrate solution, with the citrate acting as a 
chelating agent for Ca2+ ions. On the other hand, barium alginate is tough 
enough to remain in bead shape after stirring in citrate buffer for 24 h. 
However, the increased robustness of the barium alginate beads did not lead to 
a better performance during the recycling, and in both cases, the biocatalyst 
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lost about 25% of their initial activity after 15 cycles of reuse. It might be that 
cell leaching only happened within the beads’ outer surfaces, or the decrease 
of activity is simply due to the deactivation of the biocatalyst. Since the use of 
barium alginate leads to a more difficult analysis of the exact cell loading, 
calcium alginate was used for all further investigations.   
 
5.3.5  Effect of pH in the preparation of calcium alginate immobilized 
cells 
In chapter 4, we reported that the best performance of the recombinant E. coli 
in the bio-reduction of EAA was obtained in solution buffered near neutral pH. 
Therefore, the optimum pH to be used during the immobilization process in 
calcium alginate was further fine tuned. Acetate buffer pH 6 and Tris-HCl 
buffer pH 7 were used as the buffer in dissolving sodium alginate and 
preparing the cell suspension. The bio-reduction was carried out in buffered 
solutions with the respective pH at 37 oC in a repetitive batch mode manner. 
Figure 5-10 summarizes some of the results.  
 During early runs, cells immobilized at pH 6 and pH 7 gave similar 
performance; however, the activity of cells immobilized at pH 7 decreased 
more rapidly than that of cells immobilized at pH 6 and was lower by about 
20 % for the 6th cycle of re-use. Slightly acidic conditions were thus identified 




















Figure 5-10. Effect of pH on the preparation of calcium alginate immobilized 
cells. (▲) pH 6, (○) pH 7. Reaction condition: 100 mM EAA, 200 mM IPA in 




5.3.6  Reusability 
The stability and the reusability of the biocatalyst were studied in repetitive 
batch reactions and the results are shown in Figure 5-11. The conversion of 
EAA to EHB decreased drastically after the free cells had been recycled for 
six times, and less than 5 % of the initial activity remained at the 14th run. On 
the other hand, the cells immobilized in calcium alginate demonstrated 
excellent stability over many cycles, and the conversion of the EAA was more 
than 70 % even after 13 cycles. 
 Part of the drop in activity of the free cells may be caused by 
inefficient recovery of the biocatalyst by centrifugation after the reaction. The 
cell mass was checked at the end of the recycling experiment, and it was found 
that it had decreased significantly, from 0.100 g to 0.018 g. In contrast, about 
78 % of the cells remained entrapped in the calcium alginate after 14 cycles. 
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Additionally, the immobilized biocatalyst showed a higher activity as 
expressed in the productivity of 24.7 mmolEHB/gwcw compared to only 10.6 
mmolEHB/gwcw for the free cells. These results which suggest that stability and 
reusability of the biocatalyst can be significantly improved via immobilization 



















Figure 5-11. Process stability for free and immobilized cells in a repetitive 
batch reaction. (▲) calcium alginate immobilized cells, (○) free cells. 
Reaction condition: 100 mM EAA, 200 mM IPA in 50 mM acetate buffer pH 
6, 0.1 gwcw at 37 oC, 3 h.  
 
 
 The optimized calcium alginate immobilized E. coli cells were used to 
reduce different pro-chiral substrates to chiral alcohols in a batch wise mode 
(the activity of the free cells towards different substrates was reported in 
section 4.3.5). The immobilized cells generally performed as well as the free 
cells in terms of conversion and enantio-selectivity. Therefore, diffusion 





5.3.7  Continuous bio-reduction of EAA in a plug flow reactor 
In order to establish the optimum concentration of EAA for highest 
productivity, EAA concentrations from 0.3 M to 1 M were fed into the reactor. 
As shown in Table 5-4, 0.7 M of EAA (91 g/L) is the optimum concentration 
at 3 h retention time in the reactor. It is known that high concentrations of 
substrate or product can inactivate the enzyme, and a high concentration of 
organic solvents in the medium can lead to physiological changes in the cell 
wall. The maximal productivity obtained was 1.4 gEHB•gwcw-1•h-1 at a 
conversion of 81 %. However, the activity of the catalyst started to decrease 
gradually after 18 h. Further optimization of the reaction medium was carried 
out. When 2 mM Mg2+ was added to the substrate solution, the reactor could 
be operated for 30 h before eventually the activity of the catalyst gradually 
decreased as shown in Figure 5-12. Mg2+ is present in the active site of 
LbADH, and it is known that the binding of Mg2+ causes structural changes 
which activate the enzyme [31]. Therefore, the presence of Mg2+ in the 
substrate solution helps to maintain the stability of the enzymes within the 
whole cells. The effect is element specific, and no positive effect on the 
activity was observed when Ca2+ instead of Mg2+ was co-fed with the substrate 
solution. The performance of the continuous process under optimized 
condition is shown in Table 5-5. 
 The packed-bed reactor has demonstrated a productivity of 600 g• L-
1•day-1, which is comparable to the membrane reactor approach adapted by 
Schroer et al. who reported a productivity of 700 g• L-1•day-1 [23]. It is 
noteworthy that our system was operated using about ten times lower biomass 
concentration within the reactor. Thus, the biocatalyst showed significantly 
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higher efficiently in our system, which is 1.4 gEHB•gwcw-1•h-1 as compared to 
0.15 gEHB•gwcw-1•h-1in the system of Schroer et al. 
 
 
Table 5-4. Optimization of the substrate concentration.  
 
Wet cell 










(g EHB/ gwcw/ h) 
1.67 0.3 34 98 0.8 
1.67 0.5 32 97 1.2 
1.67 0.7 32 81 1.4 






























Figure 5-12. Stability of the continuous bio-reduction of EAA to (R)-EHB. 









Table 5-5. Optimized reaction conditions for continuous production of EHB. 
 
EAA concentration 0.7 M 
Conversion 0.81 
Biomass concentration 17 gwcw/L 
Space time yield 600  gEHB• L-1•day-1
Productivity 1.4  gEHB•gwcw-1•h-1
Enantiomeric excess > 99 % 
  
5.4  Conclusions 
Whole recombinant E. coli cells over-expressing LbADH were successfully 
immobilized using alginate as immobilization matrix. Cells immobilized by 
the optimized protocol show a better stability than the free cells, so that the 
activity of the biocatalyst is maintained over more cycles. Immobilization does 
not affect the reaction rate of the catalytic reduction or the excellent enantio-
selectivity obtained in the reaction. The continuous bio-reduction of EAA in a 
plug flow reactor using the immobilized cells is a simple and economical 
approach, and a productivity of 1.4 gEHB•gwcw-1•h-1 has been demonstrated by 
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Chapter 6  Cationized Bovine Serum Albumin (cBSA) as E. coli 
Immobilization Promoter for the Synthesis of Chiral Alcohols in a Micro-
reactor 
 
6.1  Introduction 
In this chapter, the potential of cationized bovine serum albumin (cBSA) as 
immobilization promoter to produce engineered biofilm within the micro-
reactor will be explored. The chapter starts with a review of enzymatic micro-
reactors, followed by the discussion on bovine serum albumin (BSA) and then 
explains the idea to cationize the protein for immobilizing the biocatalyst 
within the micro-reactor. The results obtained confirm the validity of the 
approach. 
 Considerable progress in the use of enzymatic micro-reactors has been 
reported. Even without immobilization of the enzyme, the trypsin-catalyzed 
hydrolysis of benzoyl-arginine-p-nitroanilide [1] and the glycosidase-
catalyzed hydrolysis [2] showed 3 to 5 times higher reaction yields in a 
continuous flow micro-reactor as compared to a normal batch reaction. This 
encouraging result confirms the excellent mass transfer in micro-reactor 
devices which leads to the improved chemical yields. 
  However, to be useful as a technology for industrial application, 
continuous flow enzymatic micro-reactors must integrate a convenient and 
effective recycling of the biocatalyst via immobilization. The ideal matrix for 
immobilization should have the following characteristics [3]: (i) large surface 
area, (ii) permeability, (iii) hydrophilic character, (iv) insolubility in the 
reaction medium, (v) chemical, mechanical and thermal stability, (vi) high 
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rigidity, (vii) chemical reactivity for coupling of the ligands, and (viii) 
resistance to microbial and enzymatic attack. A variety of methods is available 
for biocatalyst immobilization, and one of the most common methods is 
entrapment. Immobilization of a variety of cells by entrapment in different 
polymer matrices such as alginate, carrageenan, or polyacrylamide gels has 
been reported [4-6]. In the previous chapter, the use of calcium alginate as an 
immobilization matrix for the recombinant E. coli whole cell biocatalyst for 
the enantio-selective reduction of ethyl acetoacetate (EAA) to R-(-)ethyl 
hydroxybutyrate (EHB) has been described [7]. There, a high productivity of 
1.4 gEHB per gram of wet cell weight (gwcw) per hour with a space time yield 
of 600 gEHB•L-1•day-1 was demonstrated. However, the more common 
entrapment approach within a polymer matrix to produce immobilized beads 
might not be feasible for a micro-reactor format. Packing these immobilized 
biocatalysts in a packed bed might result in a complex flow pattern and high 
pressure drop across the micro-reactor. Therefore, covalent or non-covalent 
immobilization of the biocatalyst to produce a biofilm-coated micro-reactor 
will be more preferable, and these approaches will be reviewed in the 
following sections.   
 
6.1.1  Engineered biofilms by immobilization of the biocatalyst onto the 
micro-reactor walls 
The covalent immobilization of enzymes within micro-reactors was developed 
by Maeda et al. [8-10]. In their work, a solution of α-chymotrypsin was mixed 
with glutaraldehyde and formaldehyde as cross-linkers in aqueous buffer and 
introduced to the micro-reactor to form an engineered biofilm on the inner 
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wall of a polytetrafluoroethylene tubing (0.50 mm diameter) [10]. It was found 
that the enzymes immobilized in the micro-reactor maintained high activity for 
the enzymatic protein digestion for 40 days compared to 15 days for free 
enzymes. It was also observed that the enzymatic micro-reactor was resistant 
to chemical denaturants like urea and organic solvents like dimethyl sulfoxide 
(DMSO) in contrast to the free enzymes. These findings prove that stability of 
the enzymes can be greatly improved in their immobilized form.  
 Another more sophisticated approach was explored by Liu et al. Their 
immobilized enzymes were prepared by covalently attaching trypsin to amine-
functionalized magnetic nano-particles with glutaraldehyde as linkers [11]. 
The trypsin-immobilized magnetic nano-particles were organized on a glass 
microchip by an external magnetic field. Enzymes could be successfully 
immobilized at high density within the micro-reactor and complete protein 
digestion by the enzymes was observed within 10 seconds. 
  On the other hand, an example for non-covalent immobilization is 
electrostatic interaction. The strongest electrostatic interactions are ionic 
interactions [12]. Immobilization of different enzymes based on electrostatic 
interactions can be achieved by using mesoporous materials [13, 14], tethered 
metal ions, such as Cu2+, Co2+, or Ni2+ [15-17], and protein-coated micro-
crystals (PCMC) [18]. However, these mentioned immobilization matrices 
might not be suitable for application to the immobilization of biocatalyst 
within a micro-reactor. In the search for a more suitable immobilization matrix, 
Forrest et al. [19] introduced layer-by-layer (LbL) nano self-assembly to 
successfully immobilize organophosphorus hydrolase within a micro-reactor. 
The enzymes were immobilized on thin polymer films which were built up in 
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layers on the inner wall of the micro-reactor electrostastically. The polycation 
used was poly(ethylenimine) and the polyanion used was 
poly(styrenesulfonate). Hydrolysis of methyl-parathion was used as test 
reaction and the result showed that the rate of the reaction was faster than with 
the free enzymes. However, the activity of the micro-reactor dropped 
substantially over a period of 2 days indicating the short-coming of the micro-
reactor in terms of robustness. 
 As can be seen from this review, different approaches have been used 
in order to immobilize enzymes within micro-reactors. In general, covalent 
immobilization seems more promising because it produces a durable and 
robust coated micro-reactor. It should be noted, however, that most of the 
available reports on enzymatic micro-reactors describe the immobilization of 
enzymes instead of whole cells. A critical investigation of the immobilization 
of whole cells within micro-reactors has yet to be done to address the 
suitability of the immobilization approach. Such an investigation is important 
because whole cells are generally more sensitive towards immobilization than 
enzymes since cell viability is crucial to maintain high activity of the cells’ 
intrinsic enzymes. Therefore, whole cell immobilization via electrostatic 
interaction onto the wall of a micro-reactor is of interest due to the fact that it 
is fast, easy and mild. More importantly, it is expected to retain the viability of 
the cells since there is no need for chemical reagents which could be 
detrimental to the cells. Furthermore, the immobilization is reversible making 




6.1.2  Bovine serum albumin 
Bovine serum albumin (also known as BSA or "Fraction V") is a serum 
albumin protein with molecular weight ~ 66 kDa. This protein has been well 
characterized and the physical properties of the protein are well known [20]. 
Table 6-1 summarized the physicochemical properties of bovine albumin.  
 
Table 6-1. Physicochemical parameters of bovine albumin. 
Property Value Reference 
Sedimentation constant, S20, w x 1013 [s]   
       Monomer 4.5 22 
       Dimer 6.7 22 
Diffusion constant, D20,w x 107 [cm2/s] 5.9 23 
Partial specific volume, V20 [cm3/g] 0.733 24 
Intrinsic viscosity, η 0.0413 25 
Frictional ratio, f /fo 1.30 26 
Overall dimension, Å 40 x 140 22 
Isoelectric point (Γ/2 = 0.15) 4.7 27 
Isoionic point (Γ/2 = 0) 5.3 28 
Refractive index increment (578 nm) x 10-3 1.90 29 
Optical absorbance,  Lg nmA
/1
279
0.667 30, 31 
Estimated α-helix, % 54 32 
       β form, % 18 33 
  
 The nickname "Fraction V" refers to albumin being the fifth fraction 
obtained from blood plasma with the original purification method using cold 
ethanol precipitation developed by Edwin Cohn in 1946 [21]. The method 
makes use of differential solubility characteristics of plasma proteins. By 
manipulating parameters such as concentrations, pH, salt levels and 
temperature, it is possible to purify the albumin protein from the blood plasma. 
This process was first commercialized by purifying human serum albumin 
(HSA) for medical use and later on was adopted for production of BSA. BSA 
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can be readily purified from bovine blood which is a byproduct from cattle 
industry making it easily available at a much lower cost compared to HSA. 
 In reference [20], various natural bio-functionalities of BSA are 
discussed. The normal level of albumin in blood serum is 42 ± 3.5 g/L; 
albumin is synthesized by the liver and amounts to 60 ± 4 % of the total serum 
protein in the blood. Albumin plays an important role in several biological 
functions: It contributes to hemeostasis through the mechanism of 
hemodynamics, transport, and nutrition. Albumin exerts 80 % of the colloid 
osmotic pressure of the blood. Due to the fact that albumin binds to small 
hydrophobic molecules such as fatty acids, thyrosine, cortisol, heme, bilirubin, 
and many other metabolites, serum albumin is also important in normal fat 
metabolism which involves lipid transport and as buffer pool to stabilize the 
plasma concentrations of calcium, tryophan, and hormones. In terms of 
nutritive function, BSA can serve as a source of amino acids when circulating 
free amino acids are in short supply.  
 In general research applications, BSA has been extensively used in 
ELISAs (Enzyme-Linked ImmunoSorbent Assay), immunoblots, and 
immunohistochemistry. BSA is also commonly used as standard protein for 
the quantification of other proteins. BSA has a very stable structure which is 
kept together by the unusually high number of 18 disulfide bridges. What 
makes the molecule particularly attractive for chemical modifications is the 
fact that the first thiol residue in the chain (Cys-34) does not participate in the 




6.1.3  Cationization of bovine serum albumin 
Native BSA contains 41 aspartic acid, 59 glutamic acid, 59 lysine and 23 
arginine residues [20]. Since there are more negatively charged amino acid 
residues than basic residues, BSA carries a net negative charge at 
physiological pH [38]. In order to obtain cationzed bovine serum albumin 
which has a net positive charge at neutral pH, the acid functionalities of the 
glutamic acid and aspartic acid present in native BSA can be randomly 
converted into amino groups by reacting with ethylenediamine in the presence 
of carbodiimide as a coupling agent [39, 40]. The synthesis is shown in Figure 
6-1. After the chemical modification, the surface charge of the BSA was 
converted from anionic to cationic in physiological pH.  
 
 
Figure 6-1. Conversion of acid side groups of BSA into aminoethylene groups. 
 
6.1.4  Electrostatic immobilization of recombinant E. coli cells 
Bacterial cell walls are generally negatively charged due to the presence of 
lipopolysaccharides. Electrostatic interactions offer a fast, mild, and easy to 
implement approach for the immobilization of whole cells onto the wall of a 
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micro-reactor [41]. In contrast to the covalent attachment of cells, the 
attachment via non-covalent interactions involves less synthetic steps to 
chemically modify the glass surface and to connect the surface and the cells. 
In this way, no reactive reagents are needed, which is preferable because the 
use of chemical reagents can also decrease cell viability. The immobilization 
of several strains of E. coli with poly-L-lysine (PLL) as adhesion promoter via 
electrostatic interactions has been reported [42]. However, the application of 
PLL is limited by its cytotoxicity. On the other hand, the absence of 
cytotoxicity in cBSA was confirmed by Zöphel et al. in their study of cBSA as 
a carrier for cell transfection [40]. 
 cBSA converts the surface charge of BSA from anionic to cationic at 
physiological pH. This is important because most of the catalytic enzymes 
work best close to neutral pH. Therefore, the immobilization promoter must 
also maintain its cationic property close to neutral pH to ensure a strong 
immobilization between the whole cell and the immobilization matrix 
throughout the catalytic reaction.  
 Glass surfaces which have been incubated with cBSA assume a 
positive charge, and therefore can aid in immobilizing bacterial cells. The 
cartoon in Figure 6-2 illustrates the immobilization of E. coli cells at the glass 
surface by a cBSA coating. The glass surface can be pretreated by NaOH wash 
followed by HCl to generate a negatively charged surface to maximize the 
amount of adsorbed cBSA (positively charged) on the surface. Figure 6-3 
shows schematically the reactions taking place during the pre-treatment of the 





Figure 6-2. E. coli cells immobilization on a glass surface coated with cBSA 






Figure 6-3. Treatment of glass surface: (a) untreated silica surface, (b) after 
treatment with NaOH(aq), (c) after treatment with HCl (aq) and (d) after 
interaction with water at pH 7-8 [47].  
 
 
6.2  Materials and methods 
Tris(2-carboxyethyl)-phosphine hydrochloride (TCEP), bovine serum albumin 
(BSA) fraction V and tetramethylrhodamine-5-maleimide (TMRh-MI) were 
purchased from Sigma. Fluoresceine diacetate was obtained from Aldrich. 
Ethylenediamine (EDA) was purchased from Merck. 1-ethyl-3-(3’-
dimethylamino-propyl)-carbodiimide hydrochloride (EDC) was purchased 
from Fluka.  
 
6.2.1  Synthesis of Rhodamine-labeled bovine serum albumin  
The first thiol functional group of cystein of the BSA can be selectively 





labeling of the protein enables the subsequent qualitative or quantitative 
analysis of the Rhodamine-labeled cBSA by using fluorescence microscopy or 
UV-Vis detection. For the coupling reaction, 1 ml of a freshly prepared 
aqueous solution of TCEP (1 mM, 1µmol) was added to BSA fraction V (300 
mg, 4.5 µmol) in phosphate buffer (300 ml, 50 mM, pH 7.4) and the reaction 
mixture was stirred for 10 minutes at room temperature. A solution of TMRh-
MI (4.3 mg) in DMSO (1 ml) was added and the reaction mixture and stirred 
at room temperature for one hour under argon atmosphere. Excess dye was 
removed by ultra-filtration (Vivaspin20, 30 kDa MWCO) and size-exclusion 
chromatography (BioGel P 30, milli-Q water) and the recovered protein 
(cBSA-Rho) was lyophilized. 
 
6.2.2  Synthesis of cationized bovine serum albumin  
The procedure for achieving the highly cationic protein-polyelectrolyte has 
been disclosed by Zophël et al. [40].  EDA (10 mmol) was dissolved in 5 mL 
milli-Q water and the pH of the solution was adjusted to 4.75 with 6 N HCl. 
Rhodamine-labeled or unlabeled bovine serum albumin (0.75 μmol, 1 eq) was 
dissolved in 5 mL milli-Q water and added to the EDA solution. 1-ethyl-3-(3’-
dimethylamino-propyl)-carbodiimide hydrochloride (EDC, 94 μmol, 125 eq.) 
was added to the mixture and stirred for 2 hour at room temperature while the 
pH was maintained at 4.75. The cationization reaction was stopped by adding 
1 mL 4 M acetate buffer (pH 4.75). Low molecular weight species were 
removed by repetitive ultrafiltration (Vivaspin20, 30 kDa MWCO). The 
concentrated protein was dialysed against milli-Q water and lyophilized. The 
synthetic scheme of Rho-labeled cBSA is shown in Figure 6-4. 
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 Figure 6-4. Synthesis of Rhodamine-labeled cBSA.  
 
6.2.3  Preparation of the enzymatic micro-reactor 
A polyamide coated quartz capillary (Polymicro Technologies, Phoenix, Az, 
USA; ID: 0.53 mm, L: 30 m) was filled with 1 N NaOH and kept in an oven at 
80 oC for half an hour. The capillary was rinsed with milli-Q water to neutral 
pH, filled with 1 N HCl and allowed to stand for 10 min at room temperature. 
The capillary was again rinsed with milli-Q water to neutral pH and kept filled 
with milli-Q water until used. 
 After that, cBSA-Rho (10 mL, 10 μM) was circulated through the 
capillary at a flow rate of 0.16 mL/min. Circulation of the cBSA-Rho solution 
was monitored with a UV-Vis spectrometer at 560 nm, in order to quantify the 
amount of adsorbed cBSA-Rho from the change in absorbance in the solution; 
however, no significant decrease of the absorbance could be observed. An 
estimation of the saturation amount of cBSA which would coat the entire 
surface of the micro-reactor was made using the known parameters for native 
BSA. Taking the overall dimensions of BSA as 4 x 14 nm [44]), the 




Perimeter of the reactor,  P = πd = π x 530 μm = 1.67x10-3 m 
Surface area of the reactor A = P x L = 1.67x10-3 m x 31 m = 5.2x10-2 m2 
Surface area of one adsorbed BSA molecule = 4x10-9 m x 14 x 10-9 m 
      = 5.6x10-17 m2 
Number of adsorbed BSA molecules = 5.2x10-2 m2 / 5.6x10-17 m2  = 9.2x1014  
1 mol = 6.022x1023  molecules 
9.2x1014 molecules = 1.5x10-9 mol 
10 μM of cBSA-Rho solution = 0.1 μmol in 10 mL (stock solution) 
0.1x10-6 mol – (1.5x10-9) mol = 9.85x10-8 mol 
9.85x10-8 mol / 0.01 L = 9.85 μM 
From UV-Vis absorption (560 nm): 10 μM of cBSA-Rho = 0.195 A 
Expected absorbance (BSA saturation)= 0.195 A/ 10 μM x 9.85 μM = 0.192 A 
  
 From the calculation above, the maximum expected decrease of the 
absorbance based on the dimensions of native BSA is only 0.003 absorbance 
units. In reality, the dimension of cBSA should be slightly bigger after the 
cationization, hence the saturation amount of coated cBSA should be slightly 
lower as well. Therefore, the decrease of the absorbance will be too small to 
be observed even after reaching saturation coating point, which explains that 
there was no significant decrease of the absorbance after 3 h circulation time. 
However, the experiments described in 6.3.2 showed that complete films of 
cBSA formed rapidly on a glass surface. In view of this, the cBSA solution 
was circulated through the capillary for about 3 h for subsequent experiments, 
followed by rinsing with 50 mM phosphate buffer pH 6. For comparison, 
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poly-L-lysine [Sigma P8920, 0.1% (w/v)] was coated onto the micro-reactor 
using the same procedure.  
 After the cBSA coating, 25 mL of recombinant E. coli BL21 star (DE3) 
over expressing LbADH cell suspension (refer to section 4.2.1 and 4.2.2 for 
the procedure of transformation and cultivation of E. coli cells) with a 
concentration of 4 mg/mL was circulated through the pre-treated capillary at a 
flow rate of 0.16 mL/min. The optical density of the cell suspension was 
monitored at 660 nm. Circulation of the cell suspension was continued for 
about 4 to 5 hours until no further decrease in the optical density was detected. 
The optical density decreased initially more rapidly, starting from about 2.03 
and reached a final constant value of about 1.71. Subsequently, the resulting 
enzymatic micro-reactor was rinsed with 50 mM phosphate buffer (pH 6) and 
the amount of coated cells was determined from the difference in optical 
density of the final and the initial cell suspension. 
 
6.2.4  Bio-reduction of EAA in the micro-reactor 
The enzymatic micro-reactor was immersed in a thermostated water bath to 
maintain the reaction temperature at 37 oC. A substrate solution (25 mM EAA, 
50 mM isopropanol, 2 mM Mg2+ in 50 mM phosphate buffer pH 6) was 
pumped through the micro-reactor. The set up is shown in Figure 6-5. The 
solution exiting the reactor was collected and extracted twice with diethyl 
ether; the ethereal phase was dried over Na2SO4 and concentrated in vacuum. 
Thereafter, conversion was determined by using an Agilent GC with capillary 
HP5 column and the optical purity was quantified with a chiral column 








6.2.5 Microscopy imaging 
20 μL of a 10 μM cBSA solution was dropped onto a pre-treated teflon printed 
glass slide with 5 holes of 8 mm diameter (EMS, Electron Microscopy 
Sciences) and incubated for 10 min. The droplet was pipetted off and the slide 
was rinsed with milli-Q water. Thereafter, the slide was left to dry in a laminar 
flow hood. Then, 20 μL of an E. coli cell suspension (4 mg/mL) were added. 
After 10 min, the remaining cell suspension was pipetted off and the slide was 
again rinsed carefully with milli-Q water. Viability of the cells was examined 
by incubating the cells with fluorescein diacetate. Fluorescence images were 
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taken using an Olympus microscope BX 51. For axially resolved experiment, 
an Olympus FV300 inverted confocal microscope was used.  
 
6.2.6  Quartz crystal microbalance 
The adsorption kinetics of cBSA on a glass surface have been studied by 
means of a quartz crystal microbalance (QCM). A Q-Sense E1 model (Q-
Sense, Gothenburg, Sweden) with AT-cut quartz crystals (QSX 303) with a 
fundamental resonant frequency of 5 MHz was used. One side of each crystal 
was coated by the manufacturer with 50 nm of SiO2 on top of the gold 
electrodes to provide the surface for the adsorption measurements. The 
crystals were cleaned by immersion in a 5:1:1 mixture of milli-Q water, 
ammonia (25 % v/v) and hydrogen peroxide (30 % v/v) for 10 minutes at 75 
°C, followed by thorough rinsing with milli-Q water and drying with a dry 
nitrogen gas stream. The crystals were subsequently treated twice with UV 
light and ozone for 10 minutes and each time rinsed with ultrapure water to 
remove organic contamination. The freshly cleaned quartz crystal was directly 
mounted in a flow cell with the silicon oxide surface exposed to the solution. 
All measurements reported in this paper were done with the system 
temperature stabilized at 23±0.5°C. First the sample cell was filled with milli-
Q water and allowed to equilibrate for about 15 min. For adsorption of cBSA 
onto the bare surface, 1 mL of the protein sample solution (10 µg/mL) was 
pumped through the flow cell by a peristaltic pump at a flow rate of 250 
µL/min. The solution was incubated on the surface for approximately 30 min. 
To check if the adsorption is complete, another 500 mL of protein solution 
was added to the crystal and incubated for another 35 min. Afterwards the 
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surface was vigorously rinsed with ultrapure water at a flow rate of 1 mL/min 
for two minutes. The kinetics of sample adsorption and desorption were 
followed by changes in the resonant frequency and the dissipation of the 
crystal vibrations. Frequency and dissipation changes were recorded 
simultaneously at different overtones (n = 3 (15 MHz), 5 (25 MHz), 7 (35 
MHz), 9 (45 MHz) and 11 (55 MHz)). 
 
6.3  Results and discussion 
6.3.1  Synthesis of cationized bovine serum albumin 
Figure 6-6 shows the MALDI-TOF spectrum of the synthesized cBSA.  
















Figure 6-6. MALDI-TOF spectrum of the native and cationized BSA. 
 
 
 The increase of the molecular weight indicates the successful 
conversion of the acid group into amine group after coupling of 
ethylendiamine to the carboxylic acid group. The number of amine group on 
the protein surfaces was estimated as: number of primary amine groups = 59 
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lysine residues + 1 amino terminus + modified aminoethylene residues. For 
cBSA, the mass increased from about 66 kDa to 69.65 kDa, thus gives an 
average of about 60 + 87 aminoethylene = 147 amine groups on cBSA.  
 
6.3.2  Formation of cBSA monolayers on glass surfaces  
Cationized bovine serum albumin (cBSA) is characterized by a high density of 
primary amino groups, which are positively charged at a pH below 9. Due to 
its net positive charge, cBSA readily adsorbs on glass surfaces. The formation 
of cBSA monolayers was investigated via contact angle measurements (CA) 
as well as Atomic Force Microscopy (AFM). The contact angle between a 
water droplet and the cBSA coated surface was 61 ± 2 o compared to 30 ± 2 o 
on the blank glass slide, indicating the presence of a hydrophobic layer on the 
glass surface after exposure to cBSA. Figure 6-7 shows an AFM image of a 
glass slide before and after coating with cBSA. 
 The original glass surface was essentially smooth (Figure 6-7c); 
however, features of about 5 to 6 nm high with lateral width 150-200 nm were 
detected after incubation with the cBSA solution (Figure 6-7d). The observed 
features are slightly larger than the dimensions of the native BSA molecule (4 
x 14 nm) [44]. This is reasonable since the molecular dimensions of cBSA 
should slightly increase after the cationization process, but during adsorption 
of the protein on glass surface, the molecules might flatten themselves on the 
solid surface. The lateral dimensions are much bigger than expected because 
the resolution is limited by the dimensions of the probing tip. To confirm the 
formation of a homogeneous albumin layer, cBSA labeled with a Rhodamine 
dye was coated on a glass slide and investigated under the fluorescence 
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microscope. The observation of a uniform red emission from the entire coated 
surface indicates that within the resolution of the optical microscope, cBSA 
was evenly distributed over the entire surface. 
 
 
    (a)            (b) 
  
 
        (c)             (d)  
Figure 6-7. Atomic force microscopy (AFM) images of the glass surface (a) 
pre-treated blank glass surface (b) after incubation with 10 μM cBSA for 10 
min. Line profile section for (c) pre-treated blank glass surface (d) after 
incubation with 10 μM cBSA for 10 min. 
 
 
 Monolayer formation of cBSA on a SiO2 surface was further 
confirmed by quartz crystal microbalance (QCM) measurements. The result 
shown in Figure 6-8 reveals that cBSA adsorbs on the glass surface within the 
first two minutes of incubation. After incubation for 30 minutes, fresh cBSA 
solution was added, but no further change in frequency was observed, 
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indicating that the surface was already completely covered with cBSA. Heavy 
rinsing with milli-Q water did not yield any frequency shift. Apparently, 
cBSA was strongly bound to the glass surface. The low dissipation values of 
max. 0.2·10-6 further indicates the formation of a stiff and densely packed 
monolayer where no additional material was loosely bound on top of the first 
layer. 
 
Figure 6-8. QCM measurement of the adsorption kinetics of cBSA on bare 
glass. The line at the top correspond to the frequency shift and the bottom line 
show the dissipation. 
 
6.3.3  Formation of E. coli monolayers 
After coating of the glass surface with cBSA, the adsorption of bacterial cells 
as second layer was investigated. The driving force of the adsorption is the 
strong electrostatic interaction between positively charged proteins and 
negatively charged cell walls of the bacteria cells. Figure 6-9a depicts the 
adsorption of E. coli cells onto a glass surface treated with cBSA compared to 
a surface without cBSA coating. No cells attached to the glass slide in the 
absence of cBSA (shown in the top half of the micrograph). However, in the 
 150 
presence of cBSA, a uniform distribution of E. coli cells over the entire field 
was found. Thereafter, the cells were incubated with fluorescein diacetate and 
the pronounced green fluorescence indicates a high number of viable cells on 
the surface. The adsorption of the bacterial cells was further investigated under 
a confocal microscope (Figure 6-9b). A z-scan, where a depth of 8 μm was 
recorded with steps of 0.2 μm revealed that the E. coli cells were only 
observed in the layer directly above the glass surface. This unambiguously 
indicates the formation of a cell monolayer.  
 
(a) (b)  
Figure 6-9. (a) E. coli cells adhering electrostatically on the cBSA coated part 
of a glass slide (bottom) whereas no cells were observed on the glass surface 
without the coating (fluorescence image after incubation with fluorescein 
diacetate); scale bar: 20 μm. (b) Adhering cells at higher magnification (scale 
bar: 5 μm).  
  
 As reference and benchmark, poly-L-lysine (PLL), a well-known 
adhesion promoter which is readily available, was also investigated. PLL has 
some limitations such as nonspecific cell adhesion and cytotoxicity, and it may 
lead to abnormal cell spreading [45]. E. coli cells were indeed immobilized on 
a glass surface treated with PLL. However, an inhomogeneous cell layer was 
formed where the cells adhered in less tightly bound clusters and larger 
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aggregates. In contrast, cBSA facilitated the adsorption of individual bacterial 
cells, which were uniformly distributed over the entire surface. Typical 
micrographs are shown in Figure 6-10. In another experiment, the cell 
numbers on glass surfaces pre-incubated with varying concentrations of cBSA 
(2 μM to 10 μM) was essentially the same. This finding agrees well with the 
QCM measurements where rapid monolayer formation and coverage of the 
entire surface with the cBSA even for very dilute solutions was suggested. For 
all further experiments, a 10 μM cBSA solution was selected.  
 
 
 Figure 6-10. (a) Homogeneous layer of adhering cells on a glass surface 
coated with cBSA, and (b) layer of inhomogeneously adhering cells on a glass 
surface coated with poly-L-lysine. The E. coli cells have been stained with 





The influence of the sequence in which the individual components 
were added was also investigated. A homogenous cell layer was only obtained 
if the glass surface was first incubated with cBSA before the cell suspension 
was added (Figure 6-11c). Figure 6-11a clearly shows that no interaction of 
the E. coli cells and the glass surface occurred if no cBSA was applied since 
only very few cells were detected on the surface. In case where the cell 
suspension and cBSA were mixed before coating, large cell agglomerates 
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were found as shown in Figure 6-11b. In this case, cBSA attached most likely 
to the cell walls of different cells thus leading to interactions between the 
bacterial cells rather than to the desired surface coating. 
 
Figure 6-11. Influence of the sequence of addition: (a) application of E. coli 
cells without cBSA coating, (b) pre-mixing E. coli cells and cBSA before 
coating, (c) coating of cBSA followed by incubation with E. coli cells. 
 
6.3.4  Production of R-(-)EHB in a cBSA coated enzymatic micro-reactor 
Since it has been demonstrated that cBSA efficiently immobilized cells on a 
glass surface, it was straightforward to investigate the suitability of this novel 
biocoating for the immobilization of cells in a micro-reactor. Recombinant E. 
coli over-expressing LbADH was used as biocatalyst for the bio-reduction of 
ethyl acetoacetate (EAA) to R-(-)ethyl hydroxybutyrate (EHB) in a silica 
capillary microchannel. Both cBSA and PLL were applied independently to 
fix the cells in the reactor. Figure 6-12 shows the amount of coated cells in the 
microchannel, which was determined by monitoring the optical density of the 
cell concentration during the coating process. Three individual coating 
experiments were carried out for PLL and for cBSA. The efficiency of the cell 
coating was estimated as below by using facts about E. coli [46]: length 2 μm; 
diameter 0.8 μm; wet weight of an individual cell 1x10-12 g and dimension of 
micro-reactor: inner diameter 530 μm; length 31 m. The calculation is as 
follow: 
(a) (b) (c) 
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Perimeter of the reactor = πd = 3.142 x 530 μm = 1665 μm 
1665 μm / 0.8 μm = 2081 cells 
ls = (3.226x1010) x (1x10-12 g) = 0.032 gwcw 
 
l hown in Figure 6-12, cBSA 




2081 cells / (2x10-6 m) x 31 m = 3.226x1010 cells  
Maximum amount of coated cel
 Based on the amount of coated ce l as s
le
g ric surface area, whereas in case of PLL, only 26 % of the total surface 
area was covered with the E. coli cells. Followed by that, optimization of the 
enzymatic micro-reactor was performed. For the optimization of the reaction 
condition in a micro-reactor, the flow rate of the reaction mixture through the 
catalyst-coated micro-reactor constitutes an important parameter to yield 
maximum mass transfer and to minimize leaching of the catalyst. Therefore, 
the flow rate through the cBSA coated micro-reactor was varied in order to 
identify the impact of this parameter on the productivity of the micro-reactor. 
Figure 6-13 shows that the productivity depends on the flow rate.  
 The productivity of the reaction generally increased with higher flow 
rate due to the better mass transfer at higher flow rate. T
productivity of 2.0 gEHB•gwcw-1•h-1 was achieved at a flow rate of about 18.5 
mL/h corresponding to a retention time of about 21.4 minutes. However, when 
the flow rate was further increased to 20.6 mL/h, a slight decrease of the 
productivity had been observed. The result might suggest that the activity of 
the cells could be affected when the reactor is operated with a fast flow rate; 




Figure 6-12. Biomass of E. coli cells immobilized in differently pre-treated 
cro-reactors (inner diameter: 530 μm, length: 30 m). The data are based on 
three independent experiments and plotted as mean of the measurements with 
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Figure 6-13. Productivity of the immobilized cells on a cBSA coated micro-
reactor as a function of substrate flow rate. Reaction conditions: 30 m length, 
13.5 mgwcw, 25 mM of EAA, 50 mM IPA, 2 mM Mg2+, 37oC. 
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Productivity optimization of the micro-reactor can also be done by 
varying the substrate concentration. Figure 6-14 shows an example of the 
substrate concentration optimization at a fixed flow rate of 18.5 mL/ h. The 
highest productivity, 2.0 gEHB•gwcw-1•h-1, is obtained when the substrate 
concentration was 25 mM. However, a decrease of the productivity is 
observed with even higher concentration of the substrate, suggesting that 
substrate inhibition may occur in the reaction.  
0.0
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Figure 6-14. Productivity of the immobilized cells on a cBSA coated micro-









reactors as a function of substrate concentration. Reaction conditions: 31 m 
 mM Mg2+, 37 oC. 
 
In the previous chapter, we have shown that the formation of R-(-)EHB 
proceeded with >99% ee and a productivity up to 1.4 gEHB•gwcw-1•h-1 was 
achieved using gel-entrapped E. coli cells in a packed bed reactor. By 
optimizing the flow rate and substrate concentration, the productivity of the 








measured in a packed bed reactor. This is probably due to the improved mass 
transfer over the smaller geometrical scale. However, these results are 
sufficiently close to give us confidence that data on metabolic rates as a 
function of temperature and medium composition can be directly transferred to 
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Figure 6-15. Stability of the E. coli monolayer of the coated micro-reactor. 
2+
















Reaction condition: 30 m length, 25 mM of EAA, 50 mM IPA, 2 mM Mg , 
(●) PLL coating: 8.4 mgwcw, substrate solution flow rate 18.8 mL/h. 
In order to determine the long-time stability of the cells coated by 
cBSA or PLL in the microchannel, the micro-reactors were operated 
continuously. As control, recombinant E. coli cells were applied without any 
cationic layer via the same coating procedure. As expected, no reaction was 
observed in the absence of any cationic coating agent since only a negligible 
amount of cells adhered to the untreated glass surface in the microchannel. 
Likewise, after pre-treatment with native BSA, no bacterial cell adsorption and 
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consequently, no product formation was detected. Figure 6-15 shows the long 
term productivity of the micro-reactors coated with cBSA and PLL, 
respectively. Using cBSA as adhesion promoters, a high productivity of 2.0 
gEHB•gwcw-1•h-1 could be maintained for up to 3 days before the productivity 
gradually decreased. In contrast to cBSA, the productivity of the biocatalyst 
immobilized by PLL decreased faster after 3 days continuous operation. 
 
6.3.5  Determination of kinetic parameters with the micro-reactor 
In order to expand the application of this cBSA immobilized enzymatic micro-
reactor towards the study of kinetic parameters, a shorter reactor was used in 
Michaelis-Menten plots of the bio-reduction of EAA to EHB within the 
enzyma
the study. This is to ensure that only the initial rate of the reaction is measured, 
and the conversion of the substrate was kept < 15 %. Figure 6-16 shows the 
tic micro-reactor at different flow rates.   
 It was found that the reaction rate was faster at higher flow rate due to 
the more efficient mass transfer within the channel. There was about 10 % 
increase of the maximum reaction rate (Vmax) when the flow rate was 
increased from 0.15 to 0.25 mL/min. However, the Vmax determined from the 
enzymatic micro-reactor at 0.25 mL/min is ten fold smaller compared to 
measurements on free cells in solution. This is likely due to the hindered 
orientation of the immobilized whole cells within the micro-reactor. The 
whole cells are electrostatically adsorbed onto the cBSA coating within the 
inner wall of the capillary channel; therefore, only the part of the cell surface 
which is facing the inner channel of reactor is exposed to the substrate during 
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reaction. In this case, the decrease of the available surface area of the cells for 
mass transfer could lead to a lower reaction rate.  


























ted as the possible cause for 
the observed difference. The situation in our case is even more complicated 
since it involves living cells, and the immobilization process may influence the 
permeability of the membrane. However, since the reaction rate was found to 
depend on the flow rate of the reaction, it is expected that a higher rate of 
reaction can be obtained if the flow rate of the reactor is further increased.  
[EAA] (mM)
 
Figure 6-16. Michaelis-Menten plots of bioreduction of EAA to EHB in 
different flow rates. Reaction conditions: 3 m length, 2.7 mgwcw, EAA: IPA=1: 
2, 2 mM Mg2+, 37 oC. (●) 0.25 mL/ min, (c) 0.20 mL/ min, (○) 0.15 mL/ min. 
 
 Similar observations have also been reported by other research groups 
who obtained similar KM but lower maximum reaction rate constants when 
they compared the kinetic parameters of enzymes immobilized within a micro-
reactor with the same enzymes free in solution phase [47, 48]. Imperfect 
immobilization chemistry, altered conformation of the enzyme, and steric 
hindrance of the immobilized enzyme were sugges
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 The data set obtained for each flow rate was plotted using non-linear 
fits using Origin software, and the Michaelis-Menten constant (KM) was 
calculated. Figure 6-17 shows the plot of the KM value against different flow 
rates.  















Figure 6-17. Relationship of K  with the flow rates of the enzymatic micro-
 
 The graph clearly shows that K  value of the reaction is dependant on 
the flow rates of the enzymatic micro-reactor. There was about 30 % decrease 
in the determined K  value when the flow rate was increased by 0.7 fold. The 
lower K  value suggests that a more effective mass transfer can be achieved 
when the reactor is operated at higher flow rate. More importantly, the K  
value determined by using this enzymatic micro-reactor (ranges from 1.67 
mM to 2.4 mM) is very similar to the value determined in a batch reaction 
using free cell which was 2.38 mM. Thus, this particular experiment has 
demonstrated the feasibility of the prepared enzymatic micro-reactor to obtain 










6.4  Conclusions 
We have demonstrated that the protein-based cationic polyelectrolyte cBSA 
serves as a biocompatible adhesion promoter for the biofilm formation of 
recombinant E. coli whole cells on glass surfaces. In contrast to alternative 
coating agents such as PLL, cBSA allowed the formation of homogeneous cell 
monolayers with significantly increased cell densities. The immobilization 
process occurred very rapidly and under mild conditions. The monolayer 
contained mostly viable cells again supporting the good biocompatibility of 
cBSA. The bioreduction of ethyl acetoacetate (EAA) to R(-)-ethyl 
hydroxybutyrate (EHB) in a silica capillary micro-reactor in a continuous 
process proceeded with up to 40 % higher efficiency than that observed in a 
owed good sustainability for 3 days without any drop of activity. 
 




Due to the cost-efficient and ready availability of the starting material, bovine 
serum albumin, and the facile and reproducible preparation procedure of 
cBSA, an efficient alternative to commercially available materials such as 
PLL has been identified that might allow improved productivities and longer 
reactor process times. Rapid screening of the parameters for optimization of 
reactions has been demonstrated, and the whole cell micro-reactor has been 
found to be capable of determining kinetic parameters in an efficient manner. 
Therefore, this study has resulted in the development of a useful tool for high 
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Chapter 7  Cationized Bovine Serum Albumin with Pendant RGD 
Groups Forms Efficient Biocoatings for Cell Adhesion  
 
7.1  Introduction 
Focal adhesion of cells to the extracellular matrix (ECM) or to neighboring 
cells is important in order to maintain tissue integrity, migration, proliferation 
and function [1, 2]. To form a coherent tissue and to respond to signals from 
their immediate environment, cells must interact with neighbouring cells and 
with structural proteins of the ECM [3]. Proteins of the cadherin family such 
as adherens, junctions and desmosomes are responsible to connect the cell 
with neighbouring cells. Different cadherins are present on different cell types. 
They only bind to cadherins of their own kind to ensure the cells of the same 
kind are connecting to one another.  
 Integrins are heterodimeric molecules expressed on the cell surface 
that require divalent cations for functional activity [4-6]. The integrin family 
consists of at least 18 members based on the expression of 18 α and 8 β 
subunits; so far there are 24 known distinct integrins [7] as shown in Figure 7-
1. Focal adhesions and hemidesmosomes are cell-matrix junctions that consist 
of clustered integrin molecules. They contain proteins of the intergrin family 
which link directly to the proteins of the ECM. Examples of these ECM 
proteins include collagen, laminin, fibronectin, vitronection, fibrinogen, von 
Willebrand factor and others. A common sequence Arginine-Glycine-
Aspartate (RGD) which is responsible for focal adhesions [8] was identified in 
most of the ECM proteins. The following section will discuss the interaction 
between the RGD sequence and the integrins of the cells. 
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 Figure 7-1. Integrin family of mammalian cell adhesion receptors. The 8 β 
subunits can assort with 18 α subunits to form 24 distinct integrins [7]. 
 
7.1.1  Arginine-Glycine-Aspartate (RGD) sequence 
The RGD sequence can interact with the integrin of the cells and initiates a 
series of signaling events which lead to remodeling of the cytoskeleton, cell 
spreading and stabilization of focal adhesion [9]. Xiong et al. obtained the 
crystal structure of the extracellular segment of integrin αvβ3 in a complex 
with an RGD ligand, and the detailed interaction of RGD with αvβ3 integrin is 
elucidated in Figure 7-2 [10]. The interactions involved are hydrophobic 
interactions, hydrogen bonding and polar interactions (ion pair formation).  
 An example of RGD containing peptide: cyclic RGDfK (cRGDfK), a 
cyclic penta-peptide (f = phenylalanine in D-form) was reported to give high 
affinity in recognizing the αvβ3/ αvβ5 integrins [11-13]. In this molecule, the 
conformation of the active RGD sequence is constrained by the cyclic 
arrangement and the flanking amino acids merely serve to hold the active part 




Figure 7-2. Interaction between the cyclo(RGDf-N{Me}V) ligand (yellow 
sticks) and αvβ3 integrin. αv and β3 residues are labeled blue and red, 
respectively. Oxygen and nitrogen atoms are visualized as red and blue balls, 
respectively. Hydrogen bond and salt bridges are represented with dotted lines.  
 
 Cyclic peptides are also more resistant to degradation. During the 
synthesis of the compound, the insertion of a single D-amino acid induces 
defined conformational motifs and facilitates cyclization of the peptide 
without requiring disulfide bonds to impose conformation constraints [15]. 
Later, Kessler et al. found that the insertion of the D-amino acid at position 4 
of the cyclic RGDfK significantly altered the activity of the peptide, so that 
the activity in binding with αvβ3 integrin was ten times higher compared to 
cyclic RGDFk which has a D-amino acid insertion at position 5. Insertion of 
D-phenylalanine at position 4 improved the activity much more than other D-
amino acid such as D-proline and D-lysine. Therefore, they postulated that the 
cyclic pentapeptide interacts with the integrin as shown in Figure 7-3 where 
the D-phenylalanine makes hydrophobic interaction with αvβ3 integrin [11]. 
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The flanking amino acid at position 5 did not affect the binding activity to the 
αvβ3 integrin very much, therefore it is available for introducing a new 
functionality to the peptide for further modification. Because of the desirable 
recogonition between the RGD and intergrins of cells, RGD has been widely 
used to modifiy surfaces for enhanced cell adhesion. The following section 




Figure 7-3. Receptor model of H. Kessler et al. [11] (see text for more 
explanation). 
 
7.1.2  RGD grafted materials for cell adhesion 
The soluble form of the RGD peptide can inhibit cell adhesion because it is an 
integrin receptor antagonist [16]. Therefore, efficient immobilization of 
peptides is crucial in order to promote focal adhesion of cells on treated 
surfaces. The behaviour of cell adhesion in the presence of soluble RGD and 
immobilized RGD is illustrated in Figure 7-4. Cells will interact with the 
surface if the RGD is immobilized on the surface (Figure 7-4a), and the cells 
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will remain in the medium as suspension if the integrins of the cell are blocked 
by soluble RGD peptides (Figure 7-4b).  
 
 
Figue 7-4. Soluble and immobilized form of RGD in cell adhesion. (a) cell 
interacts with surface with immobilized RGD, (b) soluble RGD block the 
integrin of the cells, causing the cells to become unable to interact with the 
surface.  
 
In order to prepare immobilized RGD surfaces, covalent grafting of the 
peptides to the carrier material is a common strategy to improve 
biocompatibility and promote specific cell adhesion on biomaterials [17-19].  
The length of the spacer between the RGD and the surface plays an important 
role to allow the immobilized peptide to access the binding site of the integrin 
and the detailed review of the topic can be found in [8]. Beer et al. found that a 
minimum spacer length of approximately 11-32 Å was required to interact 
with the majority of the binding sites of integrins and interaction with all 
receptors was achieved with spacer length of about 46 Å, longer spacer 
lengths were reported to yield significantly reduced cells binding [20]. This 




Surface with immobilized RGD 
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Kessler et al. [12]. It was suggested that optimum spacer lengths are essential 
for cells to undergo tight binding to surfaces [21, 22]. However, Massia et al. 
demonstrated excellent cell adhesion in the absence of a spacer between the 
RGD peptide and the surfaces [23]. The role of spacer lengths is discussed 
controversially and still represents a topic of current interest in order to 
achieve improved biocoatings for efficient cell adhesion. 
 Preparation of engineered surfaces which could promote cell adhesion 
is attractive for a broad range of applications such as elucidating the 
mechanism of cell processes such as cancerogenesis, in-vitro growth of tissue 
and cell based sensors [2, 24, 25]. For engineering of tissue implants, 
biodegradable polymers such as poly(glycolic acid) and poly(L-lactic acid) 
have been extensively used as biomaterials due to their excellent mechanical 
properties and biological affinity [26,27]. However, due to the absence of 
further reactive groups, it has been difficult to impart additional functionalities 
to these polymers [28]. Other polymers such as poly-L-lysine (PLL) was 
limited due to non-specific cell adhesion, cytotoxicity and abnormal cell 
spreading was observed frequently [29]. 
 Grafting of RGD containing peptides onto native bovine serum 
albumin (nBSA) as a coating material for cell adhesion has been demonstrated 
previously [30-32]. This approach has attracted attention since serum albumin 
represents a biocompatible macromolecule bearing many functional groups 
allowing further chemical modifications [33, 34]. However, coating of RGD-
modified nBSA is merely based on physical adsorption, which leads to 
extended incubation times between 1 and 14 h and reduced stability of surface 
adhesion under mechanical stress [3, 35]. Improved cell adhesion has been 
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reported for coatings that facilitates non-specific electrostatic interactions with 
cells due to the presence of multiple positive charges [36-39]. Recently, Lai et 
al. have introduced poly-lysine trimers as a positively charged linker to 
cRGDfK and they have observed a strong cooperative effect in enhancing 
focal adhesion of fibroblast cells due to the presence of both non-specific 
(ionic) and specific RGD-based interactions. [39] Geiger et al. [40-43] 
reported that hyaluronan in the pericellular coat (PCC) at the cell surface plays 
an important role in the initial stage of cell adhesion events. This material 
carries negative charges under physiological conditions and a positively 
charged surface may therefore be conducive for adhesion.  
 In this chapter, we present our efforts towards tailored albumin-
biocoatings that promote cell adhesion via long distance, non-specific 
electrostatic interactions as well as RGD mediated adhesion. Cationized 
bovine serum albumin (cBSA) with multiple positive charges represents an 
ideal precursor for grafting RGD containing peptides since several primary 
amino groups are accessible for chemical coupling reactions [44]. Previously, 
cBSA has been studied as an efficient carrier facilitating cell transfection and 
no significant cytotoxicity has been found at the effective concentrations [33, 
44]. cBSA has been demonstrated in chapter 6 as an excellent and stable 
promoter for the adsorption of biocatalysts (recombinant E. coli) onto the 
inner walls of silica capillary micro-channels due to its high chemical stability 
as well as high charge density. The resulting enzymatic micro-reactor was 
applied for the continuous synthesis of a chiral alcohol over several days 
without cell loss. This result confirmed that incubation with cBSA leads to a 
 172 
strongly adsorbed protein layer at the surface, which is able to withstand 
mechanical stress.  
 Herein, cBSA will be decorated with different numbers of the cRGDfK 
of varying chain lengths and a set of cRGDfK-grafted cBSA proteins will be 
prepared via an isothiocyanate functionalization [45]. The materials will be 
tested for cell adhesion of NIH 3T3 fibroblasts cells. Our results pave the way 
toward tailored biocoatings for demanding medicinal applications such as 
coating of stents or implants.  
 
7.2  Materials and methods 
All the amine protected amino acids, 2-chloro-tritylchloride polystyrene resins 
(2Cl-TCP), hydroxybenzotriazole (HOBT) and o-Benzotriazol-1-yl-N,N,N',N'-
tetramethyluronium (TBTU) were purchased from GL Biochem (Shanghai, 
China). 2-mercaptobenzothiazole (MBT), piperidine and triisopropylsilane 
(TIPS) were purchased from Merck. N,N-Diisopropylethylamine (DIPEA) and 
trifluoroacetic acid (TFA) were purchased from Sigma-Aldrich. 1,4-phenylene 
diisothiocyanate, diphenylphosphoryl azide (DPPA) and 2,2,2-trifluoroethanol 
(TFE) were purchased from Aldrich. 5 % Pd/C was obtained from Degussa. 
NIH 3T3 mouse embryonic fibroblast cells and Dulbecco’s modified Eagle’s 
medium (DMEM) were purchased from Invitrogen.  
 
7.2.1 General procedures 
In solid phase peptide synthesis (SPPS), the first amino acid is covalently 
attached to a functionalized resin and subsequent amino acids can be attached 















































































































Figure 7-5. Synthetic scheme for (A) cbz deprotected cRGDfK; AA=amino 
was chosen. The trityl linker has some advantages compared to other 
alkoxybenzyl alcohol resins (e.g. Wang resin) in SPPS. Racemization during 
the loading of the first amino acid (using DIPEA) is avoided by using 2Cl-
TCP resin. Furthermore, no formation of diketopiperazine is observed due to 
acid, (B) cRGDfK: P0, (C) isothiocyanate functionalized cRGDfK: P1, (D) 
isothiocyanate functionalized cRGDfK with one Ahx spacer: P2, (E) 
isothiocyanate functionalized cRGDfK with two Ahx spacers: P3. 
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the steric bulk of the linker [46-48]. The peptide will remain covalently bound 
to the resin until it is cleaved from the resin with a reagent such as acetic acid 
or trifluoroacetic acid depending on the synthesis strategy. Normally, N-
terminal protected amino acids are used in SPPS. The C-terminal of the first 
amino acid will be attached to the resin and subsequent deprotection will 
reveal a new N-terminal for further coupling. SPPS then consists of repeating 
cycles of coupling-wash-deprotection-wash. Since the peptide is covalently 
bound to the resin, it can be easily retained by a filter frit, and excess reagents 
can be washed out from the resin. In this study, four peptides were synthesized; 
the strategy used to prepare the compounds and their structures are shown in 
Figure 7-5. 
 
7.2.1.1 Loading of 2Cl-TCP resin 
1.0 g of 2Cl-TCP resin (theoretical loading 0.8 mmol/g) was filled into a 20 
mL syringe equipped with a poly propylene frit (Torviq, USA). Fmoc-Gly-OH 
(1.2 eq., referring to theoretical loading) was directly put into the same syringe, 
and dry DCM (8 mL/ g resin) treated with DIPEA (2.5 eq., referring to amino 
acid) was sucked into the syringe. The synthetic scheme of resin-bound Gly (1) 




Figure 7-6. Loading of Fmoc-Gly onto 2Cl-TCP resin.  
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 The reaction was carried out by rotating the syringe for 1.5 h. After 
that, the resin was capped by adding 0.2 mL methanol (per gram resin) and 0.2 
eq. DIPEA to the reaction mixture and shaken an additional for 20 min. The 
loaded resin was washed 3 times with DCM, 3 times with DMF, 1 time with 
DMF/methanol 1:1 and 3 times with methanol. After drying in vacuum 
(overnight), the resin was weighed and the exact amino acid loading was 








Here,  Mtotal = mass of resin + product, MW = molecular weight of the loaded 
compound and 36.461 = molecular weight of HCl. 
 
7.2.1.2 Solid phase Fmoc deprotection 
The washed and swollen resin (in DMF) was treated twice with 8 mL of a 
solution of piperidine (20 % v/v) in DMF, 5 min and 15 min, respectively and 
washed 5 times with DMF. Figure 7-7 shows the Fmoc deprotection of resin-




Figure 7-7. Solid phase Fmoc deprotection of Fmoc-Gly. 
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7.2.1.3 Solid phase peptide coupling 
The protected amino acid (2.5 eq. referring to resin loading) was dissolved in a 
0.2 M solution of HOBt and TBTU (2.5eq.) in DMF. After addition of DIPEA 
(6.5 eq.), the solution was mixed with the Fmoc-deprotected amino acid bound 
resin (2) in a syringe equipped with a PP filter frit. The syringe was shaken for 
1.5 h at room temperature. The solution was discarded through the filter, and 
the resin was washed 5 times with DMF. Figure 7-8 shows the coupling of 




Figure 7-8. Solid phase coupling of Fmoc-Arg(Pbf)-OH to resin-bound Gly. 
 
 
7.2.1.4 Cleavage from 2Cl-TCP resin 
To cleave off the peptide from the resin while maintaining the side chain 
protecting groups of the peptide, the cleavage has to be done using a mild acid. 
After the final Fmoc-deprotection, the resin was washed 5 times with DMF, 3 
times with DCM and treated with a solution made of DCM, acetic acid and 
TFE (7:2:1 v/v). After 30 min, the filtrate was collected in a round bottom 
flask. The procedure was repeated another 2 times. Finally, the combined 
filtrate was concentrated and co-evaporated with toluene under reduced 
pressure until the smell of acetic acid had disappeared. The peptide was 
obtained as acetate (at the N-terminal).  
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 7.2.1.5 Full deprotection of the peptide 
1 mL of cleavage cocktail (95 % TFA/ 2.5 % TIPS/ 2.5 % H2O) was added for 
full deprotection of the peptide for 2 h. The product was precipitated in cold 
ether, centrifuged down, and subsequently washed twice with cold ether. After 
that, the recovered product was dried under vacuum. 
 
7.2.2  Synthesis of cRGDfK  
The synthesis strategy for cRGDfK follows the method of Kalinina et al. [45]. 
First, Fmoc-Gly-OH was loaded on 2Cl-TCP as described in procedure 7.2.1.1. 
Subsequent deprotection-wash-coupling-wash was carried out as described in 
procedure 7.2.1.2 and 7.2.1.3. Addition of the amino acids was in the order of 
Fmoc-Arg(Pbf)-OH, Fmoc-Lys(Cbz)-OH, Fmoc-D-Phe-OH, and Fmoc-
Asp(OtBu)-OH respectively. Eventually, the penta-peptide compound (3) was 
obtained. Figure 7-9 shows the synthetic scheme for the last step of the 
coupling. After Fmoc deprotection of compound (3), the product was cleaved 
off from the resin using procedure 7.2.1.4, this will retain the Pbf and tBu 
protecting group within the peptide as shown in Figure 7-10. [Compound (4) 









Figure 7-10. Cleavage of linear side-chain protected RGDfK from the 2Cl-
TCP resin.  
  
 To carry out the cyclization of the peptide, compound (4) was diluted 
with DMF to 2.5 x10-3 M. The very dilute conditions are used to ensure that 
only the intramolecular reaction takes place and to prevent intermolecular 
reaction of the peptide. The synthesis scheme is shown in Figure 7-11. After 
addition of DPPA (3 eq.) and NaHCO3 (5 eq.), the mixture was stirred 
overnight. Thereafter, the reaction mixture was concentrated under reduced 
pressure. The concentrated product was added dropwise to about 50 mL of 
water in a centrifuge tube. The precipitate (white solid) was then spun down 
by centrifugation and washed twice with water and dried under vacuum. 




Figure 7-11. Backbone cyclization of RGDfK. 
 
 
 The reaction mechanism of DPPA to form a peptide bond is shown in 
Figure 7-12 [49]. The carboxylate anion attacks the phosphorus atom in DPPA 
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to give the acyl phosphates (a) and (b). The acyl azide forms by an SNi type 
rearrangement of (a) or a SN2 type reaction of (b) with the azide anion. 
Reaction of the amine with the acyl phosphates (a) and (b) as well as the acyl 




Figure 7-12. Mechanism of peptide bond formation using DPPA [49]. 
  
 Subsequent deprotection of the carbobenzyloxy (cbz) group of lysine 
was carried out as shown in Figure 7-13. Compound (5) (0.8 mmol) was 
dissolved in 6 mL of DMA. 0.06 g of 5 % Pd/C (reduced at 150 oC, 20 
mL/min H2, 2 h) was added in an autoclave and reacted overnight at room 
temperature under 20 bar H2 atmosphere. After that, 20 mL MeOH was added 
to the reaction mixture and the Pd/C was spun down; the supernatant was 
concentrated under reduced pressure to less than 1 mL of solution. The 
solution was then precipitated down in cold ether. A white to yellowish solid 
was obtained, and the solid was washed 3 times with cold ether, recovered by 
centrifugation and dried under vacuum. [Compound (6) ESI-MS: 912.5 
(M+H+), 934.4 (M+Na+)]. 
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 Figure 7-13. Deprotection of cbz group. 
  
 Follow by that, full deprotection of compound (6) was done using 
procedure 7.2.1.5. The synthetic scheme is shown in Figure 7-14. The 
obtained peptide P0 was purified using reversed phase preparative HPLC 
column. A Waters Atlantis T3 10μm C18 column (100Å, 250 mm x 10 mm) 
was used and the gradient of eluent was  0 % A, hold 10 mins, 0→15 % A in 5 
mins, 15→80 % A in 40 mins (A=0.1% TFA in acetonitrile, B= 0.1% TFA in 
water). The isolated yield was 57 %. The chemical shifts in both 1H and 13C 
NMR spectrum obtained as shown in Table 7-1 are in agreement with those 
reported in [11]. 1H and 13C NMR (500 MHz, DMSO-d6) spectra of the 
compound in are shown in Figure 7-15 and Figure 7-16 respectivly. [P0, ESI-













































95% TFA/ 2.5%TIPS/ 2.5% H2O
 
Figure 7-14. Full deprotection for acid labile side groups of cRGDfK. 
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Table 7-1. Chemical shifts of 1H and 13C of P0 in DMSO-d6. 
 HN/HNε Hα/ Hα’ Hβ/ Hβ’ Hγ/ Hγ’ Hδ/ Hδ’ other 
Arg 7.65/7.68 4.16 1.71/1.56 1.39 3.09  
Gly 8.42 4.04/3.24     
Asp 8.09 4.63 2.71/2.35    
D-Phe 8.05 4.42 2.92/2.82    
Lys 8.11 3.96 1.56/1.39 1.4 1.03 
2.70(Hε); 
7.75(NH2) 
 Cα Cβ Cγ/Cγ’ Cδ/Cδ’ Cε  
Arg 51.8 28.5 25.2 40.2   
Gly 43.2      
Asp 48.8 35.1     
D-Phe 54.4 37.3     











Figure 7-16. 13C NMR spectrum of P0. 
 
7.2.3 Synthesis of isothiocyanate functionalized cRGDfK (P1) 
Isothiocyanate functionalization of the Lys residue of cRGDfK was done 
before the full deprotection of the peptide was performed. 1,4-phenylene 
diisothiocyanate (7 eq.) was dissolved in dry DCM in an Ar pre-purged flask 
and DIPEA (3 eq.) was added in. Compound (6) (1 eq.) was dissolved in dry 
DCM and added dropwise to the diisothiocyanate mixture. The synthetic 
scheme is shown in Figure 7-17. The reaction was stirred for 4 h. After that, 
the DCM was removed under reduced pressure and the obtained compound (7) 
was deprotected according to procedure 7.2.1.5. The product was precipitated 
down with cold ether and recovered by centrifugation. The solid product was 
washed twice with cold ether and dried under vacuum. The obtained peptide 
P1 was purified using reversed phase preparative HPLC column. A 
Phenomenex Luna 5μm C18(2) (100Å, 50 x 30 mm) column was used. Eluent 
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gradient was 30→50 % A in 10 mins, hold for 10 mins, (A= 0.1% TFA in 
acetonitrile, B= 0.1% TFA in water). Subsequently, the product solution was 
lyophilized and the product was obtained as a white solid in 30 % isolated 
yield. The LC-MC of the purified peptide P1 (Figure 7-18) confirms the 
identity and purity of the material. 
 
 
Figure 7-17. Synthesis of isothiocyanate functionalized cRGDfK. 
 




















Figure 7-18. LC-MS spectrum of P1. Mass spectrum at the bottom correspond 




7.2.4  Synthesis of isothiocyanate functionalized cRGDfK with 
aminohexanoic acid (Ahx) as spacers (P2, P3) 
First, isothiocyanate functionalized amionohexanoic acid was prepared via 
SPPS. Fmoc-Ahx-OH was used in the synthesis. Loading of Ahx onto the 2Cl-
TCP resin followed the procedure described in 7.2.1.1. For the synthesis of the 
longer spacer, deprotection-wash-coupling-wash was repeated using another 
unit of Fmoc-Ahx-OH according to procedure 7.2.1.2 and 7.2.1.3 except that 
the coupling reagent was changed to MBT/ TBTU. To further functionalize 
Ahx with isothiocyanate, 0.2 M of 7 eq. of 1, 4-phenylene diisothiocyanate in 
dry DCM was added in 5 eq. DIPEA. The solution was sucked into a syringe 
with Fmoc deprotected Ahx bound resin (pre-washed 5 times with DMF and 3 
times with dry DCM after the Fmoc deprotection to change the solvent system) 
and shaken for 3 h and washed 5 times with DCM. The isothiocyanate 
functionalized Ahx was cleaved off from the resin as described in procedure 
7.2.1.4. This yielded Ahx-NCS (compound 8) [ESI-MS: 322.2 (M-H+)] or 
AhxAhx-NCS (compound 9) [ESI-MS: 435.2 (M-H+)] in Figure 7-19. 
 To prepare isothiocyanate functionalized cRGDfK with Ahx as spacer, 
compound (8) or compound (9) (1eq.) was activated with 0.2 M of HOAT/ 
HATU (1eq.) in DMF and DIPEA (3 eq.) for 30 min. Compound (6) (1 eq.) 
was added and the reaction mixture was stirred for 2 h. DMF was removed 
under reduced pressure and compound (10) or compound (11) was obtained, 








Figure 7-19. Synthesis of isothiocyanate functionalized cRGDfK with Ahx 
spacer.  
 
 Full deprotection of compound (10) or compound (11) according to 
procedure 7.2.1.5 yielded peptide P2 or P3 respectively. The product was 
precipitated in cold ether as a yellowish solid. The solid was centrifuged down 
and subsequently washed twice with cold ether and finally dried under 
vacuum. The obtained peptide P2 was purified with a Phenomenex Luna 5μm 
C18(2) (100Å, 50 x 30 mm) HPLC column. The gradient during elution was 
20→40 % A in 8 min, hold for 8 min, 40→50 % A in 3 min, hold for 12 min 
(A= 0.1% TFA in acetonitrile, B= 0.1% TFA in water). The purified product 
solution was subsequently lyophilized to give an isolated yield of  17 % as 
white solid. The obtained peptide P3 was purified using the Waters Atlantis 
T3 10μm C18 column (100Å, 250 x 10 mm). Gradient of the eluent was 30 % 
A, hold 10 min, 30→100 % A in 60 min (A= 0.1% TFA in acetonitrile, 
B=0.1% TFA in water). The purified product solution was lyophilized and P3 
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was obtained in 10 % isolated yield as a white solid. [P2: ESI-MS: 909.4 
(M+H+); P3: 1022.4 (M+H+)]. 
 
7.2.5 Grafting of cBSA with cRGDfK 
100 μL cBSA in milli-Q water (10 mg/mL) was diluted with 100 mM 
potassium phosphate buffer pH 7.4 to the concentration of 1 mg/mL. Peptide 
(40 eq., unless otherwise stated) was dissolved in DMSO to a concentration of 
8 mg/mL, and the solution was added dropwise to the cBSA solution in an ice 
bath. The final concentration of DMSO was always kept below 6 vol %. The 
solution was stirred for 5 min in the ice bath and futher stirred at room 
temperature for 3 h. Subsequently, the solution was concentrated and purified 
using a Pierce concentrator (20 kDa MWCO). The concentrated protein 
solution was further washed 5 times with milli-Q water by centrifugation. The 
resulting protein solution was lyophilized. The structure of the product and the 
isolated yield are shown in Figure 7-20.  
 
7.2.6 Preparation of peptide coated glass surface 
Standard microscope slides (Corning, 75x25 mm) were pretreated with 1 N 
NaOH at 80 oC for 30 min, followed by milli-Q water rinsing. After that, the 
slides were immersed in 1 N HCl at room temperature for 10 min, followed by 
milli-Q water rinsing. The slides were then stored in milli-Q water.  Prior to 
use, the slides were sterilized with 70 % ethanol and dryed in an laminar flow 
hood. A sterilized FlexiPerm Micro12 cell culture chamber (Greiner Bio One 
GmbH, Germany) was fixed on the slide to create culture wells (6.5 mm 
diamter, 10 mm height). 20 μL of 10 μM of cBSA-peptide compound was 
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incubated in the well for 10 mins. The solution was then pipetted off and 
washed 3 times with 100 μL of PBS. 
 
 


















Figure 7-20. cBSA grafted with isothiocyanate functionalized cRGDfK with 
different spacer length. (a) cBSA-P1, without Ahx spacer, (b) cBSA-P2, with 
one Ahx spacer, (c) cBSA-P3, with two Ahx spacers.  
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7.2.7 Cell adhesion study 
NIH 3T3 mouse embryonic fibroblast cells were cultured in Dulbecco’s 
modified Eagle’s medium (DMEM, 4.5 g/L glucose with L-glutamine) 
supplemented with 1 % penicillin-streptomycin mixture and 10 % fetal calf 
serum at 37 oC, 5 % CO2. Confluent cultures were detached using 
trypsin/EDTA. The detached cells were spun down and washed once with 
serum-free medium before they were used for the adhesion test. Cells in serum 
free medium were seeded onto coated glass slides. Cell seeding density was 
1x105 cells/mL corresponding to 250 cells/mm2 (unless otherwise stated) and 
incubated for the stated time. After that, the medium was removed and the 
wells were washed 3 times with 100 μL of PBS to remove unattached cells. 
The FlexiPerm Micro12 was removed but the hydrophobicity created by the 
FlexiPerm still remained on the slides, therefore further fixing and staining of 
the samples was possible. The adhering cells in each spot were fixed with 50 
uL of 4 % freshly prepared paraformaldehyde solution in PBS for 15 mins. 
The spots were washed 3 times with 50 μL of PBS. The spots were stained 
with 0.5 % safranin O solution for 5 minutes and further washed 3 times with 
50 μL of PBS. The images of the sample were captured using a microscope 
(Olympus BX 51). For quantitative evaluation of the cell adhesion, attached 
cells were counted in 10 areas of 0.04 mm2 per slide, with 3 slides used for 






7.3  Results and discussion 
7.3.1 Preparation of RGD grafted cBSA 
The reaction of P1 and cBSA was carried out at different pH (7.4, 8.5 and 9.5) 
to assess the influence of the pH on the coupling efficiency. According to the 
MALDI-TOF spectra (data not shown), no sgnificant difference of the 
molecular weight of the products were found. However, when the synthesis 
was carried out at higher pH, protein precipitation occured. Therefore, all 
subsequent reactions were performed at pH 7.4. The number of equivalent of 
P1 was varied and the resulting molecular weights and molecular weight 
distributions of the cBSA-P1 were determined using SDS-PAGE and MALDI-




Figure 7-21. SDS-PAGE and MALDI-TOF spectra of cBSA-P1 obtained 
from increasing equivalents of P1. 
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 As seen in Figure 7-21, the product bands on the SDS-PAGE appeared 
at significantly higher molecular weights compared to cBSA-147. This 
indicates the successful coupling of P1 onto cBSA, yielding cBSA-P1. The 
result was further confirmed by the MALDI-TOF spectrum. The maximum of 
the signal for cBSA-P1 was shifted to a higher molecular weight compared 
with the educt cBSA. The significant broadening and the asymmetry of the 
peak indicate that variable numbers of residues P1 were attached to the protein 
through a random reaction with accessible free amino groups at the cBSA 
surface. The grafting efficiency is estimated based on a deconvolution of the 
MALDI-spectrum. From 1 to more than 10 peptide chains were attached. 50 % 
area of the total signal (in the higher mass range) was examined to determine 
the average degree of peptide substitution. Table 7-2 summarizes the 
estimated grafting efficiency. Generally, higher P1 substitution was found 
when increasing equivalents of P1 were used.  
 
Table 7-2. Grafting efficiency of cRGDfK to cBSA with different equivalents 
of P1. The number in the bracket represent the estimated number of grafted P1. 
Number of grafted P1 
Equivalents of 
P1 
Molecular weight, kDa  
max. peak 
 
(50 % peak area of the 
MALDI-TOF spectrum, in 
higher mass range) 
0 eq. (cBSA) 69.6 (0) 0 
20 eq. 70.4 (1) > 1 
30 eq. 70.5 (1) > 2 
40 eq.    71.3 (1-2) > 4 
50 eq.    71.5 (2-3) > 5 
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 Similarly, cBSA-P2 and cBSA-P3 were achieved by applying 40 eq. of 
the corresponding peptides P2 and P3. The maximum in the MALDI-TOF 
spectrum in Figure 7-22 indicates that in cBSA-P2, molecules carrying two 
substituents of (2) are most abundant, but the broad peak indicates that 50 % 
of the cBSA-P2 contained four or more peptide residues. For cBSA-P3, 
between one and two peptides were grafted on average to cBSA-147 based on 
the mass at peak maximum, but 50 % of the obtained protein was decorated 
with two or more substituents of P3. These results show that increasing the 
length of the spacer for the cRGDfK-substituent results in a somewhat lower 
grafting efficiency. 











7.3.2  Cell adhesion study on glass surfaces with different coatings 
cRGDfK are able to recognize αvβ3/ αvβ5 integrins based on the insertion of 
D-phenylalanine into its cyclic structure. Fibroblasts cells are known to 
express αvβ3 [50] and were thus chosen for the cell adhesion experiments. The 
 192 
cell adhesion was tested after one hour of culturing because fibroblasts are 
able to release fibronectin as an intrinsic adhesion promoter, the efficiency of 
the coating in promoting the focal adhesion is therefore easier to compare 
during the initiation of focal complex formation and their maturing into focal 
contacts [45]. All cell adhesion experiments were carried out under serum free 
conditions to avoid stimulation of cell adhesion due to fibronectins from the 
serum [51].  Adhesion of NIH 3T3 cells on different surface coatings on glass 
slide was studied. Typical micrographs and the statistical evaluation of the 
results are shown in Figure 7-23 and Figure 7-24, respectively. 
  
 
Figure 7-23. Adhesion behaviour of NIH 3T3 fibroblast cells on different 
coated surfaces, (a) nBSA, (b) cBSA, (c) cBSA-P1, (d) cBSA-P2, (e) cBSA-
P3, (f) cells exposed to soluble cRGDfK before seeding on cBSA-P1; scale 
bar: 50 μm. Cell seeding density: 575 cells/mm2 (2.3x105 cells/mL); 1 h 
culturing time. 
 
 Mainly round cells were observed on surfaces coated with nBSA 
(Figure 7-23a). When the cationic cBSA-147 was applied, a higher number of 
cells were attached to the surface most likely due to the presence of the high 
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number of positive charges. However, similar to the observation with nBSA, 
mainly round cells were found on the coated surface. Cells that showed 
normal adhesion appear as round spots with a diameter of 20-30 μm, while 
focal adhesion formed elongated cells with diameter in the range of 30-70 μm. 
For all surfaces coated with cBSA-P1, cBSA-P2 and cBSA-P3, cell spreading 
was observed for the majority of the cells, indicating the formation of focal 
adhesion.  
 The statistical results of the cell adhesion study on the different 
biocoatings are depicted in Figure 7-24. The number of spread fibroblast cells 
on the surfaces treated with cBSA-P1, cBSA-P2 and cBSA-P3 was greatly 
enhanced compared to the control surfaces (blank, nBSA and cBSA-147). 
After only one hour of culturing time, about 75 % of the seeded cells were 
already attached to the surfaces and 97 % of them underwent focal adhesion 
on the coated surfaces. We believe that this result can be mainly attributed to 
the fact that positively charged cBSA-P1, cBSA-P2 and cBSA-P3 are able to 
attract cells close to the coated surfaces via long distance electrostatic 
interactions which then facilitates specific interactions with the adhesion 
promoting RGD peptide attached to the surfaces.   
 In order to further prove that the spreading of the adhering cells on 
surfaces coated with cBSA-P1 was mediated via specific interaction with 
cRGDfK, a control experiment was carried out. The cells were pre-incubated 
with dissolved cRGDfK before seeded onto the surface coated with cBSA-P1. 
As expected, the number of spread cells on surfaces treated with cBSA-P1 was 
now greatly reduced (Figure 7-24). Dissolved cRGDfK binds strongly to the 
integrins and thereby acts as an antagonist for the integrin function. Blocking 
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of the integrins prevents the cells from spreading on the surface. Therefore, the 
improvement in the focal adhesion of the cells observed on the coated surfaces 








































Figure 7-24. Comparison of the number of spread and round NIH 3T3 
fibroblast cells on differently pre-treated glass surfaces. Cell seeding density: 
575 cells/mm2 (2.3x105 cells/mL); 1 h culturing time. 
  
 In order to verify and correlate the relationship between spacer length 
(distance of the RGD extended out from the immobilized surface) and cell 
adhesion, the height of the cRGDfK onto the glass slide was determined using 
AFM and the images are shown in Figure 7-25. nBSA has a overall dimension 
of (40 x 140) Å [52], after cationization, cBSA coated glass surface showed 
features with average dimension of (50 x 2000) Å, the larger value on the 
lateral axis might attributed to cluster formation of cBSA. cBSA-P1 coated 
surface displayed higher heterogenicity and agglomeration of the protein was 
observed. However, the majority of the coated objects had dimensions of (100 
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x 1500) Å. Although the distance of the RGD attached to the glass surface was 
two times larger than the optimum spacer length reported previously in [12, 
20], excellent focal adhesion of the cells on surface coated with cBSA-P1 
were observed. Furthermore, with increasing spacer length of the grafted 
peptides cBSA-P1, cBSA-P2 to cBSA-P3, no decrease in the number of 
spread cells was observed as shown in Figure 7-24. This result implies that the 
cRGDfK grafted onto cBSA could indeed promote a tight cell binding 
irrespective of the spacer length of the peptide, indicating that in all cases, 
cRGDfK was readily accessible for binding. Since cBSA-P1, cBSA-P2 and 




Figure 7-25. Atomic force microscopy images of (a) blank glass surface (b) 
cBSA coated surface (c) cBSA-P1 coated surface (d) line profile for cBSA 
coated surface, (e) line profile for cBSA-P1 coated surface.  
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7.3.3  Optimization of surface coating  
Peptide P1 was used in different molar ratios from 20 to 50 relative to cBSA 
to achieve derivatives cBSA-P1 with different numbers of cRGDfK peptides 
on the surface. The effect of the density of RGD-groups on the cell adhesion 
was then investigated and the results are shown in Figure 7-26. The number of 
round cells was higher on the surface coated with cBSA-P1 prepared from 20 
equivalent of P1. This indicates that with 20 equivalents, a lower peptide 
density on the surface was obtained and less focal adhesion of cells was found 
within the culturing period. cBSA functionalized with 30 or more equivalent 
of P1 did not yield significant changes regarding to the number of adhered 
cells. Therefore, for the subsequent experiments, cBSA-P1 prepared from 30 




Figure 7-26. Statistical study of the number of spread and round NIH 3T3 
fibroblasts cell on cBSA-P1 (prepared from different equivalent of P1) coated 




 Different concentrations (2-20 μM) of cBSA-P1 prepared from 30 
equivalent of P1 were used to coat the glass slide for the cell adhesion study. 
Figure 7-27 shows the results. With lower concentration of the cBSA-P1, there 
were more round cells observed due to the lower density of the peptide on the 



















Figure 7-27. Statistical study of the spread and round NIH 3T3 fibroblasts cell 
on cBSA-P1 (prepared from 30 eq. of P1) coated glass surfaces; cell seeding 
density: 250 cells/mm2 (1x105 cells/mL), 1 h culturing time. 
  
7.3.4  Proliferation study of NIH 3T3 cells 
Figure 7-28 shows the images of the proliferation of NIH 3T3 cells at different 
time points. The cell adhesion test was done in serum free condition for the 
first 4 h in order to prove that cBSA-P1 coated surface can promote initial cell 
adhesion. It can be seen that the cells spread and formed initial focal adhesion 
after 1 h incubation time. At 4 h, elongation of cells was observed. To further 
prove that the adhered cells are capable to proliferate and grow, the samples 
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were taken out from the incubator and unattached cells were washed off with 
medium, the adhering cells were further culture in DMEM with 10 % fetal 
bovine serum. The growth and proliferation of the adhered cells on surfaces 
coated with cBSA-P1 were clearly observed after 24 and 48 h. This confirms 
that cBSA-P1 indeed is a suitable biomaterial which allows cells to form 




Figure 7-28. Proliferation test for NIH 3T3 fibroblast cells on a cBSA-P1 
coated glass surface at (a) 1 h, (b) 4 h, (c) 24 h, (d) 48 h. Cell seeding density:  
500 cells/mm2 (2x105 cells/mL), scale bar: 50 μm. The insert in (d) shows the 
cells in higher magnification (scale bar: 50 μm). 
 
 
7.4  Conclusions 
cBSA was decorated with different numbers of the cyclic penta-peptide 
RGDfK (f =D-phenylalanine) with varying chain lengths and a set of 
cRGDfK-grafted cBSA proteins: cBSA-P1, cBSA-P2 and cBSA-P3 were 
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achieved. These highly positively charged bioconjugates can be conveniently 
coated on glass surface by simple incubation. The cRGDfK grafted cBSA 
coating can promote cell adhesion to glass surfaces, thus offering a facile, mild, 
time-saving and efficient approach for preparing surfaces for cell adhesion. 
The concept of electrostatic and specific interaction with growing cells 
appears very promising for the future development of cell scaffolds and other 























[1]   E. Zamir, B. Geiger, J. Cell Sci. 2001, 114, 3583-3590. 
[2]  M. P. Lutolf, J. A. Hubbell, Nat. Biotechnol. 2005, 23, 47-55. 
[3]  G. Meisenberg, W. H. Simmons, Principles of Medical Biochemistry 
 (Second Edition) Mosby Elsevier, Philadelphia 2006, p 217-230.  
[4]  E. Rouslahti, M. D. Pierschbacher, Science 1987, 238, 491-497. 
[5] J. W. Smith, D. A. Cheresh, J. Biol. Chem. 1988, 256, 18726-18731. 
[6]  D. R. Phillips, I. F. Charo, L. V. Parise, L. A. Fitzgerald, Blood 1988, 
 71, 831-842. 
[7]  R. O. Hynes, Cell 2002, 110, 673–687. 
[8]   U. Hersel, C. Dahmen, H. Kessler, Biomaterials 2003, 24, 4385-4415. 
[9] R. Zaidel-Bar, C. Ballestrem, Z. Kam, B. Geiger, J. Cell Sci. 2003, 
 116, 4605-4613. 
[10]  J. P. Xiong, T. Stehle, R. Zhang, A. Joachimiak, M. Frech, S.L. 
 Goodman, M.A. Arnaout, Science 2002, 296, 151-155. 
[11]  R. Haubner, R. Gratias, B. Diefenbach, S.L. Goodman, A. Jonczyk, H. 
Kessler, J. Am. Chem. Soc. 1996, 118, 7461-7472. 
[12]  M. Kantlehner, P. Schaffner, D. Finsinger, J. Meyer, A. Jonczyk, B. 
Diefenbach, B. Nies, G. Holzemann, S.L Goodman, H. Kessler, Chem. 
Bio. Chem. 2000, 1, 107-114.  
[13]  M.D. Pierschbacher, E. Ruoslahti, J. Bio. Chem. 1987, 262, 17294-
17298. 
[14] H. Kessler, Angew. Chem. 1982, 21, 512-523. 
[15]  M. Aumailley, M. Gurrath, G. Müller, J. Calvete, R. Timpl, H. Kessler, 
 FEBS  Lett. 1991, 2, 50-54. 
 201 
[16]   U. Staubli, D. Chun, G. Lynch, J. Neurosci. 1998, 18, 3460-3469. 
[17]  E. Lieb, M. Hacker, J. Tessmar, L. A. Kunz-Schughart, J. Fiedler, C. 
 Dahmen, U. Hersel, H. Kessler, M.B. Schulz, A. Göpferich, 
 Biomaterials 2005, 26, 2333-2341. 
[18]   D. S. Hwang, S. B. Sim, H. J. Cha, Biomaterials 2007, 28, 4039-4046. 
[19]  J. Hyun, H. Ma, P. Banerjee, J. Cole, K. Gonsalves, A. Chilkoti, 
 Langmuir 2002, 18, 2975-2979. 
[20]  J. H. Beer, K. T. Springer, B. S. Coller, Blood 1992, 79, 117-128.  
[21] C. M Lo, H. B. Wang, M. Dembo, Y. L. Wang, Biophys. J. 2000, 79, 
 144-152. 
[22]  D. L. Elbert, J. A. Hubbel, Biomacromolecules 2001, 2, 430-441. 
[23]  S. P Massia, J. A. Hubbel, J. Cell Biol. 1991, 114, 1089-1100. 
[24]  V. Marchi-Artzner, B. Lortz, C. Gosse, L. Jullien, R. Markel, H. 
 Kessler, Langmuir 2003, 19, 835-841. 
[25] F. Asphahani, M. Thein, O. Veiseh, D. Edmondson, R. Kosai, M. 
 Veiseh, J. Xu, M. Zhang, Biosens. Bioelectron. 2008, 23, 1307-1313. 
[26]   M. Vert, Makromol. Chem. Makromol. Symp. 1986, 6, 109. 
[27]  D. L. Hay, J. A. von Fraunhofer, N. Chegini, B. J. Masterson, J. 
 Biomed. Mater. Res. 1988, 22, 179. 
[28]   H. J. Jung, K. -D. Ahn, D. K. Han, Macromol. Res. 2005, 13, 446-452. 
[29]  A. Bershadsky, A. Chausovsky, E. Becker, A. Lyubimova, B. Geiger, 
 Curr. Biol. 1996, 6, 1279-1289. 
[30] Y. U. Katagiri, M. Murakami, K. Mori, J. Lizuka, T. Hara, K. Tanaka, 
 W.-Y.  Jia, A. F. Chambers, T. Uede, J. Cell. Biochem. 1996, 62, 123-
 131. 
 202 
[31]  W. J. Grzesikl, B. Ivanov, F. A. Robey, J. Southerlandt, M. Yamauchi, 
 J. Dent. Res. 1998, 77, 1606-1612. 
[32]  D. Delforge, B. Gillon, M. Art, J. Dewelle, M. Raes, J. Remacle, Lett. 
 Pept. Sci. 1998, 5, 87–91. 
[33]  L. Zöphel, K. Eisele, R. Gropeanu, A. Rouhanipour, K. Koynov, I. 
 Lieberwirth, K. Müllen, T. Weil, Macromol. Chem. Phys. 2010, 211, 
 146–153. 
[34] K. Eisele, R. Gropeanu, A. Musante, C. Li, K. Muellen, T. Weil, 
 Macromol Rapid Commun. 2010, 31, 1501–1508. 
[35]  B. D. Ratner, S. J. Bryant, Annu. Rev. Biomed. Eng. 2004, 6, 41-75. 
[36]  J. M Curran, R. Chen, J. A. Hunt, Biomaterials 2005, 26, 7057-7067. 
[37]  J. M. Curran, R. Chen, J. A. Hunt, Biomaterials 2010, 31, 1463-1464. 
[38]  J. T. Wilson, V. R. Krishnamurthy, W. Cui, Z. Qu, E. L. Chaikof,  J. 
 Am. Chem. Soc. 2009, 131, 18228-18229. 
[39]  Y. Lai, C. Xie, Z. Zhang, W. Lu, J. Ding, Biomaterials 2010, 31, 4809-
 4817. 
[40]  M. Cohen, D. Joester, I. Sabanay, L. Addadi, B. Geiger, Soft Matter. 
 2007, 3, 327-332. 
[41]  M. Cohen, E. Klein, B. Geiger, L. Addadi, Biophys. J. 2003, 85, 1996-
 2005. 
[42]  E. Zimmerman, B. Geiger, L. Addadi, Biophys. J. 2002, 82, 1848-1857. 




[44] K. Eisele, R. A. Gropeanu, C. M. Zehendner, A. Rouhanipour, A. 
 Ramanathan, G. Mihov, K. Koynov, C. R. W. Kuhlmann, S. G. 
 Vasudevan, H. J. Luhmann, T. Weil,  Biomaterials 2010, 31, 8789-
 8801. 
[45]  S. Kalinina, H. Gliemann, M. López-García, A. Petershans, J. 
 Auernheimer, T. Schimmel, M. Bruns, A. Schambony, H. Kessler, D. 
 Wedlich, Biomaterials 2008, 29, 3004-3013. 
[46]  K. Barlos, D. Gatos, S. Kapolos, G. Papaphotiu, W. Schäfer, W. Yao, 
Tetrahedron Lett. 1989, 30, 3947-3950. 
[47]  K. Barlos, O. Chatzi, D. Gatos, G. Stavropoulos, Int. J. Pept. Protein 
Res. 1991, 37, 513-520. 
[48]  K. Barlos, D. Gatos, G. Papaphotiu, W. Schäfer, Liebigs Ann. Chem. 
1993, 215-220. 
[49] T. Shiori, TCI MAIL 2007, 134. 
[50]  N. S. Bartfeld, E. B. Pasqualeg, J. E. Geltosky, L. R. Languino, J. Biol. 
Chem. 1993, 268, 17270-17276. 
[51]   R. O. Hynes, Fibronectins, Springer, New York 1989.  
[52]   B. G. Squire, P. Moser, C.T. O’Konski, Biochemistry 1968, 7, 4261. 
 
 204 
Chapter 8  Conclusions 
The work presented in this thesis has demonstrated practical examples for the 
application of catalyst coated micro-reactors in the production of chemicals 
and for the rapid screening of the reaction conditions. The catalyst coated 
micro-reactors demonstrated in this study eliminate common obstacles 
encountered with packed bed reactors such as complex flow patterns and 
increased pressure drop across the reactor.  
The direct formation of hydrogen peroxide from hydrogen and oxygen 
was used to test the reactor concept. Using the wall-coated micro-reactor, the 
reaction could be carried out at atmospheric pressure with reasonable flow rate. 
The immobilization of a palladium catalyst within the micro-reactor by the 
polymer encapsulation (incarceration) approach has been evaluated. The 
crosslinkable polystyrene backbone polymer showed excellent properties for 
the immobilization of the palladium catalyst, which could be produced in the 
form of spherical nano-particles in the range of 2.5 to 3.6 nm depending on the 
metal precursor loading used. We found that 2 wt% palladium loading, which 
produced particles of an average diameter of 3 nm, gave the highest 
productivity in the direct synthesis of hydrogen peroxide from hydrogen and 
oxygen in the capillary micro-reactor. The presence of acid and halogens such 
as bromide ions was found to be essential in order to produce a high yield of 
hydrogen peroxide by suppressing the decomposition and further 
hydrogenation of hydrogen peroxide to water. It is noteworthy that the wall-
coated micro-reactor showed little leaching even in the presence of acidic 
effluent. Furthermore, we have demonstrated that this type of reactor is a 
convenient tool for the rapid screening of various reaction parameters. The 
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stability of the catalyst has been demonstrated with the continuous production 
of hydrogen peroxide for eleven days with a maximum concentration of 1.4 wt 
% of H2O2 corresponding to a turnover frequency of 0.54 molH2O2/h·gPd. With 
this simple but innovative reaction set up, we realized the in-situ generation of 
hydrogen peroxide at atmospheric pressure and room temperature. 
The study was extended from noble metal catalysts to biocatalysts. 
Recombinant E. coli over expressing LbADH was successfully transformed 
and cultured. This biocatalyst is able to catalyze the reduction of several pro-
chiral ketones to (R)-alchohols with high conversion and stereo-selectivity.  
The whole cell biocatalyst approach is particularly promising in bio-reduction 
reactions which involve the cofactor NAD(P)H. The subsequent regeneration 
of the cofactor using a substrate-coupled approach (isopropanol) is highly 
effective and economic. 
 For this thesis, several operational aspects such as the immobilization 
of the biocatalyst have been studied. When the recombinant E. coli cells had 
been immobilized in calcium alginate beads, they showed better stability than 
free cells, particularly with respect to recycle ability. This observation is in 
agreement with previous results which established that the stability of whole 
cell biocatalysts can be enhanced dramatically by immobilization. 
Subsequently, the large scale production of (R)-ethyl hydroxybutyrate from 
ethyl acetoacetate using a packed bed continuous flow reactor was successful 
and a space time yield of 600 gEHB• L-1•day-1 was obtained. This particular 
study has demonstrated that large scale production of fine chemicals using 
immobilized recombinant E. coli is possible. In this transformation, it was 
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found that the biocatalytic process is milder, cleaner and more economic 
compared to the use of a chemical catalyst. 
 Immobilization of the recombinant E. coli within a biofilm on the walls 
of the micro-reactor has been achieved by using cationized bovine serum 
albumin (cBSA) as adhesion promoter. The immobilization of the recombinant 
E. coli cells to the cBSA coated surface is driven by electrostatic forces. We 
have shown in the study that a low concentration of the cBSA (<10 μM) was 
sufficient to cover a glass surface and to promote adsorption of the cells. A 
uniform monolayer of adsorbed E. coli cells was observed on a cBSA coated 
glass surface. We succeeded to affix a high number density of viable 
recombinant E. coli cells to the surface of a capillary using this mild 
immobilization strategy and were able to produce an engineered biofilm 
within the micro-reactor. The reduction of ethyl acetoacetate was tested under 
continuous flow conditions in this micro-reactor, and its long term stability 
was assessed. Our results clearly demonstrate that cBSA is well suited for 
immobilizing recombinant E. coli as biocatalyst since it only marginally 
affects cell viability and cell function. cBSA as a promoter for the 
immobilization of E. coli cells was found to be superior compared to poly-L-
lysine since the cBSA coated surface supported a higher amount of coated 
cells, resulted in better homogeneity of the adsorbed E. coli film and lead to 
higher stability of the resulting micro-reactor. The micro-reactor format is 
particularly well suited for the rapid screening of flow rates and concentrations. 
This study has provided a useful tool for optimization of biocatalytic reactions, 
and the results of this work are a first step towards the integration of 
continuous biotechnology processes for research and production of chemicals. 
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 The potential of cBSA as adhesion promoter was further explored with 
mammalian cells. cBSA is highly cationized due to the high number of amine 
groups on its surfaces. These readily accessible amine groups make the further 
chemical modification of the material possible. Cyclic RGDfK (cRGDfK) 
which is a potent peptide to promote focal adhesion of mammalian cell 
expressing the αvβ3 integrin was grafted on the surface of cBSA via 
isothiocyanate functionalization. This cRGDfK grafted cBSA was coated to a 
glass surface and excellent cell adhesion of NIH 3T3 cells was observed. 
Nearly 75 % of the seeded cells adhered on the cBSA-P1 coated glass slide 
and 95 % of them underwent focal adhesion within 1 h culturing time in serum 
free conditions. In contrast, only round cells were spotted on the control 
surfaces (nBSA, cBSA). We also confirmed that the focal adhesion of the cells 
is RGD-integrin mediated because the spreading of cells was greatly reduced 
when the integrin of the cells were blocked by a dissolved RGD peptide. Very 
important is the fact that the cells were able to proliferate on the cBSA-P1 
coated surfaces. This is a further proof of the biocompatibility of this novel 
biomaterial. This study has provided a very convenient way to prepare 
surfaces which are suitable for the adhesion of mammalian cells. Therefore, 
our results have paved the way toward tailored biocoatings for demanding 







Bibliography (List of Publications and Awards) 
 
Journal papers 
1) Cationized Bovine Serum Albumin with Pendant RGD Groups forms 
 Efficient Biocoatings for Cell Adhesion. 
 J. F. Ng, T. Weil and S. Jaenicke 
 J. Biomed. Mater. Res. B: Appl. Biomater. 2011, Accepted.  
 
2) cBSA-147 for the Preparation of Bacterial Biofilms in a Microchannel 
 Reactor.  
 J. F. Ng, K. Eisele, J. Dorn, T. Weil and S. Jaenicke   
 Biointerphases 2010, 5, FA41-47.  
 
3) A Wall-Coated Catalytic Capillary Microreactor for the Direct 
 Formation of Hydrogen Peroxide 
  J. F. Ng, Y. Nie, G. K. Chuah and S. Jaenicke 
  J. Catal. 2010, 269, 302-308.  
 
4)  Immobilized Whole Cells as Effective Catalysts for  Chiral Alcohol 
  Production. 
  J. F. Ng and S. Jaenicke 






5)  Synergy between Brønsted Acid Sites and Lewis Acid Sites.  
  S. Telalović, J. F. Ng, R. Maheswari, A. Ramanathan, G. K. Chuah and 
  U. Hanefeld 
  Chem. Commun. 2008, 4631–4633. 
 
6)  On the Synergistic Catalytic Properties of Bimetallic Mesoporous 
  Materials Containing Aluminum and Zirconium: The Prins Cyclisation 
  of Citronellal. 
 S. Telalović, A. Ramanathan, J. F. Ng, R. Maheswari, C. Kwakernaak, 
 F. Soulimani, H. C. Brouwer, G. K. Chuah, B. M. Weckhuysen and U. 
 Hanefeld 
 Chem. Eur. J. 2011, 17, 2077-2088. 
 
Conference papers 
1) Engineered Biofilms for Chiral Reduction in a Microchannel Reactor. 
 J.F. Ng, T. Weil and S. Jaenicke 
 (Poster presentation at the 6th Asian-European Symposium on Metal 
 Mediated Efficient Reactions, June 7-9, 2010, Singapore) 
 
2) Engineered Biofilms for Chiral Reduction in a Microchannel Reactor. 
 J. F. Ng, T. Weil and S. Jaenicke 
 (Poster presentation at the 3rd Singapore Catalysis Forum, May 17, 




3) Immobilized Whole Cells as Effective Catalyst for Chiral Alcohol 
 Production. 
 J. F. Ng and S. Jaenicke 
 (Oral presentation at the Singapore International Chemical Conference 
 6 (SICC-6), December 15-18, 2009, Singapore) 
 
4) Synthesis of Chiral Alcohol by Calcium Alginate Immobilized 
 Recombinant Escherichia coli. 
 J. F. Ng and S. Jaenicke 
 (Poster presentation at the 2nd Singapore Catalysis Forum, August 17, 
 2009, Singapore) 
 
5) Synthesis of Chiral Alchohol by Calcium Alginate Immobilized 
 Recombinant Escherichia coli. 
 J. F. Ng and S. Jaenicke 
 (Oral and poster presentation at the 1st Singapore-Hong Kong Bilateral 
 Graduate Student Congress, May 28-30, 2009, Singapore) 
  
6) Polymer Incarcerated Pd nano-particles as Catalyst for the Direct 
 Formation of Hydrogen Peroxide in a Capillary Micro-reactor. . 
 J. F. Ng, Y. Nie, G. K. Chuah and S. Jaenicke 
 (Oral presentation at the 9th Frontier Science Symposium, October 15-




7) Polymer Incarcerated Pd nano-particles as Catalyst for the Direct 
 Formation of Hydrogen Peroxide in a Capillary Micro-reactor.  
 J. F. Ng, Y. Nie, G. K. Chuah and S. Jaenicke 
 (Poster presentation at the 3rd Materials Research Society of Singapore   
 (3rd MRS-S), February 25-27, 2008, Singapore) 
 
8) Polymer Incarcerated Pd nano-particles as Catalyst for the Direct 
 Formation of Hydrogen Peroxide in a Capillary Micro-reactor. 
 J. F. Ng, Y. Nie, G. K. Chuah and S. Jaenicke 
 (Poster presentation at the Singapore International Chemical 
 Conference 5  (SICC-5), December 16-19, 2007, Singapore) 
 
9) Polymer Incarcerated Pd nano-particles as Catalyst for the Direct 
 Formation of Hydrogen Peroxide in a Capillary Micro-reactor. 
 J. F. Ng, Y. Nie, G. K. Chuah and S. Jaenicke 
 (Poster presentation at the International Conference on Material for 
 Advance Technologies (ICMAT 2007), July 1-6, 2007, Singapore) 
 
 
List of Awards 
1) Best poster prize for the 1st Singapore-Hong Kong Bilateral Graduate 
 Student Congress, 2009. 
2) Poster prize (2nd prize) for the 2nd Singapore Catalysis Forum, 2009. 
3) Best poster prize for the 5th Singapore International Chemistry 
 Conference (SICC-5), 2007.  
 212 
